Ingredion (INGR) 10-K22 Feb 222021 FY Annual reportFinancial data

Company Profile

Document and Entity Information

Document and Entity Information - USD ($)	12 Months Ended
Document and Entity Information - USD ($)	Dec. 31, 2021	Feb. 18, 2022	Jun. 30, 2021
Cover [Abstract]
Document Type	10-K
Document Annual Report	true
Document Period End Date	Dec. 31, 2021
Document Transition Report	false
Entity File Number	1-13397
Entity Registrant Name	INGREDION INCORPORATED
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	22-3514823
Entity Address, Address Line One	5 Westbrook Corporate Center
Entity Address, City or Town	Westchester
Entity Address, State or Province	IL
Entity Address, Postal Zip Code	60154
City Area Code	708
Local Phone Number	551-2600
Title of 12(b) Security	Common Stock
Trading Symbol	INGR
Security Exchange Name	NYSE
Entity Well-known Seasoned Issuer	Yes
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
ICFR Auditor Attestation Flag	true
Entity Shell Company	false
Entity Public Float			$ 6,055,000,000
Entity Common Stock, Shares Outstanding		66,714,756
Auditor Name	KPMG LLP
Auditor Location	Chicago, IL
Auditor Firm ID	185
Entity Central Index Key	0001046257
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2021
Document Fiscal Period Focus	FY
Amendment Flag	false

Consolidated Statements of Inco

Consolidated Statements of Income - USD ($) shares in Millions, $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Consolidated Statements of Income
Net sales	$ 6,894	$ 5,987	$ 6,209
Cost of sales	5,563	4,715	4,897
Gross profit	1,331	1,272	1,312
Operating expenses	668	628	610
Other operating (income)	(34)	(31)	(19)
Restructuring/impairment charges and related adjustments	387	93	57
Operating income	310	582	664
Financing costs	74	81	81
Other non-operating (income) expense	(12)	(5)	1
Income before income taxes	248	506	582
Provision for income taxes	123	152	158
Net income	125	354	424
Less: Net income attributable to non-controlling interests	8	6	11
Net income attributable to Ingredion	$ 117	$ 348	$ 413
Weighted average common shares outstanding:
Basic	67.1	67.2	66.9
Diluted	67.8	67.6	67.4
Earnings per common share of Ingredion:
Basic	$ 1.74	$ 5.18	$ 6.17
Diluted	$ 1.73	$ 5.15	$ 6.13

Consolidated Statements of Comp

Consolidated Statements of Comprehensive Income - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Consolidated Statements of Comprehensive Income
Net income	$ 125	$ 354	$ 424
Other comprehensive income:
Gains (losses) on cash flow hedges, net of income tax effect of $58, $2 and $5, respectively	160	3	(14)
(Gains) losses on cash flow hedges reclassified to earnings, net of income tax effect of $55, $17, and $4, respectively	(154)	48	10
Actuarial gains (losses) on pension and other postretirement obligations, settlements and plan amendments, net of income tax effect of $9, $1, and $2, respectively	19	(1)	9
Currency translation adjustment	211	(25)	(9)
Comprehensive income	361	379	420
Less: Comprehensive income attributable to non-controlling interests	9	5	9
Comprehensive income attributable to Ingredion	$ 352	$ 374	$ 411

Consolidated Statements of Co_2

Consolidated Statements of Comprehensive Income (Parenthetical) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Consolidated Statements of Comprehensive Income
Gains (losses) on cash flow hedges, income tax effect	$ (58)	$ (2)	$ 5
(Gains) losses on cash flow hedges reclassified to earnings, net of income tax effect	55	(17)	(4)
Actuarial gains (losses) on pension and other postretirement obligations, settlements and plan amendments, net of income tax effect	$ (9)	$ 1	$ (2)

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
Current assets:
Cash and cash equivalents	$ 328	$ 665
Short-term investments	4
Accounts receivable, net	1,130	1,011
Inventories	1,172	917
Prepaid expenses	63	54
Total current assets	2,697	2,647
Property, plant and equipment, net of accumulated depreciation of $3,232 and $3,175, respectively	2,423	2,455
Intangible assets	1,348	1,346
Other assets	531	410
Total assets	6,999	6,858
Current liabilities:
Short-term borrowings	308	438
Accounts payable	774	599
Accrued liabilities	430	421
Total current liabilities	1,512	1,458
Long-term debt	1,738	1,748
Other non-current liabilities	524	580
Total liabilities	3,774	3,786
Share-based payments subject to redemption	36	30
Redeemable non-controlling interests	71	70
Ingredion stockholders' equity:
Preferred stock - authorized 25,000,000 shares - $0.01 par value, none issued
Common stock - authorized 200,000,000 shares - $0.01 par value, 77,810,875 issued at December 31, 2021 and December 31, 2020	1	1
Additional paid-in capital	1,158	1,150
Less: Treasury stock (common stock: 11,154,203 and 10,795,346 shares at December 31, 2021 and December 31, 2020, respectively) at cost	(1,061)	(1,024)
Accumulated other comprehensive loss	(897)	(1,133)
Retained earnings	3,899	3,957
Total Ingredion stockholders' equity	3,100	2,951
Non-redeemable non-controlling interests	18	21
Total equity	3,118	2,972
Total liabilities and equity	$ 6,999	$ 6,858

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
Consolidated Balance Sheets
Property, plant and equipment, Accumulated depreciation	$ 3,232	$ 3,175
Preferred stock, authorized (in shares)	25,000,000	25,000,000
Preferred stock, par value (in dollars per share)	$ 0.01	$ 0.01
Preferred stock, issued (in shares)	0	0
Common stock, authorized (in shares)	200,000,000	200,000,000
Common stock, par value (in dollars per share)	$ 0.01	$ 0.01
Common stock, issued (in shares)	77,810,875	77,810,875
Treasury stock (in shares)	11,154,203	10,795,346

Consolidated Statements of Equi

Consolidated Statements of Equity - USD ($) $ in Millions	Common Stock	Additional Paid-in Capital	Treasury Stock	Accumulated Other Comprehensive Income (Loss)	Retained Earnings	Noncontrolling Interest	Total
Balance at beginning of period at Dec. 31, 2018	$ 1	$ 1,096	$ (1,091)	$ (1,154)	$ 3,536	$ 20
Increase (Decrease) in Stockholders' Equity
Net income (loss)					413	11
Dividends declared					(169)	(8)
Repurchases of common stock		32	31
Share-based compensation, net of issuance		9	20
Other				(4)		(2)
Balance at end of period at Dec. 31, 2019	1	1,137	(1,040)	(1,158)	3,780	21
Increase (Decrease) in Stockholders' Equity
Net income (loss)					348	10
Dividends declared					(171)	(8)
Share-based compensation, net of issuance		13	16
Other comprehensive income (loss)				25		(1)
Other						(1)
Balance at end of period at Dec. 31, 2020	1	1,150	(1,024)	(1,133)	3,957	21	$ 2,972
Increase (Decrease) in Stockholders' Equity
Net income (loss)					117	11
Dividends declared					(175)	(11)
Repurchases of common stock			(68)
Share-based compensation, net of issuance		8	31
Other comprehensive income (loss)				236		(3)
Balance at end of period at Dec. 31, 2021	$ 1	$ 1,158	$ (1,061)	$ (897)	$ 3,899	$ 18	$ 3,118

Consolidated Statement of Redee

Consolidated Statement of Redeemable Equity $ in Millions	USD ($)
Share-based Payments Subject to Redemption, Beginning Balance at Dec. 31, 2018	$ 37
Increase (Decrease) in Temporary Equity
Share-based compensation, net of issuance	(6)
Share-based Payments Subject to Redemption, Ending Balance at Dec. 31, 2019	31
Increase (Decrease) in Temporary Equity
Share-based compensation, net of issuance	(1)
Share-based Payments Subject to Redemption, Ending Balance at Dec. 31, 2020	30
Increase (Decrease) in Temporary Equity
Net income (loss) attributable to non-controlling interests	(4)
Acquisition of redeemable non-controlling interests	74
Redeemable Non-Controlling Interests, Ending Balance at Dec. 31, 2020	70
Increase (Decrease) in Temporary Equity
Share-based compensation, net of issuance	6
Share-based Payments Subject to Redemption, Ending Balance at Dec. 31, 2021	36
Increase (Decrease) in Temporary Equity
Net income (loss) attributable to non-controlling interests	(3)
Other comprehensive income (loss)	4
Redeemable Non-Controlling Interests, Ending Balance at Dec. 31, 2021	$ 71

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Cash provided by operating activities
Net income	$ 125	$ 354	$ 424
Non-cash charges to net income:
Depreciation and amortization	220	213	220
Mechanical stores expense	55	54	57
Impairment on disposition of assets	340
Deferred income taxes	(61)	(7)	3
Other non-cash charges	8	105	33
Changes in working capital:
Accounts receivable and prepaid expenses	(162)	(3)	(61)
Inventories	(312)	(14)	(43)
Accounts payable and accrued liabilities	226	124	51
Margin accounts	(32)	43	(1)
Other	(15)	(40)	(3)
Cash provided by operating activities	392	829	680
Cash used for investing activities
Capital expenditures and mechanical stores purchases	(300)	(340)	(328)
Proceeds from disposal of manufacturing facilities and properties	18	7	2
Payments for acquisitions, net of cash acquired	(40)	(236)	(42)
Other	(13)	(2)	(6)
Cash used for investing activities	(335)	(571)	(374)
Cash (used for) provided by financing activities
Proceeds from borrowings	1,300	1,550	1,209
Payments on debt	(1,690)	(1,224)	(1,465)
Debt issuance cost		(9)
Commercial paper borrowings, net	250
(Repurchases) issuances of common stock, net	(49)	4	66
Dividends paid, including to non-controlling interests	(184)	(178)	(174)
Cash (used for) provided by financing activities	(373)	143	(364)
Effects of foreign exchange rate changes on cash	(21)		(5)
(Decrease) increase in cash and cash equivalents	(337)	401	(63)
Cash and cash equivalents, beginning of period	665	264	327
Cash and cash equivalents, end of period	$ 328	$ 665	$ 264

Description of the Business and

Description of the Business and Summary of Significant Accounting Policies	12 Months Ended
	Dec. 31, 2021
Description of the Business and Summary of Significant Accounting Policies
Description of the Business and Summary of Significant Accounting Policies	NOTE 1 – Description of the Business and Summary of Significant Accounting Policies Description of the Business Basis of presentation The preparation of the accompanying Consolidated Financial Statements in conformity with U.S. Generally Accepted Accounting Principles (“GAAP”) requires management to make estimates and assumptions about future events. These estimates and the underlying assumptions affect the amounts of assets and liabilities reported, disclosures about contingent assets and liabilities, and reported amounts of revenues and expenses. Such estimates include the value of purchase consideration, valuation of accounts receivable, inventories, certain investments, goodwill, intangible assets and other long-lived assets, legal contingencies and assumptions used in the calculation of income taxes and pension and other postretirement benefits, among others. These estimates and assumptions are based on our best estimates and judgment. We evaluate our estimates and assumptions on an ongoing basis using historical experience and other factors, including the current economic environment, which we believe to be reasonable under the circumstances. We will adjust such estimates and assumptions when facts and circumstances dictate. Foreign currency devaluations versus the U.S. dollar, corn price volatility, access to credit markets and adverse changes in the global economic environment have combined to increase the uncertainty inherent in such estimates and assumptions. As future events and their effects cannot be determined with precision, actual results could differ significantly from these estimates. Changes in these estimates will be reflected in the financial statements in future periods. Assets and liabilities of foreign subsidiaries, other than those whose functional currency is the U.S. dollar, are translated at current exchange rates with the related translation adjustments reported in equity as a component of accumulated other comprehensive loss (“AOCL”) and income statement accounts are translated at the average exchange rate during the period. However, significant non-recurring items related to specific events are recognized at the exchange rate on the date of each significant event. The U.S. dollar is the functional currency for Ingredion’s subsidiaries in Mexico and Argentina. If the U.S. dollar is the functional currency, we translate the subsidiary’s monetary assets and liabilities at current exchange rates with the related adjustment included in net income and non-monetary assets and liabilities at historical exchange rates with the related translation adjustments included in AOCL. Net Sales: Ingredion identifies customer purchase orders, which in some cases are governed by a master sales agreement, as the contracts with its customers. For each contract, Ingredion considers the transfer of products, each of which is distinct, to be the identified performance obligation. In determining the transaction price for the performance obligation, Ingredion evaluates whether the price is subject to adjustment to determine the consideration to which Ingredion expects to be entitled. The pricing model can be fixed or variable within the contract. The variable pricing model is based on historical commodity pricing and is determinable prior to completion of the performance obligation. Additionally, Ingredion has certain sales adjustments for volume incentive discounts and other discount arrangements that reduce the transaction price. The reduction of transaction price is estimated using the expected value method based on an analysis of historical volume incentives or discounts, over a period of time considered adequate to account for current pricing and business trends. Historically, actual volume incentives and discounts relative to those estimated and included when determining the transaction price have not materially differed. Volume incentives and discounts are accrued at the satisfaction of the performance obligation and accounted for in Accounts payable and Accrued liabilities in the Consolidated Balance Sheets. The product price as specified in the contract, net of any discounts, is considered the standalone selling price as it is an observable input that represents the price if we sold the product to a similar customer in similar circumstances. Payment is received shortly after the performance obligation is satisfied and thus, we do not recognize any significant financing components. Revenue is recognized when Ingredion’s performance obligation is satisfied and control is transferred to the customer, which occurs at a point in time, either upon delivery to an agreed upon location or to the customer. Further, in determining whether control has transferred, Ingredion considers if there is a present right to payment and legal title, along with risks and rewards of ownership having transferred to the customer. Shipping and handling activities related to contracts with customers represent fulfillment costs and are recorded in Cost of sales in the Consolidated Statements of Income. Taxes assessed by governmental authorities and collected from customers are accounted for on a net basis and excluded from net sales. We expense costs to obtain a contract when we incur the costs since most contracts are one year or less. These costs primarily include Ingredion’s internal sales force compensation. Under the terms of these programs, the compensation is generally earned, and the costs are recognized when we recognize the revenue. From time to time, Ingredion may enter into long-term contracts with its customers. Historically, the contracts entered into by Ingredion do not result in significant contract assets or liabilities. Any such arrangements are accounted for in Other assets or Accrued liabilities in the Consolidated Balance Sheets. Cash and cash equivalents: Accounts receivable Inventories: Long-term investments: Equity investments in companies for which Ingredion does not have the ability to exercise significant influence are accounted for at fair value, with changes in fair value recorded in Other non-operating (income) expense in the Consolidated Statements of Income. Equity securities without readily determinable fair values are carried at cost, less impairments, if any, and adjusted for observable price changes for the identical or a similar investment of the same issuer. We perform a qualitative impairment assessment to determine if such investments are impaired. The qualitative assessment considers all available information, including declines in the financial performance of the issuing entity, the issuing entity’s operating environment and general market conditions. Impairments of equity securities without readily determinable fair value are recorded in Other non-operating (income) expense in the Consolidated Statements of Income. Equity investments in companies for which Ingredion has the ability to exercise significant influence, but not control, are accounted for using the equity method of accounting. Ingredion’s share of the earnings or losses as reported by equity method investees, are recognized in Other operating (income) in the Consolidated Statements of Income. Each reporting period, Ingredion evaluates declines in the fair value of equity method investments below carrying value to determine if they are other-than-temporary and if so, Ingredion writes down the investment to its estimated fair value. Impairments are recognized in Restructuring/impairment charges and related adjustments in the Consolidated Statements of Income. Leases: over the lease term. As most of Ingredion’s leases do not provide an implicit rate, Ingredion uses an incremental borrowing rate based on the information available at the commencement date in determining the present value of lease payments. The lease asset value includes in our calculation any prepaid lease payments made and any lease incentives received from the arrangement as a reduction of the asset. Ingredion’s lease terms may include options to extend or terminate the lease and the impact of these options are included in the lease liability and lease asset calculations when the exercise of the option is at Ingredion’s sole discretion and it is reasonably certain that we will exercise that option. Ingredion will not separate lease and non-lease components for its leases when it is impracticable to separate them, such as leases with variable payment arrangements. Leases with an initial term of 12 months or less are not recorded on the Consolidated Balance Sheets. Ingredion has operating leases for certain rail cars, office space, warehouses and machinery and equipment. The commencement date used for the calculation of the lease obligations recorded is the latter of January 1, 2019 or the lease start date. Certain leases have options to extend the life of the lease, which are included in the liability calculation when the option is at the sole discretion of Ingredion and it is reasonably certain that Ingredion will exercise the option. Ingredion has certain leases that have variable payments based solely on output or usage of the leased asset. These variable operating lease assets are excluded from Ingredion’s Consolidated Balance Sheets presentation and expensed as incurred. Lease expense is recognized on a straight-line basis over the lease term. Property, plant and equipment and definite-lived intangible assets: two two Indefinite-lived intangible assets and Goodwill In testing indefinite-lived intangible assets for impairment, Ingredion first assesses qualitative factors to determine whether it is more-likely-than-not that the fair value of an indefinite-lived intangible asset is impaired. After assessing the qualitative factors, if Ingredion determines that it is more-likely-than-not that the fair value of an indefinite-lived intangible asset is greater than its carrying amount, then we are not required to compute the fair value of the indefinite-lived intangible asset. If the qualitative assessment leads Ingredion to conclude otherwise, then we are required to determine the fair value of the indefinite-lived intangible assets and perform a quantitative impairment test. In performing the qualitative analysis, Ingredion considers various factors including net sales derived from these intangibles and certain market and industry conditions. Based on the results of the annual assessment, Ingredion concluded that as of July 1, 2021, there were no impairments in our indefinite-lived intangible assets. In testing goodwill for impairment, Ingredion first assesses qualitative factors in determining whether it is more-likely-than-not that the fair value of a reporting unit is less than its carrying amount. After assessing the qualitative factors, if Ingredion determines that it is more-likely-than-not that the fair value of a reporting unit is greater than its carrying amount, then Ingredion does not perform an impairment test. If Ingredion concludes otherwise, then Ingredion performs an impairment test that compares the fair value of the reporting unit to its carrying value. If the fair value of the reporting unit exceeds the carrying value of its net assets, goodwill is not considered impaired, and no further testing is required. If the carrying value of the net assets exceeds the fair value of the reporting unit, then an impairment exists for the difference between the fair value and carrying value of the reporting unit. This difference is not to exceed the goodwill recorded at the reporting unit. Based on the results of the annual assessment, Ingredion concluded that as of July 1, 2021, there were no impairments in our reporting units. Hedging instruments: When Ingredion enters a derivative contract, we designate the derivative as a hedge of variable cash flows to be paid related to certain forecasted transactions (“a cash flow hedge”), as a hedge of the fair value of certain firm commitments (“a fair value hedge”), or as a non-designated hedging instrument. This process includes linking all derivatives that are designated as cash flow or fair value hedges to specific assets and liabilities on the Consolidated Balance Sheets, or to specific firm commitments or forecasted transactions. For all hedging relationships, Ingredion documents the hedging relationships and its risk-management objective and strategy for undertaking the hedge transactions, the hedging instrument, the hedged item, the nature of the risk being hedged, how the hedging instrument’s effectiveness in offsetting the hedged risk will be assessed and a description of the method of measuring ineffectiveness. Ingredion also formally assesses both, at the hedge’s inception and on an ongoing basis, whether the derivatives that are used in hedging transactions are highly effective in offsetting changes in cash flows or fair values of hedged items. Unrealized gains and losses associated with marking cash flow hedging contracts to market (fair value) are recorded as a component of other comprehensive loss (“OCL”). Ingredion discontinues hedge accounting prospectively when it is unlikely that a forecasted transaction will occur or when we determine that the designation of the derivative as a hedging instrument is no longer appropriate since the derivative is no longer effective in offsetting changes in the cash flows or fair value of the originally intended hedged transaction. When hedge accounting is discontinued, Ingredion continues to carry the derivative on the Consolidated Balance Sheets at its fair value and any accumulated gains and losses that were included in AOCL in the period a hedge was determined to be ineffective, as well as future gains and losses of the derivative, are recognized in earnings in the same line item affected by the originally intended hedged transaction. Pension and other postemployment benefits For defined benefit plans, the service cost component of net periodic benefit cost is presented within either Cost of sales or operating expenses on the Consolidated Statements of Income. The interest cost, expected return on plan assets, amortization of actuarial loss, amortization of prior service credit and settlement loss components of net periodic benefit cost are presented as Other non-operating (income) expense on the Consolidated Statements of Income. Actuarial gains and losses in excess of 10 percent of the greater of the projected benefit obligation or the market-related value of plan assets are classified in AOCL, along with the related tax impact, and recognized as a component of net periodic benefit cost over the average remaining service period of a plan’s active employees for active defined benefit pension plans and over the average remaining life of a plan’s active employees for frozen defined benefit pension plans. Share-based compensation: Earnings per common share: Risks and uncertainties: New Accounting Standards Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting

Acquisitions

Acquisitions	12 Months Ended
Acquisitions	Dec. 31, 2021
Acquisitions
Acquisitions	NOTE 2 – Acquisitions On April 1, 2021, Ingredion acquired KaTech, a privately held company headquartered in Germany. KaTech provides advanced texture and stabilization solutions to the food and beverage industry. To complete the closing, Ingredion made a total cash payment of $40 million, net of cash acquired, which we funded from cash on hand. The acquisition added $26 million of goodwill and intangible assets, as well as $14 million of tangible assets, which we preliminarily recorded on the acquisition date based on available information and incorporating our best estimates. Beginning at the acquisition date, our Consolidated Financial Statements reflect the effects of the acquisition and KaTech’s financial results, which we report on a one-month lag in our Europe, Middle East and Africa (“EMEA”) reportable business segment. On November 3, 2020, Ingredion acquired 80 percent of the outstanding shares of Verdient Foods, Inc. (“Verdient”), as well as land and buildings Verdient leased from a third party. Verdient is a Canada-based producer of pulse-based protein concentrates and flours from peas, lentils and fava beans for human food applications. To complete the closing, Ingredion made a total cash payment of CAD $33 million (USD $26 million), which we funded from cash on hand. Before the acquisition, Ingredion owned 20 percent of Verdient’s outstanding shares, which we had reported as an equity method investment until we acquired the remaining shares. The acquisition of Verdient added $15 million of goodwill and $14 million of tangible assets assumed on the acquisition date of November 3, 2020. Beginning on that date, the financial results of Verdient are wholly consolidated into our North America business segment in our Consolidated Financial Statements. On July 1, 2020, Ingredion acquired a 75 percent controlling interest in PureCircle Limited (“PureCircle”), which is one of the leading producers and innovators of plant-based stevia sweeteners for global food and beverage industries. To complete the closing, Ingredion made a total cash payment of $208 million, net of $14 million of cash acquired, which we funded from cash on hand. Beginning at the acquisition date, we wholly consolidate PureCircle’s financial statements into our Asia-Pacific business segment in our Consolidated Financial Statements and net income attributable to non-controlling interests that is deducted from our net income is the portion of net income attributable to the remaining 25 percent portion of PureCircle owned by non-controlling shareholders. The following table summarizes the final purchase price allocations for the fair value of the PureCircle net assets at the date of acquisition, which included non-redeemable non-controlling interests for the non-controlling shareholders: (in millions) PureCircle Working capital (excluding cash) $ 68 Property, plant and equipment 91 Other, net (33) Identifiable intangible assets 68 Goodwill 88 Total fair value, net of cash 282 Less: Non-redeemable non-controlling interests 74 Total purchase price, net of cash $ 208 The PureCircle acquisition’s identifiable intangible assets include customer relationships, tradenames and proprietary technology. The fair values of these intangible assets under the fair value hierarchy were determined to be Level 3, which include unobservable inputs to determine the fair value of an asset or liability. Unobservable inputs are used to measure fair value to the extent that observable inputs are not available, thereby allowing for fair value estimates to be made in situations in which there is little, if any, market activity for an asset or liability at the measurement date. For more information on the fair value hierarchy, see Note 7. The following table presents the fair values, valuation techniques and estimated remaining useful lives for PureCircle’s identifiable assets at the acquisition date for these Level 3 measurements (dollars in millions): Estimated Intangible Asset Fair Value Valuation Technique Useful Life Proprietary technology $ 32 Relief-from-royalty method 12 years Tradenames 18 Relief-from-royalty method 15 years Customer relationships 18 Multi-period excess earnings method 12 years The fair values of proprietary technology, tradenames and customer relationships were determined through the valuation techniques described above using various judgmental assumptions such as discount rates, royalty rates and customer attrition rates, as applicable. The fair values of property, plant and equipment associated with the acquisitions were determined to be Level 3 under the fair value hierarchy. Property, plant and equipment values were estimated using either the cost or market approach. On March 1, 2019, Ingredion completed its acquisition of Western Polymer LLC (“Western Polymer”), a U.S.-based producer of native and modified potato starches for industrial and food applications for $42 million, net of cash acquired. Beginning on the acquisition date, our Consolidated Financial Statements reflect the effects of the acquisition and Western Polymer’s financial results in our North America reportable business segment. Pro-forma results of operation for any of the foregoing acquisitions have not been presented as the effect of each acquisition individually and in the aggregate with other acquisitions would not be material to Ingredion’s results of operations for any periods presented. Ingredion incurred $5 million, $11 million and $3 million of pre-tax acquisition and integration costs in 2021, 2020 and 2019, respectively, associated with our acquisitions.

Intangible Assets

Intangible Assets	12 Months Ended
Intangible Assets	Dec. 31, 2021
Intangible Assets
Intangible Assets	NOTE 3 – Intangible Assets Goodwill The original carrying value of goodwill and accumulated impairment charges by reportable business segment at December 31, 2021, was as follows: North South Asia- (in millions) America America Pacific EMEA Total Goodwill before impairment charges $ 622 $ 50 $ 316 $ 69 $ 1,057 Accumulated impairment charges (1) (33) (121) — (155) Balance at January 1, 2021 621 17 195 69 902 Acquisitions 2 — 6 9 17 Currency translation — (2) 1 (4) (5) Balance at December 31, 2021 $ 623 $ 15 $ 202 $ 74 $ 914 Based on the results of our impairment assessments, we concluded that as of July 1, 2021, there were no impairments to goodwill. Other Intangible Assets The following tables summarizes Ingredion’s other intangible assets as of December 31, 2021 and 2020: 2021 (in millions) Gross Accumulated Amortization Net Weighted Average Useful Life (years) Trademarks/tradenames (indefinite-lived) $ 143 $ — $ 143 — Patents 33 (4) 29 12 Customer relationships 365 (134) 231 19 Technology 103 (101) 2 9 Other 43 (14) 29 15 Total other intangible assets $ 687 $ (253) $ 434 17 2020 (in millions) Gross Accumulated Amortization Net Weighted Average Useful Life (years) Trademarks/tradenames (indefinite-lived) $ 143 $ — $ 143 — Patents 33 (2) 31 12 Customer relationships 356 (115) 241 20 Technology 103 (101) 2 9 Other 38 (11) 27 19 Total other intangible assets $ 673 $ (229) $ 444 17 Amortization expense related to intangible assets was $27 million, $30 million and $29 million for 2021, 2020 and 2019, respectively. Based on the results of our impairment assessments, we concluded that as of July 1, 2021, there were no impairments to our indefinite-lived other intangible assets. Based on acquisitions completed through 2021, intangible asset amortization expense for the next five years is shown below: (in millions) Year Amortization Expense 2022 $ 27 2023 26 2024 26 2025 26 2026 25

Investments

Investments	12 Months Ended
Investments	Dec. 31, 2021
Investments
Investments	NOTE 4 – Investments Investments consisted of the following as of December 31, 2021 and 2020: (in millions) 2021 2020 Equity investments $ 16 $ 8 Equity method investments 104 10 Marketable securities 12 11 Total investments $ 132 $ 29 Amyris Joint Venture On June 1, 2021, Ingredion entered into an agreement with Amyris, Inc. (“Amyris”) for certain exclusive commercialization rights to Amyris’ rebaudioside M by fermentation product, the exclusive licensing of the product’s manufacturing technology and a 31 percent ownership stake in a joint venture for the products (the “Amyris joint venture”). In exchange, we contributed $28 million of total consideration, which included $10 million of cash, as well as non-exclusive intellectual property licenses and other consideration valued at $18 million. The transaction resulted in an $8 million gain recorded in Other operating (income), which included $18 million related to the non-exclusive intellectual property licenses, offset by the $10 million cash payment. Beginning June 1, 2021, Ingredion accounts for the investment under the equity method. Arcor Joint Venture On February 12, 2021, Ingredion entered into an agreement with an affiliate of Grupo Arcor, an Argentine food company, to establish Ingrear Holding S.A. (the “Arcor joint venture”), a joint venture to operate five manufacturing facilities in Argentina to sell value-added ingredients to customers in the food, beverage, pharmaceutical and other industries in Argentina, Chile and Uruguay. On August 2, 2021, Ingredion and Grupo Arcor completed all closing conditions to combine the manufacturing facilities, finalize the transaction and formally establish the Arcor joint venture, which is managed by a jointly appointed team of executives and is accounted for under the equity method. We exchanged certain assets and liabilities with a fair value of $71 million from our Argentina, Chile and Uruguay operations for 49 percent of the outstanding shares of the Arcor joint venture valued at $64 million, as well as $7 million of other consideration, including cash, from Grupo Arcor as of August 2, 2021. The transaction also resulted in an impairment charge for the transferred assets and liabilities more fully described in Note 5. Beginning on the dates Ingredion entered into the agreements for equity method investees, our share of income from them is included in Other operating (income). Ingredion incurred $6 million of pre-tax transaction and integration costs to acquire the Arcor and Amyris joint venture investments in 2021.

Restructuring and Impairment Ch

Restructuring and Impairment Charges	12 Months Ended
Restructuring and Impairment Charges	Dec. 31, 2021
Restructuring and Impairment Charges
Restructuring and Impairment Charges	NOTE 5 – Restructuring and Impairment Charges During 2021, Ingredion recorded $387 million of net pre-tax restructuring and impairment charges. Ingredion recorded a pre-tax impairment charge of $340 million related to the net assets we contributed to the Arcor joint venture and pre-tax restructuring charges of $44 million primarily related to Ingredion’s Cost Smart program. During 2020 Ingredion recorded a total of $93 million of pre-tax restructuring and impairment charges, including $48 million of pre-tax restructuring costs and $45 million of pre-tax impairment charges. During 2019 Ingredion recorded $57 million of pre-tax restructuring charges related to Ingredion’s Cost Smart program. Impairment Charges At the announcement of our agreement to invest in the Arcor joint venture in the first quarter of 2021, we reclassified assets and liabilities we expected to contribute to the joint venture as held for sale in Other assets in the Consolidated Balance Sheets and we recorded an impairment charge of $360 million based on our preliminary estimates of their fair value. Upon completion of the transaction in the third quarter of 2021, Ingredion finalized the fair value of the held for sale assets and liabilities, which resulted in a $20 million favorable adjustment to the impairment charge in the quarter. Of the final $340 million impairment charge for the net assets contributed to the Arcor joint venture in 2021, $311 million was related to the write-off of the cumulative translation losses associated with the contributed net assets and $29 million was related to the final write-down of the contributed net assets to fair value. During 2020 Ingredion recorded a $35 million impairment charge for its indefinite-lived intangible asset associated with the TIC Gums tradename due to our decision to change our marketing strategy related to the brand. Additionally, we recorded a $10 million other-than-temporary impairment of our equity method investment in Verdient when we agreed to acquire the remaining 80 percent interest in Verdient. Restructuring Charges During 2021 Ingredion recorded $47 million of pre-tax net restructuring related charges. Ingredion recorded pre-tax net restructuring charges of $27 million as part of our Cost Smart Cost of sales program, which primarily consisted of accelerated depreciation and other costs recorded in our North America segment. We also recorded $17 million of employee-related and other costs associated with our Cost Smart selling, general and administrative expense (“SG&A”) program, consisting of professional services and employee-related severance costs primarily in our North America and EMEA segments. During 2020 Ingredion recorded a total of $48 million of pre-tax restructuring related charges. Ingredion recorded pre-tax restructuring charges of $25 million for our Cost Smart SG&A program, which were primarily for employee-related severance costs recorded in our North America and EMEA segments, professional services costs in our North America segment and other costs. We also recorded $23 million of pre-tax restructuring charges for our Cost Smart Cost of sales program, which were primarily for inventory and mechanical stores write-offs and other costs associated with the closure of our Lane Cove, Australia production facility and closures of North America facilities and product lines including our Berwick, Pennsylvania manufacturing facility and the cessation of ethanol production at our Cedar Rapids, Iowa facility. During 2019 Ingredion recorded a total of $57 million of pre-tax restructuring charges. We recorded $29 million of pre-tax restructuring charges for our Cost Smart Cost of sales program, which were primarily for accelerated depreciation and employee-related severance associated with the closure of our Lane Cove, Australia production facility and professional services and other costs primarily in North America. Pre-tax restructuring charges of $28 million were recorded for the Cost Smart SG&A program, which were primarily professional services and employee-related severance costs recorded in our North America and South America segments. The Cost Smart Cost of sales and Cost Smart SG&A programs began in 2018, during which we incurred $49 million of costs as part of the Cost Smart cost of sales program and $11 million of costs as part of the Cost Smart SG&A program. A summary of Ingredion’s severance accrual at December 31, 2021, which we expect to fully pay in 2022, is as follows ($ in millions): Balance in severance accrual as of December 31, 2020 $ 12 Joint venture related 1 Cost Smart 1 Payments made to terminated employees (11) Balance in severance accrual as of December 31, 2021 $ 3

Derivatives Instruments and Hed

Derivatives Instruments and Hedging Activities	12 Months Ended
Derivatives Instruments and Hedging Activities	Dec. 31, 2021
Derivatives Instruments and Hedging Activities
Derivatives Instruments and Hedging Activities	NOTE 6 – Derivative Instruments and Hedging Activities Ingredion is exposed to market risk stemming from changes in commodity prices (primarily corn and natural gas), foreign currency exchange rates and interest rates. In the normal course of business, we actively manage our exposure to these market risks by entering various hedging transactions authorized under established policies that place controls on these activities. These transactions utilize exchange-traded derivatives or over-the-counter derivatives with investment grade counterparties. We have no collateral to counterparties under collateral funding arrangements as of December 31, 2021. Derivative financial instruments used by Ingredion consist of commodity-related futures, options and swap contracts, foreign currency-related forward contracts, interest rate swaps and treasury locks (“T-Locks”). Commodity price hedging generally over the next 12 to 24 months. Ingredion maintains a commodity-price risk management strategy that uses derivative instruments to minimize significant, unanticipated earnings fluctuations caused by commodity-price volatility. To manage price risk related to corn purchases primarily in North America, Ingredion uses corn futures and option contracts that trade on regulated commodity exchanges to lock in corn costs associated with fixed-priced customer sales contracts. Ingredion also uses over-the-counter natural gas swaps in North America to hedge a portion of its natural gas usage. These derivative financial instruments limit the impact that volatility resulting from fluctuations in market prices will have on corn and natural gas purchases. Ingredion’s natural gas derivatives and the majority of its corn derivatives have been designated as cash flow hedging instruments. For certain corn derivative instruments that are not designated as hedging instruments for accounting purposes, all realized and unrealized gains and losses from these instruments are recognized in Cost of sales during each accounting period. We enter these derivative instruments to further mitigate commodity price risk related to anticipated purchases of corn. For commodity hedges designated as cash flow hedges, unrealized gains and losses associated with marking the commodity hedging contracts to market (fair value) are recorded as a component of OCL and included in the equity section of the Consolidated Balance Sheets as part of AOCL. These amounts, as well as their related tax effects, are subsequently reclassified into earnings in the same line item affected by the hedged transaction and in the same period or periods during which the hedged transaction affects earnings, or in the period a hedge is determined to be ineffective. Ingredion assesses the effectiveness of a commodity hedge contract based on changes in the contract’s fair value. The changes in the market value of such contracts have historically been, and are expected to continue to be, highly effective at offsetting changes in the price of the hedged items. Gains and losses from cash flow hedging instruments reclassified from AOCL to earnings are reported as Cash provided by operating activities on the Consolidated Statements of Cash Flows. Ingredion had outstanding futures and option contracts that hedged the forecasted purchase of approximately 135 million and 95 million bushels of corn as of December 31, 2021 and 2020, respectively. Ingredion also had outstanding swap contracts that hedged the forecasted purchase of approximately 35 million and 33 million mmbtus of natural gas as of December 31, 2021 and 2020, respectively. Foreign currency hedging Ingredion hedges certain assets using foreign currency derivatives not designated as hedging instruments, which had a notional value of $360 million and $410 million as of December 31, 2021 and 2020, respectively. Ingredion also hedges certain liabilities using foreign currency derivatives not designated as hedging instruments, which had a notional value of $205 million and $224 million as of December 31, 2021 and 2020, respectively. Ingredion hedges certain assets using foreign currency cash flow hedging instruments, which had a notional value of $505 million and $401 million as of December 31, 2021 and 2020, respectively. Ingredion also hedges certain liability positions using foreign currency cash flow hedging instruments, which had a notional value of $708 million and $542 million as of December 31, 2021 and 2020, respectively. Interest rate hedging Ingredion periodically enters into interest rate swaps to hedge its exposure to interest rate changes. The changes in fair value of interest rate swaps designated as hedging instruments that effectively offset the variability in the fair value of outstanding debt obligations are reported in earnings. These amounts offset the gains or losses (the changes in fair value) of the hedged debt instruments that are attributable to changes in interest rates (the hedged risk), which are also recognized in earnings. During 2020 Ingredion settled an outstanding interest rate swap agreement that converted the interest rates on $200 million of its $400 million 4.625 percent senior notes due November 1, 2020, to variable rates. Ingredion redeemed these notes in July 2020 and settled the outstanding interest rate swap. Ingredion did not have any outstanding interest rate swaps as of December 31, 2021 or December 31, 2020. Ingredion periodically enters into T-Locks to hedge its exposure to interest rate changes. The T-Locks are designated as hedges of the variability in cash flows associated with future interest payments caused by market fluctuations in the benchmark interest rate until the fixed interest rate is established and are accounted for as cash flow hedges. Accordingly, changes in the fair value of the T-Locks are recorded to AOCL until the consummation of the underlying debt offering, at which time any realized gain (loss) is amortized to earnings over the life of the debt. During 2020, Ingredion entered into and settled T-Locks associated with the issuance of senior notes due in 2030 and 2050. The realized loss upon settlement of the T-Locks was recorded in AOCL and is amortized into earnings over the term of the senior notes. Ingredion did not have outstanding T-Locks as of December 31, 2021 and December 31, 2020. The derivative instruments designated as cash flow hedges included in AOCL as of December 31, 2021 and 2020, are reflected below: Derivatives in Cash Flow Hedging Relationships Gains (Losses) included in AOCL as of December 31, (in millions) 2021 2020 Commodity contracts, net of income tax effect of $19 and $16, respectively $ 51 $ 47 Foreign currency contracts, net of income tax effect of $ — — (1) Interest rate contracts, net of income tax effect of $1 (3) (4) Total $ 48 $ 42 The fair value and balance sheet location of Ingredion’s derivative instruments, presented gross in the Consolidated Balance Sheets, are reflected below: Fair Value of Hedging Instruments as of December 31, 2021 Designated Hedging Instruments (in millions) Non-Designated Hedging Instruments (in millions) Balance Sheet Location Commodity Contracts Foreign Currency Contracts Total Commodity Contracts Foreign Currency Contracts Total Accounts receivable, net $ 45 $ 9 $ 54 $ 4 $ 3 $ 7 Other assets 7 6 13 — — — Assets 52 15 67 4 3 7 Accounts payable and accrued liabilities 5 12 17 2 4 6 Non-current liabilities 2 6 8 — 1 1 Liabilities 7 18 25 2 5 7 Net (Liabilities)/Assets $ 45 $ (3) $ 42 $ 2 $ (2) $ — Fair Value of Hedging Instruments as of December 31, 2020 Designated Hedging Instruments (in millions) Non-Designated Hedging Instruments (in millions) Balance Sheet Location Commodity Contracts Foreign Currency Contracts Total Commodity Contracts Foreign Currency Contracts Total Accounts receivable, net $ 50 $ 7 $ 57 $ 3 $ 4 $ 7 Other assets 4 — 4 — 1 1 Assets 54 7 61 3 5 8 Accounts payable and accrued liabilities 4 12 16 1 8 9 Non-current liabilities 2 — 2 — 2 2 Liabilities 6 12 18 1 10 11 Net (Liabilities)/Assets $ 48 $ (5) $ 43 $ 2 $ (5) $ (3) Additional information relating to Ingredion’s derivative instruments is presented below: Derivatives in Cash Flow Hedging Relationships Gains (Losses) Recognized in OCL on Derivatives Income Statement Gains (Losses) Reclassified from AOCL into Income (in millions) 2021 2020 2019 Location 2021 2020 2019 Commodity contracts $ 218 $ 17 $ (24) Cost of sales $ 211 $ (62) $ (12) Foreign currency contracts — (7) 5 Net sales/Cost of sales (1) (2) — Interest rate contracts — (5) — Financing costs (1) (1) (2) Total $ 218 $ 5 $ (19) $ 209 $ (65) $ (14) Derivatives in Fair Value Hedging Relationships Income Statement Location of Derivatives Designated as Gains (Losses) Recognized in Income Income Statement Location Gains (Losses) Recognized in Income (in millions) Hedging Instruments 2021 2020 2019 of Hedged Items 2021 2020 2019 Interest rate contracts Financing costs $ — $ (1) $ 2 Financing costs $ — $ 1 $ (2) As of December 31, 2021, AOCL included $45 million of net gains (net of income taxes of $16 million) on commodities-related derivative instruments, T-Locks and foreign currency hedges designated as cash flow hedges that are expected to be reclassified into earnings during the next 12 months.

Fair Value Measurements

Fair Value Measurements	12 Months Ended
Fair Value Measurements	Dec. 31, 2021
Fair Value Measurements
Fair Value Measurements	NOTE 7 – Fair Value Measurements We measure certain assets and liabilities at fair value, which is defined as the price that would be received to sell an asset or paid to transfer a liability (i.e., the “exit price”) in an orderly transaction between market participants at the measurement date. In determining fair value, we use various valuation approaches. The hierarchy of those valuation approaches is in three levels based on the reliability of inputs. Assets and liabilities are classified in their entirety based on the lowest level of input that is significant to the fair value measurement. Below is a summary of the hierarchy levels: ● Level 1 inputs consist of quoted prices (unadjusted) in active markets for identical assets or liabilities. ● Level 2 inputs are inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly for substantially the full term of the financial instrument. Level 2 inputs are based on quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, or inputs other than quoted prices that are observable for the asset or liability or can be derived principally from or corroborated by observable market data. ● Level 3 inputs are unobservable inputs for the asset or liability. Unobservable inputs are used to measure fair value to the extent that observable inputs are not available, thereby allowing for situations in which there is little, if any, market activity for the asset or liability at the measurement date. Assets and liabilities measured at fair value on a recurring basis are presented below: As of December 31, 2021 As of December 31, 2020 (in millions) Total Level 1 Level 2 Level 3 Total Level 1 Level 2 Level 3 Available for sale securities $ 12 $ 12 $ — $ — $ 11 $ 11 $ — $ — Derivative assets 74 49 25 — 69 53 16 — Derivative liabilities 32 22 10 — 29 3 26 — Long-term debt 1,957 — 1,957 — 1,751 — 1,751 — The carrying values of cash equivalents, short-term investments, accounts receivable, accounts payable and short-term borrowings approximate fair values. Commodity futures, options and swaps contracts are recognized at fair value. Foreign currency forward contracts, swaps and options are also recognized at fair value. The fair value of Ingredion’s Long-term debt is estimated based on quotations of major securities dealers who are market makers in the securities. See Note 11 for information on the fair value of pension plan assets.

Financing Arrangements

Financing Arrangements	12 Months Ended
Financing Arrangements	Dec. 31, 2021
Financing Arrangements
Financing Arrangements	NOTE 8 – Financing Arrangements Ingredion had total debt outstanding of approximately $2.0 billion and $2.2 billion at December 31, 2021 and 2020, respectively. Short-term borrowings at December 31, 2021, consist primarily of commercial paper borrowings and amounts outstanding under various unsecured local country operating lines of credit. During 2021, Ingredion amended, restated and later repaid in full the $380 million of borrowings outstanding under the term loan credit agreement that was amended and restated on March 16, 2021 (the “Term Loan Credit Agreement”). The Term Loan Credit Agreement restated the previous agreement by extending the maturity date of the borrowings under the previous agreement until March 15, 2022. No new borrowings under the Term Loan Credit Agreement were incurred in connection with the amendment and restatement. Borrowings under the Term Loan Credit Agreement bore interest at a variable annual rate based on a London Interbank Offering Rate (“LIBOR”) or a base rate, at Ingredion’s election, subject to the terms and conditions thereof, plus, in each case, an applicable margin. The Term Loan Credit Agreement reduced the applicable interest rate margin for loans accruing interest based on LIBOR from 0.80 percent to 0.75 percent. Ingredion was required to pay a fee on the unused availability under the Term Loan Credit Agreement. The Term Loan Credit Agreement contained customary representations, warranties, covenants and events of default, including covenants restricting the incurrence of liens, the incurrence of indebtedness by Ingredion’s subsidiaries, and certain fundamental changes involving Ingredion and its subsidiaries, subject to certain exceptions in each case. Ingredion also had to maintain a specified maximum consolidated leverage ratio and a specified minimum consolidated interest coverage ratio. On June 30, 2021, Ingredion entered into a new revolving credit agreement (the “Revolving Credit Agreement”) to replace the previous revolving credit agreement, which was terminated. The Revolving Credit Agreement provides for a five-year unsecured revolving credit facility in an aggregate principal amount of $1 billion outstanding at any time and the facility will mature on June 30, 2026. Loans under the facility will accrue interest at a per annum rate equal, at Ingredion’s option, to either a specified LIBOR plus an applicable margin, or a base rate (generally determined according to the highest of the prime rate, the federal funds rate or the specified LIBOR plus 1.00 percent) plus an applicable margin. The Revolving Credit Agreement contains customary affirmative and negative covenants that, among other matters, specify customary reporting obligations, and that, subject to exceptions, restrict the incurrence of additional indebtedness by Ingredion’s subsidiaries, the incurrence of liens and the consummation of certain mergers, consolidations and sales of assets. Ingredion is subject to compliance, as of the end of each quarter, with a maximum leverage ratio of 3.5 to 1.0 and a minimum ratio of consolidated EBITDA to consolidated net interest expense of 3.5 to 1.0, as each such financial covenant is calculated for the most recently completed four-quarter period. As of December 31, 2021, Ingredion was in compliance with these financial covenants. In addition to borrowing availability under its Revolving Credit Agreement, as of December 31, 2021, Ingredion had approximately $641 million of unused operating lines of credit in the various foreign countries in which it operates. On July 27, 2021, Ingredion established a commercial paper program under which Ingredion may issue senior unsecured notes of short maturities up to a maximum aggregate principal amount of $1 billion outstanding at any time. The notes may be sold from time to time on customary terms in the U.S. commercial paper market. Ingredion intends to use the note proceeds for general corporate purposes. Since the program was established, the average amount of commercial paper outstanding was $670 million with an average interest rate of 0.27 percent and a weighted average maturity of 48 days . As of December 31, 2021, $250 million of commercial paper was outstanding with an average interest rate of 0.35 percent and a weighted average maturity of 40 days . The amount of commercial paper outstanding under this program in 2022 is expected to fluctuate. Presented below are Ingredion’s debt carrying amounts, net of related discounts, premiums and debt issuance costs and fair values as of December 31, 2021 and 2020: 2021 2020 Carrying Fair Carrying Fair (in millions) Value Value Value Value 2.900% senior notes due June 1, 2030 $ 595 $ 619 $ 594 $ 596 3.200% senior notes due October 1, 2026 498 531 497 500 3.900% senior notes due June 1, 2050 390 455 390 395 6.625% senior notes due April 15, 2037 253 350 253 246 Revolving credit agreement — — — — Other long-term borrowings 2 2 14 14 Total long-term debt 1,738 1,957 1,748 1,751 Term loan credit agreement due April 12, 2021 — — 380 380 Commercial paper 250 250 — — Other short-term borrowings 58 58 58 58 Total short-term borrowings 308 308 438 438 Total debt $ 2,046 $ 2,265 $ 2,186 $ 2,189 Ingredion guarantees certain obligations of its consolidated subsidiaries. The amount of the obligations guaranteed aggregated was $61 million and $58 million at December 31, 2021 and 2020, respectively.

Leases

Leases	12 Months Ended
Leases	Dec. 31, 2021
Leases
Leases	NOTE 9 – Leases The components of lease expense for the indicated periods were as follows: (in millions) 2021 2020 2019 Operating lease cost $ 58 $ 58 $ 55 Variable operating lease cost 26 29 24 Short term lease cost 4 4 3 Lease expense $ 88 $ 91 $ 82 Ingredion currently has no finance leases. The following is a reconciliation of future undiscounted cash flows to the operating lease liabilities and the related operating lease assets as presented within Other non-current liabilities and Other assets, respectively, on Ingredion’s Consolidated Balance Sheets as of December 31, 2021 ($ in millions): 2022 $ 52 2023 43 2024 33 2025 24 2026 19 Thereafter 52 Total future lease payments 223 Less imputed interest 22 Present value of future lease payments 201 Less current lease liabilities 47 Non-current operating lease liabilities $ 154 Operating lease assets $ 193 Additional information related to Ingredion’s operating leases is listed below. Year Ended Other Information December 31, ($ in millions) 2021 2020 Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows from operating leases $ 58 $ 60 Right-of-use assets obtained in exchange for lease liabilities: Operating leases $ 77 $ 76 As of As of December 31, 2021 December 31, 2020 Weighted average remaining lease term: Operating leases 6.5 years 5.5 years Weighted average discount rate: Operating leases 4.0 % 4.9 %

Income Taxes

Income Taxes	12 Months Ended
Income Taxes	Dec. 31, 2021
Taxes
Taxes	NOTE 10 – Income Taxes The components of income before income taxes and the provision for income taxes for the years indicated are shown below: (in millions) 2021 2020 2019 Income before income taxes: U.S. $ 39 $ (15) $ 74 Foreign 209 521 508 Total income before income taxes 248 506 582 Provision for income taxes: Current tax (benefit) expense: U.S. federal 2 1 6 State and local 2 2 2 Foreign 180 156 147 Total current tax expense 184 159 155 Deferred tax expense (benefit): U.S. federal (57) (18) (8) State and local (2) (1) — Foreign (2) 12 11 Total deferred tax expense (benefit) (61) (7) 3 Total provision for income taxes $ 123 $ 152 $ 158 Deferred income taxes are provided for the tax effects of temporary differences between the financial reporting basis and tax basis of assets and liabilities. Significant temporary differences as of December 31, 2021 and 2020, are summarized as follows: (in millions) 2021 2020 Deferred tax assets attributable to: Employee benefit accruals $ 28 $ 20 Pensions and postretirement plans 14 21 Lease liabilities 49 44 Bad debt 14 2 Inventory reserve 13 9 Net operating loss carryforwards 64 32 Tax credit carryforwards 18 11 Other 36 43 Total deferred tax assets 236 182 Valuation allowances (67) (30) Net deferred tax assets 169 152 Deferred tax liabilities attributable to: Property, plant and equipment 175 173 Identified intangibles 47 46 Right-of-use lease assets 46 42 Foreign withholding and state taxes on unremitted earnings 1 31 Goodwill 27 20 Brazilian indirect tax credits 5 18 Derivative contracts 19 16 Total deferred tax liabilities 320 346 Net deferred tax liabilities $ 151 $ 194 Of the $64 million of tax-effected net operating loss carryforwards as of December 31, 2021, $5 million and $14 million are for U.S. federal and state loss carryforwards, respectively and $45 million are for foreign loss carryforwards. U.S. federal and state loss carryforwards have various expiration periods starting in 2024. Of the $45 million of foreign loss carryforwards, $17 million are related to Canada, $9 million to Argentina and $8 million to Australia with carryforward periods of 20 years, 5 years and indefinite, respectively. A valuation allowance is established when it is more likely than not that all or a portion of a deferred tax asset will not be realized. Prior to establishing a valuation allowance, we consider historical taxable income, scheduled reversal of deferred tax liabilities, tax planning strategies, tax carryovers and projected future taxable income. As of December 31, 2021, Ingredion maintained valuation allowances of $5 million and $14 million for U.S. federal and state loss carryforwards, respectively and $32 million for foreign loss carryforwards. Ingredion also maintained valuation allowances of $6 million for state credits and carryforwards, $1 million for certain foreign tax credits and $9 million on foreign subsidiaries’ net deferred tax assets including other carryforwards, all of which we have determined will more likely than not expire prior to realization. Net operating loss carryforwards disclosed in the financial statements differ from the as-filed tax returns due to an unrecognized tax benefit. Foreign net operating loss carryforwards and valuation allowances would increase $11 million, absent the unrecognized tax benefit. A reconciliation of the U.S. federal statutory tax rate to Ingredion’s effective tax rate follows: 2021 2020 2019 Provision for tax at U.S. statutory rate 21.0 % 21.0 % 21.0 % Tax rate difference on foreign income 13.3 9.1 6.2 Foreign currency FX 3.2 1.2 (0.2) Inflation adjustments (4.0) (0.8) (0.3) Tax benefit of intercompany financing (1.6) (0.8) (1.2) U.S. international tax implications 0.8 0.6 2.2 Valuation allowance in Argentina (0.4) (0.6) 0.3 Favorable judgment on the treatment of credits and interest on indirect taxes (4.8) (0.6) — Unremitted earnings (12.1) — — Impairment charge related to Accor joint venture 35.5 — — Other items, net (1.3) 0.9 (0.9) Provision at effective tax rate 49.6 % 30.0 % 27.1 % Ingredion has significant operations in Mexico, Pakistan and Colombia, where the 2021 statutory tax rates are 30 percent, 29 percent and 31 percent, respectively. In addition, Ingredion's subsidiary in Brazil has a statutory tax rate of 34 percent before the application of local incentives that vary each year. During 2021 Ingredion Brazil received favorable judgments related to the taxability of interest earned on indirect tax credits (discussed in Note 14) and interest paid on previously recovered tax credits. In addition, Ingredion Brazil recovered income taxes paid on government subsidies. These items resulted in a tax benefit of $12 million or 4.8 percentage points on the effective tax rate for 2021. Ingredion recorded a $340 million impairment charge during 2021 for the net assets contributed to the Arcor joint venture (discussed in Note 5). No tax benefit was recorded for this impairment resulting in a 35.5 percentage point increase in the effective tax rate for 2021. During 2021 Ingredion reversed an accrual for unremitted earnings due to restructuring and recorded a tax benefit of $30 million or 12.1 percentage points on the effective rate. As of December 31, 2021, the remaining balance was a $1 million accrual for foreign withholding on certain unremitted earnings from foreign subsidiaries. No foreign withholding taxes, federal and state taxes or foreign currency gains/losses have been provided on distributions of approximately $2.2 billion of unremitted earnings of Ingredion’s foreign subsidiaries, as such amounts are considered permanently reinvested. It is not practicable to estimate the additional income taxes, including applicable foreign withholding taxes that would be due upon the repatriation of these earnings. A reconciliation of the beginning and ending amounts of unrecognized tax benefits, excluding interest and penalties, for 2021 and 2020 is as follows: (in millions) 2021 2020 Balance at January 1 $ 46 $ 22 Additions for tax positions related to prior years 2 33 Reductions for tax positions related to prior years (9) — Additions based on tax positions related to the current year 2 — Reductions related to a lapse in the statute of limitations (12) (9) Balance at December 31 $ 29 $ 46 Of the $29 million of unrecognized tax benefits as of December 31, 2021, $18 million represents the amount that, if recognized, could affect the effective tax rate in future periods. The remaining $11 million includes an offset for net operating loss carryforwards that would have otherwise had a valuation allowance. Ingredion accounts for interest and penalties related to income tax matters within the provision for income taxes. Ingredion has accrued $3 million of interest expense and penalties related to the unrecognized tax benefits as of December 31, 2021. Ingredion is subject to U.S. federal income tax as well as income tax in multiple states and non-U.S. jurisdictions. The U.S. federal tax returns are subject to audit for the years 2017 through 2020. In general, Ingredion’s foreign subsidiaries remain subject to audit for years 2010 and later. It is reasonably possible that the total amount of unrecognized tax benefits including interest and penalties will increase or decrease within 12 months of December 31, 2021. Ingredion believes it is reasonably possible that none of the unrecognized tax benefits may be recognized within 12 months of December 31, 2021, as a result of a lapse of the statute of limitations. Ingredion has classified none of the unrecognized tax benefits as current because they are not expected to be resolved within the next 12 months.

Pension and Other Postretiremen

Pension and Other Postretirement Benefits	12 Months Ended
Pension and Other Postretirement Benefits	Dec. 31, 2021
Pension and Other Postretirement Benefits
Pension and Other Postretirement Benefits	NOTE 11 – Pension and Other Postretirement Benefits Ingredion and its subsidiaries sponsor noncontributory defined benefit pension plans (qualified and non-qualified) covering a substantial portion of employees in the U.S. and Canada and certain employees in other foreign countries. Plans for most salaried employees provide pay-related benefits based on years of service. Plans for hourly employees generally provide benefits based on flat dollar amounts and years of service. Ingredion’s general funding policy is to make contributions to the plans in amounts that comply with minimum funding requirements and are within the limits of deductibility under current tax regulations. Certain foreign countries allow income tax deductions without regard to contribution levels and Ingredion’s policy in those countries is to make contributions required by the terms of the applicable plan. Included in Ingredion’s pension obligation are nonqualified supplemental retirement plans for certain key employees. Benefits provided under these plans are unfunded and payments to plan participants are made directly by Ingredion. Ingredion also provides healthcare and/or life insurance benefits for retired employees in the U.S., Canada and Brazil. Healthcare benefits for retirees outside the U.S., Canada and Brazil are generally covered through local government plans. Pension Plans Pension Obligation and Funded Status: U.S. Plans Non-U.S. Plans (in millions) 2021 2020 2021 2020 Benefit obligation At January 1 $ 409 $ 387 $ 275 $ 254 Service cost 4 5 4 4 Interest cost 8 11 9 10 Benefits paid (24) (23) (13) (12) Actuarial (gain) loss (14) 29 (15) 14 Curtailment/settlement/amendments — — (1) — Foreign currency translation — — (5) 5 Benefit obligation at December 31 $ 383 $ 409 $ 254 $ 275 Fair value of plan assets At January 1 $ 439 $ 408 $ 249 $ 231 Actual return on plan assets 4 53 3 22 Employer contributions 1 1 7 4 Benefits paid (24) (23) (13) (12) Plan settlements — — (1) — Foreign currency translation — — (1) 4 Fair value of plan assets at December 31 $ 420 $ 439 $ 244 $ 249 Funded status $ 37 $ 30 $ (10) $ (26) As of December 31, 2021, the decrease in the benefit obligation for U.S. and non-U.S. plans was primarily driven by actuarial gains, which mainly resulted from an increase in discount rates due to an increase in bond yields compared to the prior year. As of December 31, 2020, the increase in benefit obligations for U.S. and non-U.S. plans was driven by actuarial losses, which mainly resulted from a decline in discount rates due to the fall in bond yields compared to the prior year. Amounts recorded in the Consolidated Balance Sheets as of December 31, 2021 and 2020 were as follows: U.S. Plans Non-U.S. Plans (in millions) 2021 2020 2021 2020 Non-current asset $ 47 $ 41 $ 44 $ 36 Current liabilities (1) (1) (1) (1) Non-current liabilities (9) (10) (53) (61) Net asset (liability) recognized $ 37 $ 30 $ (10) $ (26) Amounts recorded in AOCL, excluding tax effects that have not yet been recognized as components of net periodic benefit cost at December 31, 2021 and 2020, were as follows: U.S. Plans Non-U.S. Plans (in millions) 2021 2020 2021 2020 Net actuarial loss $ 11 $ 12 $ 38 $ 61 Transition obligation — — — 1 Prior service (credit) cost (4) (5) — — Net amount recognized $ 7 $ 7 $ 38 $ 62 The amount recognized in AOCL at December 31, 2021 was flat compared to prior year, for the U.S. pension plans, mainly due to the increase in discount rates used to measure Ingredion’s obligations under its U.S. pension which was offset by the actual return on assets being less than the expected return on assets. The decrease in the net amount recognized in AOCL at December 31, 2021, for the non-U.S. pension plans, as compared to December 31, 2020, was primarily due to higher discount rates used to measure Ingredion’s obligations under its non-U.S. pension plans. The accumulated benefit obligation for all defined benefit pension plans was $619 million and $664 million at December 31, 2021 and 2020, respectively. Information for pension plans with a projected benefit obligation in excess of plan assets and an accumulated benefit obligation in excess of plan assets was as follows: U.S. Plans Non-U.S. Plans (in millions) 2021 2020 2021 2020 Projected benefit obligation $ (10) $ (11) $ (57) $ (81) Accumulated benefit obligation (9) (10) (48) (70) Fair value of plan assets — — 3 19 Components of net periodic benefit cost consist of the following for 2021, 2020 and 2019: U.S. Plans Non-U.S. Plans (in millions) 2021 2020 2019 2021 2020 2019 Service cost $ 4 $ 5 $ 5 $ 4 $ 4 $ 3 Interest cost 8 11 14 9 10 10 Expected return on plan assets (17) (21) (18) (8) (8) (8) Amortization of actuarial loss — — 1 2 2 2 Amortization of prior service credit (1) (1) (1) — — — Net periodic benefit cost $ (6) $ (6) $ 1 $ 7 $ 8 $ 7 Total amounts recorded in other comprehensive income and net periodic benefit cost were as follows: (in millions, pre-tax) U.S. Plans Non-U.S. Plans 2021 2020 2019 2021 2020 2019 Net actuarial (gain) loss $ (1) $ (3) $ (25) $ (11) $ 1 $ 7 Prior service cost — — — — — 1 Amortization of actuarial loss — — (1) (2) (2) (2) Amortization of prior service credit 1 1 1 — — — Foreign currency translation — — — (11) — — Total recorded in other comprehensive income — (2) (25) (24) (1) 6 Net periodic benefit cost (6) (6) 1 7 8 7 Total recorded in other comprehensive income and net periodic benefit cost $ (6) $ (8) $ (24) $ (17) $ 7 $ 13 The following weighted average assumptions were used to determine Ingredion’s obligations for the pension plans for the given years: U.S. Plans Non-U.S. Plans 2021 2020 2021 2020 Discount rate 2.91 % 2.58 % 3.47 % 2.84 % Rate of compensation increase 4.18 4.26 3.67 3.54 Cash balance interest credit rate 4.11 3.76 — — The following weighted average assumptions were used to determine Ingredion’s net periodic benefit cost for the pension plans for the given years: U.S. Plans Non-U.S. Plans 2021 2020 2019 2021 2020 2019 Discount rate 2.58 % 3.34 % 4.38 % 2.84 % 3.55 % 4.33 % Expected long-term return on plan assets 4.10 5.30 5.30 3.37 3.81 4.37 Rate of compensation increase 4.26 4.21 4.31 3.54 3.68 3.63 Cash balance interest crediting rate 3.76 4.16 4.49 — — — For 2021, Ingredion assumed an expected long-term rate of return on assets of 4.10 percent for U.S. plans and 3.06 percent for Canadian plans. In developing the expected long-term rate of return assumption on plan assets, which consist mainly of U.S. and Canadian debt and equity securities, we evaluated historical rates of return achieved on plan assets and the asset allocation of the plans, input from Ingredion’s independent actuaries and investment consultants, and historical trends in long-term inflation rates. Projected return estimates are based upon broad equity and bond indices. The discount rate reflects a rate of return on high-quality fixed income investments that match the duration of the expected benefit payments. Ingredion has typically used returns on long-term, high-quality corporate AA bonds as a benchmark in establishing this assumption. Ingredion elects to use a full yield curve approach in the estimation of these components of benefit cost by applying the specific spot rates along the yield curve used in the determination of the benefit obligation to the relevant projected cash flows. Plan Assets: Ingredion’s weighted average asset allocations as of December 31, 2021 and 2020, for U.S. and non-U.S. pension plan assets are as follows: U.S. Plans Non-U.S. Plans Asset Category 2021 2020 2021 2020 Equity securities 14 % 20 % 18 % 18 % Debt securities 85 79 57 58 Cash and other 1 1 25 24 Total 100 % 100 % 100 % 100 % With the exception of cash, which is considered Level 1 in the fair value hierarchy, all significant pension plan assets are held in collective trusts by Ingredion’s U.S. and non-U.S. plans. The fair values of shares of collective trusts are based upon the net asset values of the funds reported by the fund managers based on quoted market prices of the underlying securities as of the balance sheet date and are considered to be Level 2 fair value measurements. Investments measured at net asset value (“NAV”), as a practical expedient for fair value, are excluded from the fair value hierarchy. This may produce a fair value measurement that may not be indicative of net realizable value or reflective of future fair values. Furthermore, while Ingredion believes its valuation methods are appropriate and consistent with those of other market participants, the use of different methodologies could result in different fair value measurements at the reporting date. The fair values of Ingredion’s plan assets by asset category are as follows: Fair Value Measurements at December 31, 2021 NAV Level 1 Level 2 Total (in millions) 2021 2020 2021 2020 2021 2020 2021 2020 U.S. Plans: Equity index: U.S. a $ — $ — $ — $ — $ 37 $ 45 $ 37 $ 45 International b — — — — 22 44 22 44 Fixed income index: Long bond c — — — — 179 276 179 276 Long government bond d — — — — 109 69 109 69 Other (e) 69 — — — — — 69 — Cash (f) — — — — 4 5 4 5 Total U.S. Plans $ 69 $ — $ — $ — $ 351 $ 439 $ 420 $ 439 Non-U.S. Plans: Equity index: U.S. a $ — $ — $ — $ — $ 26 $ 26 $ 26 $ 26 International b — — — — 17 19 17 19 Fixed income index: Short bond (g) — — — — 34 31 34 31 Intermediate bond (h) — — — — 45 38 45 38 Long bond (i) — — — — 93 106 93 106 Other (j) — — — — 21 26 21 26 Cash (f) — — 8 3 — — 8 3 Total Non-U.S. Plans $ — $ — $ 8 $ 3 $ 236 $ 246 $ 244 $ 249 (a) This category consists of both passively and actively managed equity index funds that track the return of large capitalization U.S. equities. (b) This category consists of both passively and actively managed equity index funds that track an index of returns on international developed market equities. (c) This category consists of an actively managed fixed income index fund that invests in a diversified portfolio of fixed-income corporate securities with maturities generally exceeding 10 years . (d) This category consists of an actively managed fixed income index fund that invests in a diversified portfolio of fixed-income U.S. treasury securities with maturities generally exceeding 10 years . (e) This category consists of an actively managed common collective fund that invests in government bonds, collateralized mortgage obligations, investment grade private credit and real estate debt. This fund is priced monthly at the aggregated market value of the underlying investments and can be redeemed with 95 days notification. (f) This category represents cash or cash equivalents. (g) This category consists of both passively and actively managed fixed income index funds that track the return of short-duration government and investment grade corporate bonds. (h) This category consists of both passively and actively managed fixed income index funds that track the return of intermediate duration government and investment grade corporate bonds. (i) This category consists of both passively and actively managed fixed income index funds that track the return of government bonds and investment grade corporate bonds. (j) This category mainly consists of investment products provided by insurance companies that offer returns that are subject to a minimum guarantee and mutual funds. During 2021 Ingredion made cash contributions of $1 million and $7 million to its U.S. and non-U.S. pension plans, respectively. Ingredion anticipates that in 2022 we will make cash contributions of $1 million and $3 million to our U.S. and non-U.S. pension plans, respectively. Cash contributions in subsequent years will depend on a number of factors including the performance of plan assets. The following benefit payments to beneficiaries, which reflect anticipated future service, as appropriate, are expected to be made in the following years: (in millions) U.S. Plans Non-U.S. Plans 2022 23 12 2023 24 13 2024 24 13 2025 23 13 2026 25 13 Years 2027 - 2031 125 72 Ingredion also maintains defined contribution plans. We make matching contributions to these plans that are subject to certain vesting requirements and are based on a percentage of employee contributions. Amounts charged to expense for defined contribution plans totaled $22 million, $22 million and $20 million in 2021, 2020 and 2019, respectively. Postretirement Benefit Plans Ingredion’s postretirement benefit plans currently are not funded. The information presented below includes plans in the U.S., Brazil and Canada. The changes in the benefit obligations of the plans during 2021 and 2020, as well as the amounts recognized in Ingredion’s Consolidated Balance Sheets at December 31, 2021 and 2020, are as follows: (in millions) 2021 2020 Accumulated postretirement benefit obligation At January 1 $ 68 $ 69 Service cost 1 — Interest cost 2 3 Amendments 4 — Actuarial (gain) loss (5) 4 Benefits paid (4) (5) Foreign currency translation (1) (3) At December 31 65 68 Fair value of plan assets — — Funded status $ (65) $ (68) As of December 31, 2021, the decrease in the postretirement benefit obligation was mainly driven by higher actuarial gains, partially offset by a $4 million amendment and favorable foreign currency translation related to Ingredion’s Canada and Brazil postretirement plans. The North Kansas City retiree medical group shifted from a multiemployer plan to the Ingredion Post Retirement Medical Health and Life Plan at the end of 2021, causing an increase to the postretirement obligation of $4 million in 2021. As of December 31, 2020, the decrease in the postretirement benefit obligation was mainly driven by favorable foreign currency translation related to Ingredion’s Canada and Brazil postretirement plans. Amounts recorded in the Consolidated Balance Sheets at December 31, 2021 and 2020 consist of: (in millions) 2021 2020 Current liabilities $ (4) $ (4) Non-current liabilities (61) (64) Net liability recognized $ (65) $ (68) Amounts recorded in AOCL, excluding tax effects that have not yet been recognized as components of net periodic benefit cost at December 31, 2021 and 2020 were as follows: (in millions) 2021 2020 Net actuarial loss $ 8 $ 17 Prior service cost 5 — Net amount recognized $ 13 $ 17 Components of net periodic benefit cost consisted of the following for 2021, 2020 and 2019: (in millions) 2021 2020 2019 Service cost $ 1 $ — $ 1 Interest cost 2 3 3 Amortization of actuarial loss 1 1 — Amortization of prior service credit (2) (2) (2) Net periodic benefit cost $ 2 $ 2 $ 2 Total amounts recorded in other comprehensive income and net periodic benefit cost for 2021, 2020 and 2019 was as follows: (in millions, pre-tax) 2021 2020 2019 Net actuarial loss (gain) $ (5) $ 4 $ 6 Prior service cost 4 — — Amortization of prior service credit 2 2 2 Amortization of actuarial loss (1) (1) — Foreign currency translation (4) — — Total recorded in other comprehensive income (4) 5 8 Net periodic benefit cost 2 2 2 Total recorded in other comprehensive income and net periodic benefit cost $ (2) $ 7 $ 10 The following weighted average assumptions were used to determine Ingredion’s obligations under the postretirement plans in the given years: 2021 2020 Discount rate 4.22 % 3.69 % The following weighted average assumptions were used to determine Ingredion’s net postretirement benefit cost: 2021 2020 2019 Discount rate 3.69 % 4.42 % 5.49 % The discount rate reflects a rate of return on high-quality fixed-income investments that match the duration of expected benefit payments. Ingredion has typically used returns on long-term, high-quality corporate AA bonds as a benchmark in establishing this assumption. The healthcare cost trend rates used in valuing Ingredion’s postretirement benefit obligations are established based upon actual healthcare trends and consultation with actuaries and benefit providers. The following assumptions were used as of December 31, 2021: U.S. Canada Brazil 2021 increase in per capita cost 6.00 % 5.74 % 7.79 % Ultimate trend 4.50 % 4.00 % 7.79 % Year ultimate trend reached 2032 2040 2021 The following benefit payments to beneficiaries, which reflect anticipated future service, as appropriate, are expected to be made under Ingredion’s postretirement benefit plans: (in millions) 2022 $ 4 2023 4 2024 4 2025 4 2026 4 Years 2027 - 2031 21 Multi-employer Plan Ingredion participates in and contributes to one multi-employer benefit plan under the terms of collective bargaining agreements that cover certain union-represented employees and retirees in the U.S. The plan covers medical and dental benefits for active hourly employees and retirees represented by the United Steelworkers Union for certain U.S. locations. The risks of participating in this multi-employer plan are different from single-employer plans. This plan receives contributions from two or more unrelated employers pursuant to one or more collective bargaining agreements and the assets contributed by one employer may be used to fund the benefits of all employees covered within the plan. Ingredion is required to make contributions to this multi-employer plan as determined by the terms and conditions of the collective bargaining agreements and plan terms, but Ingredion does not provide more than five percent of the total contributions to the plan. For 2021, 2020 and 2019, Ingredion made regular contributions of $14 million, $14 million and $13 million, respectively, to the plan. Ingredion cannot currently estimate the amount of multi-employer plan contributions that will be required in 2022 and future years, but these contributions could increase due to healthcare cost trends. The North Kansas City retiree medical group shifted from a multiemployer plan to the U.S. postretirement benefit plan at the end of 2021. The remaining collective bargaining agreements associated with the multi-employer plan expire during 2023 through 2024.

Equity

Equity	12 Months Ended
Equity	Dec. 31, 2021
Equity
Equity	NOTE 12 – Equity Preferred stock: Treasury stock: On November 5, 2018, Ingredion entered into a Variable Timing Accelerated Share Repurchase (“ASR”) program with JPMorgan (“JPM”). Under the ASR program, Ingredion paid $455 million on November 5, 2018 and acquired 4 million shares of its common stock having an approximate value of $423 million on that date. On February 5, 2019, Ingredion and JPM settled the difference between the initial price and average daily volume-weighted average price (“VWAP”) less the agreed upon discount during the term of the agreement. The final VWAP was $98.04 per share, which was less than originally paid. Ingredion settled the difference in cash, resulting in JPM returning $63 million of the upfront payment to Ingredion on February 6, 2019, which lowered the total cost of repurchasing the 4 million shares of common stock to $392 million. Ingredion adjusted Additional paid-in capital and Treasury stock by $32 million and $31 million, respectively, in 2019 for this inflow of cash. During 2021, Ingredion repurchased 765 thousand shares of common stock in open market transactions at a net cost of $68 million. Ingredion did not repurchase any shares of common stock in open market transactions in 2020. Set forth below is a reconciliation of common stock share activity for 2021, 2020 and 2019: (Shares of common stock, in thousands) Issued Held in Treasury Outstanding Balance at December 31, 2018 77,811 11,285 66,526 Issuance of restricted stock units as compensation — (105) 105 Performance shares and other share-based awards — (5) 5 Stock options exercised — (182) 182 Purchase/acquisition of treasury stock — — — Balance at December 31, 2019 77,811 10,993 66,818 Issuance of restricted stock units as compensation — (69) 69 Performance shares and other share-based awards — (5) 5 Stock options exercised — (124) 124 Purchase/acquisition of treasury stock — — — Balance at December 31, 2020 77,811 10,795 67,016 Issuance of restricted stock units as compensation — (69) 69 Performance shares and other share-based awards — (6) 6 Stock options exercised — (331) 331 Purchase/acquisition of treasury stock — 765 (765) Balance at December 31, 2021 77,811 11,154 66,657 Share-based payments (in millions) 2021 2020 2019 Stock options: Pre-tax compensation expense $ 3 $ 4 $ 3 Income tax benefit — — — Stock option expense, net of income taxes 3 4 3 Restricted stock units ("RSUs"): Pre-tax compensation expense 12 12 10 Income tax benefit (1) (1) (2) RSUs, net of income taxes 11 11 8 Performance shares and other share-based awards: Pre-tax compensation expense 8 7 5 Income tax benefit (1) (1) — Performance shares and other share-based compensation expense, net of income taxes 7 6 5 Total share-based compensation: Pre-tax compensation expense 23 23 18 Income tax benefit (2) (2) (2) Total share-based compensation expense, net of income taxes $ 21 $ 21 $ 16 Ingredion has a stock incentive plan (“SIP”) administered by the People, Culture and Compensation Committee (“Compensation Committee”) of its Board of Directors that provides for the granting of stock options, restricted stock, restricted stock units and other share-based awards to certain key employees. A maximum of 8 million shares were originally authorized for awards under the SIP. On May 19, 2021, Ingredion’s stockholders approved an increase in the number of shares then available under the SIP by 2.5 million shares. As of December 31, 2021, 3.8 million shares were available for future grants under the SIP. Shares covered by awards that expire, terminate or lapse will again be available for the grant of awards under the SIP. Stock Options: Ingredion granted non-qualified options to purchase 358 thousand, 336 thousand and 247 thousand shares for the years ended December 31, 2021, 2020 and 2019, respectively. The fair value of each option grant was estimated using the Black-Scholes option-pricing model with the following assumptions: For the Year Ended December 31, 2021 2020 2019 Expected life (in years) 5.5 5.5 5.5 Risk-free interest rate 0.6 % 1.4 % 2.5 % Expected volatility 23.2 % 19.8 % 19.7 % Expected dividend yield 2.9 % 2.9 % 2.7 % The expected life of options represents the weighted average period of time that options granted are expected to be outstanding giving consideration to vesting schedules and Ingredion’s historical exercise patterns. The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the grant date for the period corresponding to the expected life of the options. Expected volatility is based on historical volatilities of Ingredion’s common stock. Dividend yields are based on Ingredion’s dividend yield at the date of issuance. A summary of stock option transactions in 2021 is as follows: Number of Options (in thousands) Weighted Average Exercise Price per Share Average Remaining Contractual Term (Years) Aggregate Intrinsic Value (in millions) Outstanding as of December 31, 2020 2,238 $ 86.55 5.15 $ 14 Granted 358 87.12 Exercised (331) 62.05 Cancelled (111) 91.39 Outstanding as of December 31, 2021 2,154 $ 90.39 5.26 $ 26 Exercisable as of December 31, 2021 1,591 $ 91.21 4.09 $ 21 For 2021, 2020 and 2019, cash received from the exercise of stock options was $21 million, $6 million and $6 million, respectively. As of December 31, 2021, the unrecognized compensation cost related to non-vested stock options totaled $2 million, which is expected to be amortized over the weighted-average period of approximately 1.7 years. Additional information pertaining to stock option activity is as follows: Year Ended December 31, (dollars in millions, except per share) 2021 2020 2019 Weighted average grant date fair value of stock options granted (per share) $ 12.31 $ 11.48 $ 14.02 Total intrinsic value of stock options exercised 10 5 10 Restricted Stock Units: The following table summarizes RSU activity in 2021: Weighted Number of Average Restricted Fair Value (shares in thousands) Shares per Share Non-vested at December 31, 2020 418 $ 96.45 Granted 239 87.79 Vested (95) 121.80 Cancelled (76) 89.52 Non-vested at December 31, 2021 486 $ 88.34 The total fair value of RSUs that vested in 2021, 2020 and 2019 was $12 million, $17 million and $16 million, respectively. At December 31, 2021, the total remaining unrecognized compensation cost related to RSUs was $17 million, which will be amortized on a weighted-average basis over approximately 1.8 years. Recognized compensation cost related to unvested RSUs is included in Share-based payments subject to redemption in the Consolidated Balance Sheets and totaled $25 million and $23 million at December 31, 2021 and 2020, respectively. Performance Shares: For the 2021 performance shares awarded based on Ingredion’s total shareholder return, the number of shares that ultimately vest can range from zero to 200 percent of the grant depending on Ingredion’s total shareholder return as compared to the total shareholder return of its peer group. The share award vesting will be calculated at the end of the three-year period and is subject to approval by management and the Compensation Committee of the Board of Directors. Compensation expense is based on the fair value of the performance shares at the grant date, established using a Monte Carlo simulation model. The total compensation expense for these awards is amortized over a three-year graded vesting schedule. For the 2021 performance shares awarded based on Adjusted ROIC, the number of shares that ultimately vest can range from zero to 200 percent of the grant depending on Ingredion’s Adjusted ROIC performance against the target. The share award vesting will be calculated at the end of the three-year period and is subject to approval by management and the Compensation Committee. Compensation expense is based on the market price of our common stock on the date of the grant and the final number of shares that ultimately vest. Ingredion will estimate the potential share vesting at least annually to adjust the compensation expense for these awards over the vesting period to reflect Ingredion’s estimated Adjusted ROIC performance against the target. The total compensation expense for these awards is amortized over a three-year graded vesting schedule. Ingredion awarded 108 thousand, 81 thousand and 70 thousand performance shares in 2021, 2020 and 2019, respectively. The weighted average fair value of the shares granted during the 2021, 2020 and 2019 was $100.29, $94.48 and $92.57, respectively. The 2018 performance share awards that vested during 2021 achieved a zero percent payout of the granted performance shares. As of December 31, 2021, the 2019 performance share awards are estimated to pay out at zero percent. Additionally, there were 27 thousand shares cancelled during 2021. As of December 31, 2021, the unrecognized compensation cost relating to these plans was $7 million, which will be amortized over the remaining requisite service periods of 1.9 years. Recognized compensation cost related to these unvested awards is included in share-based payments subject to redemption in the Consolidated Balance Sheets and totaled $11 million and $7 million at December 31, 2021 and 2020, respectively. Other share-based awards under the SIP: Accumulated Other Comprehensive Loss: (in millions) Cumulative Translation Adjustment Hedging Activities Pension and Postretirement Adjustment AOCL Balance, December 31, 2018 $ (1,080) (5) (69) (1,154) Other comprehensive (loss) income before reclassification adjustments (9) (19) 11 (17) Amount reclassified from accumulated OCL — 14 — 14 Tax benefit (provision) — 1 (2) (1) Net other comprehensive (loss) income (9) (4) 9 (4) Balance, December 31, 2019 (1,089) (9) (60) (1,158) Other comprehensive (loss) income before reclassification adjustments (25) 5 (2) (22) Amount reclassified from accumulated OCL — 65 — 65 Tax (provision) benefit — (19) 1 (18) Net other comprehensive (loss) income (25) 51 (1) 25 Balance, December 31, 2020 $ (1,114) $ 42 $ (61) $ (1,133) Other comprehensive (loss) gain before reclassification adjustments (100) 218 28 146 Loss (gain) reclassified from accumulated OCL 311 (209) — 102 Tax (provision) — (3) (9) (12) Net other comprehensive income 211 6 19 236 Balance, December 31, 2021 $ (903) $ 48 $ (42) $ (897) Supplemental Information 2021 2020 2019 Net Income Weighted Per Net Income Weighted Per Net Income Weighted Per Available Average Share Available Average Share Available Average Share (in millions, except per share amounts) to Ingredion Shares Amount to Ingredion Shares Amount to Ingredion Shares Amount Basic EPS $ 117 67.1 $ 1.74 $ 348 67.2 $ 5.18 $ 413 66.9 $ 6.17 Effect of Dilutive Securities: Incremental shares from assumed exercise of dilutive stock options and vesting of dilutive RSUs and other awards 0.7 0.4 0.5 Diluted EPS $ 117 67.8 $ 1.73 $ 348 67.6 $ 5.15 $ 413 67.4 $ 6.13 Approximately 0.9 million, 1.7 million and 1.1 million share-based awards of common stock were excluded in 2021, 2020 and 2019, respectively, from the calculation of the weighted average number of shares outstanding for diluted EPS because their effects were anti-dilutive.

Segment Information

Segment Information	12 Months Ended
Segment Information	Dec. 31, 2021
Segment Information
Segment Information	NOTE 13 – Segment Information Ingredion is principally engaged in the production and sale of starches and sweeteners for a wide range of industries and is managed geographically on a regional basis. The nature, amount, timing and uncertainty of Ingredion’s Net sales are managed by Ingredion primarily based on our geographic segments, which we classify and report as North America, South America, Asia-Pacific and collectively Europe, Middle East and Africa (“EMEA”). Our North America segment includes businesses in the U.S., Mexico and Canada. Our South America segment includes businesses and our share of earnings from investments in joint ventures in Brazil, Argentina, Chile, Colombia, Ecuador, Peru and Uruguay. Our Asia-Pacific segment includes businesses in South Korea, Thailand, China, Australia, Japan, New Zealand, Indonesia, Singapore, the Philippines, Malaysia, India and Vietnam. Our EMEA segment includes businesses in Pakistan, Germany, Poland, the United Kingdom and South Africa. Net sales by product are not presented because to do so would be impracticable. Presented below are Ingredion’s net sales to unaffiliated customers by reportable segment for the years indicated: (in millions) 2021 2020 2019 Net sales to unaffiliated customers: North America $ 4,137 $ 3,662 $ 3,834 South America 1,057 919 960 Asia-Pacific 997 813 823 EMEA 703 593 592 Total net sales $ 6,894 $ 5,987 $ 6,209 Presented below is Ingredion’s operating income by reportable segment for the years indicated: (in millions) 2021 2020 2019 Operating income: North America $ 487 $ 487 $ 522 South America 138 112 96 Asia-Pacific 87 80 87 EMEA 106 102 99 Corporate (133) (122) (99) Subtotal 685 659 705 Acquisition/integration costs (3) (11) (3) Restructuring/impairment charges (47) (93) (57) Impairment on disposition of assets (340) - - Other matters 15 27 19 Total operating income $ 310 $ 582 $ 664 Presented below are Ingredion’s total assets by reportable segment as of December 31, 2021 and 2020: As of December 31, (in millions) 2021 2020 Assets: North America (a) $ 4,203 $ 4,231 South America 799 818 Asia-Pacific 1,403 1,255 EMEA 594 554 Total assets $ 6,999 $ 6,858 (a) For purposes of presentation, North America includes Corporate assets. Presented below are Ingredion’s depreciation and amortization, mechanical stores expense and capital expenditures and mechanical stores purchases by reportable segment: (in millions) 2021 2020 2019 Depreciation and amortization: North America (a) $ 146 $ 147 $ 146 South America 18 19 22 Asia-Pacific 40 32 37 EMEA 16 15 15 Total $ 220 $ 213 $ 220 Mechanical stores expense (b) : North America (a) $ 43 $ 39 $ 40 South America 6 7 10 Asia-Pacific 3 4 4 EMEA 3 4 3 Total $ 55 $ 54 $ 57 Capital expenditures and mechanical stores purchases: North America (a) $ 166 $ 243 $ 226 South America 38 39 45 Asia-Pacific 81 46 40 EMEA 15 12 17 Total $ 300 $ 340 $ 328 (a) North America includes Corporate activities. (b) Represents costs for spare parts used in the production process that are recorded in PP&E as part of machinery and equipment until they are utilized in the manufacturing process and expensed as a period cost. The following table presents net sales to unaffiliated customers by country of origin for the years indicated: Net Sales (in millions) 2021 2020 2019 U.S. $ 2,509 $ 2,284 $ 2,368 Mexico 1,170 984 1,075 Brazil 586 447 479 Canada 459 393 390 Korea 323 268 270 Others 1,847 1,611 1,627 Total $ 6,894 $ 5,987 $ 6,209 The following table presents long-lived assets (excluding intangible assets and deferred income taxes) by country as of December 31, 2021 and 2020: Long-lived Assets (in millions) 2021 2020 U.S. $ 1,317 $ 1,276 Mexico 320 342 Canada 272 245 Brazil 189 202 Thailand 156 165 Germany 135 137 China 128 52 Others 423 423 Total $ 2,940 $ 2,842

Commitments and Contingencies

Commitments and Contingencies	12 Months Ended
Commitments and Contingencies	Dec. 31, 2021
Commitments and Contingencies
Commitments and Contingencies	NOTE 14 – Commitments and Contingencies In January 2019, Ingredion’s Brazilian subsidiary received a favorable decision from the Federal Court of Appeals (“Lower Court”) in Sao Paulo, Brazil, related to certain indirect taxes collected in prior years (referred as “Brazil indirect tax matters” in these financial statements). Ingredion finalized its calculation of the amount of the credits and interest due from the favorable decision, concluding that Ingredion could be entitled to approximately $66 million of credits spanning a period from 2005 to 2018. The Department of Federal Revenue of Brazil, however, issued an Internal Ruling in which it charged that Ingredion was entitled to only $22 million of the calculated indirect tax credits and interest for the period from 2005 to 2014. As a result of the Internal Ruling, Ingredion recorded $22 million in pre-tax benefits in Other operating (income) in the Consolidated Statements of Income in 2019. The Brazil National Treasury filed a motion for clarification with the Brazilian Supreme Court (“Court”), asking the Court, among other things, to modify the Lower Court’s decision to approve the Internal Ruling. In 2020, Ingredion received another favorable Lower Court judgment that clarified the calculation of Ingredion’s benefit, allowing Ingredion to claim gross treatment within the indirect tax claim calculation and a larger indirect tax claim against the government. As a result of the decision, Ingredion recorded an additional $35 million pre-tax benefit in the Consolidated Income Statements in Other operating (income) in 2020 related to the open period of 2005 to 2014. In May 2021, the Court issued its ruling related to the calculation of certain indirect taxes, which affirmed the Lower Court rulings that Ingredion had received in previous years and affirmed that Ingredion is entitled to the previously recorded tax credits. The Court ruling ensures that Ingredion will be entitled to $15 million of additional credits from the period of 2015 to 2018 that was previously unrecorded pending a final Court ruling. Ingredion recorded the $15 million of additional credits in 2021 within Other operating (income) in the Consolidated Statements of Income. As of December 31, 2021, Ingredion has $41 million of remaining indirect tax credits recorded in Other assets and Prepaid expenses on the Consolidated Balance Sheets that result in deferred income taxes of $5 million. Ingredion will use the income tax offsets to eliminate its Brazilian federal tax payments in 2022 and future years, including the income tax payable for the indirect taxes recovered. Ingredion is currently subject to claims and suits arising in the ordinary course of business, including labor matters, certain environmental proceedings and other commercial claims. Ingredion also routinely receives inquiries from regulators and other government authorities relating to various aspects of its business, including with respect to compliance with laws and regulations relating to the environment, and at any given time, Ingredion has matters at various stages of resolution with the applicable governmental authorities. The outcomes of these matters are not within Ingredion’s complete control and may not be known for prolonged periods of time. Ingredion does not believe that the results of currently known legal proceedings and inquires will be material to it. There can be no assurance, however, that such claims, suits or investigations or those arising in the future, whether taken individually or in the aggregate, will not have a material adverse effect on Ingredion’s financial condition or results of operations.

Supplementary Information

Supplementary Information	12 Months Ended
Supplementary Information	Dec. 31, 2021
Supplementary Information
Supplementary Information	NOTE 15 – Supplementary Information Accounts Receivable, Net Accounts receivable, net as of December 31, 2021 and 2020, consist of: (in millions) 2021 2020 Accounts receivable — trade $ 950 $ 855 Accounts receivable — other 193 170 Allowance for credit losses (13) (14) Total accounts receivable $ 1,130 $ 1,011 No customer accounted for 10 percent or more of Accounts receivable, net as of December 31, 2021 or 2020 and write-offs of accounts receivable were immaterial in 2021 and 2020. There were no significant contract assets associated with customers as of December 31, 2021 or 2020. Inventories Inventories as of December 31, 2021 and 2020, consist of: (in millions) 2021 2020 Finished and in process $ 688 $ 584 Raw materials 380 236 Manufacturing supplies 104 97 Total inventories $ 1,172 $ 917 PP&E PP&E as of December 31, 2021 and 2020, consist of: (in millions) 2021 2020 Land $ 206 $ 207 Buildings 812 802 Machinery and equipment 4,637 4,621 Property, plant and equipment, at cost 5,655 5,630 Accumulated depreciation (3,232) (3,175) Property, plant and equipment, net $ 2,423 $ 2,455 Ingredion capitalized to PP&E interest of $4 million, $7 million and $5 million for 2021, 2020 and 2019, respectively. Ingredion recognized depreciation expense of $194 million, $183 million and $191 million in 2021, 2020 and 2019, respectively. Accrued Liabilities Accrued liabilities as of December 31, 2021 and 2020, consist of: (in millions) 2021 2020 Compensation-related costs $ 105 $ 96 Current lease liabilities 47 46 Dividends payable 44 43 Taxes payable other than income taxes 44 44 Other accrued liabilities 190 192 Total accrued liabilities $ 430 $ 421 There were no significant contract liabilities associated with our customers as of December 31, 2021 and 2020. Liabilities for volume discounts and incentives were also not significant as of December 31, 2021 and 2020. Other Non-Current Liabilities Other non-current liabilities as of December 31, 2021 and 2020, consist of: (in millions) 2021 2020 Deferred tax liabilities $ 165 $ 217 Non-current operating lease liabilities 154 136 Pension and postretirement liabilities 123 139 Other 82 88 Total other non-current liabilities $ 524 $ 580 Supplemental Income Statements Information Supplemental Cash Flow Information The following represents additional cash flow information for the indicated years: (in millions) 2021 2020 2019 Interest paid $ 72 $ 78 $ 80 Income taxes paid 168 120 145 Quarterly Financial Data (Unaudited) Earnings per share for each quarter and the year are calculated individually and may not sum to the total for the respective year. Summarized quarterly financial data is as follows: (in millions, except per share amounts) 1 st QTR (b) 2 nd QTR (c) 3 rd QTR (d) 4 th QTR (e) 2021 Net sales $ 1,614 $ 1,762 $ 1,763 $ 1,755 Gross profit 351 367 323 290 Net income attributable to Ingredion (246) 178 118 67 Basic earnings per common share of Ingredion (3.66) 2.65 1.76 1.00 Diluted earnings per common share of Ingredion (3.66) 2.62 1.75 0.99 Per share dividends declared $ 0.64 $ 0.64 $ 0.65 $ 0.65 (in millions, except per share amounts) 1 st QTR (e) 2 nd QTR (f) 3 rd QTR (g) 4 th QTR (h) 2020 Net sales $ 1,543 $ 1,349 $ 1,502 $ 1,593 Gross profit 323 271 326 352 Net income attributable to Ingredion 75 66 92 115 Basic earnings per common share of Ingredion 1.12 0.98 1.37 1.71 Diluted earnings per common share of Ingredion 1.11 0.98 1.36 1.70 Per share dividends declared $ 0.63 $ 0.63 $ 0.64 $ 0.64 (a) All items in the footnotes below are presented after-tax unless otherwise noted. (b) In the first quarter of 2021, Ingredion recorded $360 million in held for sale impairment charges related to the Arcor joint venture with no income tax benefit, $8 million in net restructuring costs, $3 million in charges for tax matters and $1 million in acquisition/integration costs. (c) In the second quarter of 2021, Ingredion recorded $32 million in income for tax matters, $10 million in other matters income, $4 million in acquisition/integration costs, $3 million in equity method acquisition benefits and $2 million in net restructuring costs. (d) In the third quarter of 2021, Ingredion recorded a $20 million favorable adjustment to the impairment charges related to the Arcor joint venture with no income tax expense, $7 million in net restructuring costs, $4 million in acquisition/integration costs and $4 million in charges for tax matters. (e) In the fourth quarter of 2021, Ingredion recorded $19 million in net restructuring and impairment costs, $12 million in benefits for other matters, $5 million in benefits for fair value adjustments to equity investments, $4 million in charges for tax matters and $1 million in net acquisition/integration costs. (f) In the first quarter of 2020, Ingredion recorded $11 million in net restructuring costs. (g) In the second quarter of 2020, Ingredion recorded $8 million in net restructuring costs and $2 million in acquisition/integration costs. (h) In the third quarter of 2020, Ingredion recorded $15 million in net restructuring costs, $6 million in charges for other tax matters, $4 million in acquisition/integration costs, $4 million in charges for early extinguishment of debt, $3 million in charges for fair value markup of acquired inventory and $2 million in North America storm damage costs. (i) In the fourth quarter of 2020, Ingredion recorded $40 million in net restructuring and impairment costs, $27 million in income for other matters, $4 million in acquisition/integration costs, $3 million in income for other tax matters, $1 million in charges for fair value markup of acquired inventory and $1 million in North America storm damage costs.

Description of the Business a_2

Description of the Business and Summary of Significant Accounting Policies (Policies)	12 Months Ended
	Dec. 31, 2021
Description of the Business and Summary of Significant Accounting Policies
Basis of presentation	Basis of presentation The preparation of the accompanying Consolidated Financial Statements in conformity with U.S. Generally Accepted Accounting Principles (“GAAP”) requires management to make estimates and assumptions about future events. These estimates and the underlying assumptions affect the amounts of assets and liabilities reported, disclosures about contingent assets and liabilities, and reported amounts of revenues and expenses. Such estimates include the value of purchase consideration, valuation of accounts receivable, inventories, certain investments, goodwill, intangible assets and other long-lived assets, legal contingencies and assumptions used in the calculation of income taxes and pension and other postretirement benefits, among others. These estimates and assumptions are based on our best estimates and judgment. We evaluate our estimates and assumptions on an ongoing basis using historical experience and other factors, including the current economic environment, which we believe to be reasonable under the circumstances. We will adjust such estimates and assumptions when facts and circumstances dictate. Foreign currency devaluations versus the U.S. dollar, corn price volatility, access to credit markets and adverse changes in the global economic environment have combined to increase the uncertainty inherent in such estimates and assumptions. As future events and their effects cannot be determined with precision, actual results could differ significantly from these estimates. Changes in these estimates will be reflected in the financial statements in future periods. Assets and liabilities of foreign subsidiaries, other than those whose functional currency is the U.S. dollar, are translated at current exchange rates with the related translation adjustments reported in equity as a component of accumulated other comprehensive loss (“AOCL”) and income statement accounts are translated at the average exchange rate during the period. However, significant non-recurring items related to specific events are recognized at the exchange rate on the date of each significant event. The U.S. dollar is the functional currency for Ingredion’s subsidiaries in Mexico and Argentina. If the U.S. dollar is the functional currency, we translate the subsidiary’s monetary assets and liabilities at current exchange rates with the related adjustment included in net income and non-monetary assets and liabilities at historical exchange rates with the related translation adjustments included in AOCL. Net Sales: Ingredion identifies customer purchase orders, which in some cases are governed by a master sales agreement, as the contracts with its customers. For each contract, Ingredion considers the transfer of products, each of which is distinct, to be the identified performance obligation. In determining the transaction price for the performance obligation, Ingredion evaluates whether the price is subject to adjustment to determine the consideration to which Ingredion expects to be entitled. The pricing model can be fixed or variable within the contract. The variable pricing model is based on historical commodity pricing and is determinable prior to completion of the performance obligation. Additionally, Ingredion has certain sales adjustments for volume incentive discounts and other discount arrangements that reduce the transaction price. The reduction of transaction price is estimated using the expected value method based on an analysis of historical volume incentives or discounts, over a period of time considered adequate to account for current pricing and business trends. Historically, actual volume incentives and discounts relative to those estimated and included when determining the transaction price have not materially differed. Volume incentives and discounts are accrued at the satisfaction of the performance obligation and accounted for in Accounts payable and Accrued liabilities in the Consolidated Balance Sheets. The product price as specified in the contract, net of any discounts, is considered the standalone selling price as it is an observable input that represents the price if we sold the product to a similar customer in similar circumstances. Payment is received shortly after the performance obligation is satisfied and thus, we do not recognize any significant financing components. Revenue is recognized when Ingredion’s performance obligation is satisfied and control is transferred to the customer, which occurs at a point in time, either upon delivery to an agreed upon location or to the customer. Further, in determining whether control has transferred, Ingredion considers if there is a present right to payment and legal title, along with risks and rewards of ownership having transferred to the customer. Shipping and handling activities related to contracts with customers represent fulfillment costs and are recorded in Cost of sales in the Consolidated Statements of Income. Taxes assessed by governmental authorities and collected from customers are accounted for on a net basis and excluded from net sales. We expense costs to obtain a contract when we incur the costs since most contracts are one year or less. These costs primarily include Ingredion’s internal sales force compensation. Under the terms of these programs, the compensation is generally earned, and the costs are recognized when we recognize the revenue. From time to time, Ingredion may enter into long-term contracts with its customers. Historically, the contracts entered into by Ingredion do not result in significant contract assets or liabilities. Any such arrangements are accounted for in Other assets or Accrued liabilities in the Consolidated Balance Sheets.
Revenue recognition	Net Sales: Ingredion identifies customer purchase orders, which in some cases are governed by a master sales agreement, as the contracts with its customers. For each contract, Ingredion considers the transfer of products, each of which is distinct, to be the identified performance obligation. In determining the transaction price for the performance obligation, Ingredion evaluates whether the price is subject to adjustment to determine the consideration to which Ingredion expects to be entitled. The pricing model can be fixed or variable within the contract. The variable pricing model is based on historical commodity pricing and is determinable prior to completion of the performance obligation. Additionally, Ingredion has certain sales adjustments for volume incentive discounts and other discount arrangements that reduce the transaction price. The reduction of transaction price is estimated using the expected value method based on an analysis of historical volume incentives or discounts, over a period of time considered adequate to account for current pricing and business trends. Historically, actual volume incentives and discounts relative to those estimated and included when determining the transaction price have not materially differed. Volume incentives and discounts are accrued at the satisfaction of the performance obligation and accounted for in Accounts payable and Accrued liabilities in the Consolidated Balance Sheets. The product price as specified in the contract, net of any discounts, is considered the standalone selling price as it is an observable input that represents the price if we sold the product to a similar customer in similar circumstances. Payment is received shortly after the performance obligation is satisfied and thus, we do not recognize any significant financing components. Revenue is recognized when Ingredion’s performance obligation is satisfied and control is transferred to the customer, which occurs at a point in time, either upon delivery to an agreed upon location or to the customer. Further, in determining whether control has transferred, Ingredion considers if there is a present right to payment and legal title, along with risks and rewards of ownership having transferred to the customer. Shipping and handling activities related to contracts with customers represent fulfillment costs and are recorded in Cost of sales in the Consolidated Statements of Income. Taxes assessed by governmental authorities and collected from customers are accounted for on a net basis and excluded from net sales. We expense costs to obtain a contract when we incur the costs since most contracts are one year or less. These costs primarily include Ingredion’s internal sales force compensation. Under the terms of these programs, the compensation is generally earned, and the costs are recognized when we recognize the revenue. From time to time, Ingredion may enter into long-term contracts with its customers. Historically, the contracts entered into by Ingredion do not result in significant contract assets or liabilities. Any such arrangements are accounted for in Other assets or Accrued liabilities in the Consolidated Balance Sheets.
Cash and cash equivalents	Cash and cash equivalents:
Accounts receivable, net	Accounts receivable
Inventories	Inventories:
Long-term investments	Long-term investments: Equity investments in companies for which Ingredion does not have the ability to exercise significant influence are accounted for at fair value, with changes in fair value recorded in Other non-operating (income) expense in the Consolidated Statements of Income. Equity securities without readily determinable fair values are carried at cost, less impairments, if any, and adjusted for observable price changes for the identical or a similar investment of the same issuer. We perform a qualitative impairment assessment to determine if such investments are impaired. The qualitative assessment considers all available information, including declines in the financial performance of the issuing entity, the issuing entity’s operating environment and general market conditions. Impairments of equity securities without readily determinable fair value are recorded in Other non-operating (income) expense in the Consolidated Statements of Income. Equity investments in companies for which Ingredion has the ability to exercise significant influence, but not control, are accounted for using the equity method of accounting. Ingredion’s share of the earnings or losses as reported by equity method investees, are recognized in Other operating (income) in the Consolidated Statements of Income. Each reporting period, Ingredion evaluates declines in the fair value of equity method investments below carrying value to determine if they are other-than-temporary and if so, Ingredion writes down the investment to its estimated fair value. Impairments are recognized in Restructuring/impairment charges and related adjustments in the Consolidated Statements of Income. Leases: over the lease term. As most of Ingredion’s leases do not provide an implicit rate, Ingredion uses an incremental borrowing rate based on the information available at the commencement date in determining the present value of lease payments. The lease asset value includes in our calculation any prepaid lease payments made and any lease incentives received from the arrangement as a reduction of the asset. Ingredion’s lease terms may include options to extend or terminate the lease and the impact of these options are included in the lease liability and lease asset calculations when the exercise of the option is at Ingredion’s sole discretion and it is reasonably certain that we will exercise that option. Ingredion will not separate lease and non-lease components for its leases when it is impracticable to separate them, such as leases with variable payment arrangements. Leases with an initial term of 12 months or less are not recorded on the Consolidated Balance Sheets. Ingredion has operating leases for certain rail cars, office space, warehouses and machinery and equipment. The commencement date used for the calculation of the lease obligations recorded is the latter of January 1, 2019 or the lease start date. Certain leases have options to extend the life of the lease, which are included in the liability calculation when the option is at the sole discretion of Ingredion and it is reasonably certain that Ingredion will exercise the option. Ingredion has certain leases that have variable payments based solely on output or usage of the leased asset. These variable operating lease assets are excluded from Ingredion’s Consolidated Balance Sheets presentation and expensed as incurred. Lease expense is recognized on a straight-line basis over the lease term.
Leases	Leases: over the lease term. As most of Ingredion’s leases do not provide an implicit rate, Ingredion uses an incremental borrowing rate based on the information available at the commencement date in determining the present value of lease payments. The lease asset value includes in our calculation any prepaid lease payments made and any lease incentives received from the arrangement as a reduction of the asset. Ingredion’s lease terms may include options to extend or terminate the lease and the impact of these options are included in the lease liability and lease asset calculations when the exercise of the option is at Ingredion’s sole discretion and it is reasonably certain that we will exercise that option. Ingredion will not separate lease and non-lease components for its leases when it is impracticable to separate them, such as leases with variable payment arrangements. Leases with an initial term of 12 months or less are not recorded on the Consolidated Balance Sheets. Ingredion has operating leases for certain rail cars, office space, warehouses and machinery and equipment. The commencement date used for the calculation of the lease obligations recorded is the latter of January 1, 2019 or the lease start date. Certain leases have options to extend the life of the lease, which are included in the liability calculation when the option is at the sole discretion of Ingredion and it is reasonably certain that Ingredion will exercise the option. Ingredion has certain leases that have variable payments based solely on output or usage of the leased asset. These variable operating lease assets are excluded from Ingredion’s Consolidated Balance Sheets presentation and expensed as incurred. Lease expense is recognized on a straight-line basis over the lease term.
Property, plant and equipment and depreciation	Property, plant and equipment and definite-lived intangible assets: two two
Intangible assets	Indefinite-lived intangible assets and Goodwill In testing indefinite-lived intangible assets for impairment, Ingredion first assesses qualitative factors to determine whether it is more-likely-than-not that the fair value of an indefinite-lived intangible asset is impaired. After assessing the qualitative factors, if Ingredion determines that it is more-likely-than-not that the fair value of an indefinite-lived intangible asset is greater than its carrying amount, then we are not required to compute the fair value of the indefinite-lived intangible asset. If the qualitative assessment leads Ingredion to conclude otherwise, then we are required to determine the fair value of the indefinite-lived intangible assets and perform a quantitative impairment test. In performing the qualitative analysis, Ingredion considers various factors including net sales derived from these intangibles and certain market and industry conditions. Based on the results of the annual assessment, Ingredion concluded that as of July 1, 2021, there were no impairments in our indefinite-lived intangible assets. In testing goodwill for impairment, Ingredion first assesses qualitative factors in determining whether it is more-likely-than-not that the fair value of a reporting unit is less than its carrying amount. After assessing the qualitative factors, if Ingredion determines that it is more-likely-than-not that the fair value of a reporting unit is greater than its carrying amount, then Ingredion does not perform an impairment test. If Ingredion concludes otherwise, then Ingredion performs an impairment test that compares the fair value of the reporting unit to its carrying value. If the fair value of the reporting unit exceeds the carrying value of its net assets, goodwill is not considered impaired, and no further testing is required. If the carrying value of the net assets exceeds the fair value of the reporting unit, then an impairment exists for the difference between the fair value and carrying value of the reporting unit. This difference is not to exceed the goodwill recorded at the reporting unit. Based on the results of the annual assessment, Ingredion concluded that as of July 1, 2021, there were no impairments in our reporting units.
Hedging instruments	Hedging instruments: When Ingredion enters a derivative contract, we designate the derivative as a hedge of variable cash flows to be paid related to certain forecasted transactions (“a cash flow hedge”), as a hedge of the fair value of certain firm commitments (“a fair value hedge”), or as a non-designated hedging instrument. This process includes linking all derivatives that are designated as cash flow or fair value hedges to specific assets and liabilities on the Consolidated Balance Sheets, or to specific firm commitments or forecasted transactions. For all hedging relationships, Ingredion documents the hedging relationships and its risk-management objective and strategy for undertaking the hedge transactions, the hedging instrument, the hedged item, the nature of the risk being hedged, how the hedging instrument’s effectiveness in offsetting the hedged risk will be assessed and a description of the method of measuring ineffectiveness. Ingredion also formally assesses both, at the hedge’s inception and on an ongoing basis, whether the derivatives that are used in hedging transactions are highly effective in offsetting changes in cash flows or fair values of hedged items. Unrealized gains and losses associated with marking cash flow hedging contracts to market (fair value) are recorded as a component of other comprehensive loss (“OCL”). Ingredion discontinues hedge accounting prospectively when it is unlikely that a forecasted transaction will occur or when we determine that the designation of the derivative as a hedging instrument is no longer appropriate since the derivative is no longer effective in offsetting changes in the cash flows or fair value of the originally intended hedged transaction. When hedge accounting is discontinued, Ingredion continues to carry the derivative on the Consolidated Balance Sheets at its fair value and any accumulated gains and losses that were included in AOCL in the period a hedge was determined to be ineffective, as well as future gains and losses of the derivative, are recognized in earnings in the same line item affected by the originally intended hedged transaction.
Pension and Other Postemployment Benefits	Pension and other postemployment benefits For defined benefit plans, the service cost component of net periodic benefit cost is presented within either Cost of sales or operating expenses on the Consolidated Statements of Income. The interest cost, expected return on plan assets, amortization of actuarial loss, amortization of prior service credit and settlement loss components of net periodic benefit cost are presented as Other non-operating (income) expense on the Consolidated Statements of Income. Actuarial gains and losses in excess of 10 percent of the greater of the projected benefit obligation or the market-related value of plan assets are classified in AOCL, along with the related tax impact, and recognized as a component of net periodic benefit cost over the average remaining service period of a plan’s active employees for active defined benefit pension plans and over the average remaining life of a plan’s active employees for frozen defined benefit pension plans.
Share-based compensation	Share-based compensation:
Earnings per common share	Earnings per common share:
Risks and uncertainties	Risks and uncertainties:
Recently adopted accounting standards and New accounting standards	New Accounting Standards Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting

Acquisitions (Tables)

Acquisitions (Tables)	12 Months Ended
Acquisitions (Tables)	Dec. 31, 2021
Acquisitions
Summarizes the preliminary purchase price allocations for the PureCircle acquisition	(in millions) PureCircle Working capital (excluding cash) $ 68 Property, plant and equipment 91 Other, net (33) Identifiable intangible assets 68 Goodwill 88 Total fair value, net of cash 282 Less: Non-redeemable non-controlling interests 74 Total purchase price, net of cash $ 208
Schedule of fair values, valuation techniques and estimated remaining useful life of acquired intangible assets	Estimated Intangible Asset Fair Value Valuation Technique Useful Life Proprietary technology $ 32 Relief-from-royalty method 12 years Tradenames 18 Relief-from-royalty method 15 years Customer relationships 18 Multi-period excess earnings method 12 years

Intangible Assets (Tables)

Intangible Assets (Tables)	12 Months Ended
Intangible Assets (Tables)	Dec. 31, 2021
Intangible Assets
Schedule of goodwill	North South Asia- (in millions) America America Pacific EMEA Total Goodwill before impairment charges $ 622 $ 50 $ 316 $ 69 $ 1,057 Accumulated impairment charges (1) (33) (121) — (155) Balance at January 1, 2021 621 17 195 69 902 Acquisitions 2 — 6 9 17 Currency translation — (2) 1 (4) (5) Balance at December 31, 2021 $ 623 $ 15 $ 202 $ 74 $ 914
Schedule of intangible assets	2021 (in millions) Gross Accumulated Amortization Net Weighted Average Useful Life (years) Trademarks/tradenames (indefinite-lived) $ 143 $ — $ 143 — Patents 33 (4) 29 12 Customer relationships 365 (134) 231 19 Technology 103 (101) 2 9 Other 43 (14) 29 15 Total other intangible assets $ 687 $ (253) $ 434 17 2020 (in millions) Gross Accumulated Amortization Net Weighted Average Useful Life (years) Trademarks/tradenames (indefinite-lived) $ 143 $ — $ 143 — Patents 33 (2) 31 12 Customer relationships 356 (115) 241 20 Technology 103 (101) 2 9 Other 38 (11) 27 19 Total other intangible assets $ 673 $ (229) $ 444 17
Schedule of amortization expense related to intangible assets	(in millions) Year Amortization Expense 2022 $ 27 2023 26 2024 26 2025 26 2026 25

Investments (Tables)

Investments (Tables)	12 Months Ended
Investments (Tables)	Dec. 31, 2021
Investments
Schedule of investments	(in millions) 2021 2020 Equity investments $ 16 $ 8 Equity method investments 104 10 Marketable securities 12 11 Total investments $ 132 $ 29

Restructuring and Impairment _2

Restructuring and Impairment Charges (Tables)	12 Months Ended
Restructuring and Impairment Charges (Tables)	Dec. 31, 2021
Restructuring and Impairment Charges
Summary of restructuring reserve	A summary of Ingredion’s severance accrual at December 31, 2021, which we expect to fully pay in 2022, is as follows ($ in millions): Balance in severance accrual as of December 31, 2020 $ 12 Joint venture related 1 Cost Smart 1 Payments made to terminated employees (11) Balance in severance accrual as of December 31, 2021 $ 3

Derivatives Instruments and H_2

Derivatives Instruments and Hedging Activities (Tables)	12 Months Ended
Derivatives Instruments and Hedging Activities (Tables)	Dec. 31, 2021
Derivatives Instruments and Hedging Activities
Schedule of cash flow hedges included in AOCI	Derivatives in Cash Flow Hedging Relationships Gains (Losses) included in AOCL as of December 31, (in millions) 2021 2020 Commodity contracts, net of income tax effect of $19 and $16, respectively $ 51 $ 47 Foreign currency contracts, net of income tax effect of $ — — (1) Interest rate contracts, net of income tax effect of $1 (3) (4) Total $ 48 $ 42
Schedule of location and amount of assets and liabilities reported in balance sheet	Fair Value of Hedging Instruments as of December 31, 2021 Designated Hedging Instruments (in millions) Non-Designated Hedging Instruments (in millions) Balance Sheet Location Commodity Contracts Foreign Currency Contracts Total Commodity Contracts Foreign Currency Contracts Total Accounts receivable, net $ 45 $ 9 $ 54 $ 4 $ 3 $ 7 Other assets 7 6 13 — — — Assets 52 15 67 4 3 7 Accounts payable and accrued liabilities 5 12 17 2 4 6 Non-current liabilities 2 6 8 — 1 1 Liabilities 7 18 25 2 5 7 Net (Liabilities)/Assets $ 45 $ (3) $ 42 $ 2 $ (2) $ — Fair Value of Hedging Instruments as of December 31, 2020 Designated Hedging Instruments (in millions) Non-Designated Hedging Instruments (in millions) Balance Sheet Location Commodity Contracts Foreign Currency Contracts Total Commodity Contracts Foreign Currency Contracts Total Accounts receivable, net $ 50 $ 7 $ 57 $ 3 $ 4 $ 7 Other assets 4 — 4 — 1 1 Assets 54 7 61 3 5 8 Accounts payable and accrued liabilities 4 12 16 1 8 9 Non-current liabilities 2 — 2 — 2 2 Liabilities 6 12 18 1 10 11 Net (Liabilities)/Assets $ 48 $ (5) $ 43 $ 2 $ (5) $ (3)
Schedule of amount of gains and losses recognized in OCI and location and income statement location	Derivatives in Cash Flow Hedging Relationships Gains (Losses) Recognized in OCL on Derivatives Income Statement Gains (Losses) Reclassified from AOCL into Income (in millions) 2021 2020 2019 Location 2021 2020 2019 Commodity contracts $ 218 $ 17 $ (24) Cost of sales $ 211 $ (62) $ (12) Foreign currency contracts — (7) 5 Net sales/Cost of sales (1) (2) — Interest rate contracts — (5) — Financing costs (1) (1) (2) Total $ 218 $ 5 $ (19) $ 209 $ (65) $ (14)
Schedule of location and amount of gain (loss) recognized in income	Derivatives in Fair Value Hedging Relationships Income Statement Location of Derivatives Designated as Gains (Losses) Recognized in Income Income Statement Location Gains (Losses) Recognized in Income (in millions) Hedging Instruments 2021 2020 2019 of Hedged Items 2021 2020 2019 Interest rate contracts Financing costs $ — $ (1) $ 2 Financing costs $ — $ 1 $ (2)

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	12 Months Ended
Fair Value Measurements (Tables)	Dec. 31, 2021
Fair Value Measurements
Schedule of assets and liabilities measured at fair value	As of December 31, 2021 As of December 31, 2020 (in millions) Total Level 1 Level 2 Level 3 Total Level 1 Level 2 Level 3 Available for sale securities $ 12 $ 12 $ — $ — $ 11 $ 11 $ — $ — Derivative assets 74 49 25 — 69 53 16 — Derivative liabilities 32 22 10 — 29 3 26 — Long-term debt 1,957 — 1,957 — 1,751 — 1,751 —

Financing Arrangements (Tables)

Financing Arrangements (Tables)	12 Months Ended
Financing Arrangements (Tables)	Dec. 31, 2021
Financing Arrangements
Schedule of debt	2021 2020 Carrying Fair Carrying Fair (in millions) Value Value Value Value 2.900% senior notes due June 1, 2030 $ 595 $ 619 $ 594 $ 596 3.200% senior notes due October 1, 2026 498 531 497 500 3.900% senior notes due June 1, 2050 390 455 390 395 6.625% senior notes due April 15, 2037 253 350 253 246 Revolving credit agreement — — — — Other long-term borrowings 2 2 14 14 Total long-term debt 1,738 1,957 1,748 1,751 Term loan credit agreement due April 12, 2021 — — 380 380 Commercial paper 250 250 — — Other short-term borrowings 58 58 58 58 Total short-term borrowings 308 308 438 438 Total debt $ 2,046 $ 2,265 $ 2,186 $ 2,189

Leases (Tables)

Leases (Tables)	12 Months Ended
Leases (Tables)	Dec. 31, 2021
Leases
Summary of components of lease expense	(in millions) 2021 2020 2019 Operating lease cost $ 58 $ 58 $ 55 Variable operating lease cost 26 29 24 Short term lease cost 4 4 3 Lease expense $ 88 $ 91 $ 82
Reconciliation of future undiscounted cash flows to the operating lease liabilities and the related ROU assets	The following is a reconciliation of future undiscounted cash flows to the operating lease liabilities and the related operating lease assets as presented within Other non-current liabilities and Other assets, respectively, on Ingredion’s Consolidated Balance Sheets as of December 31, 2021 ($ in millions): 2022 $ 52 2023 43 2024 33 2025 24 2026 19 Thereafter 52 Total future lease payments 223 Less imputed interest 22 Present value of future lease payments 201 Less current lease liabilities 47 Non-current operating lease liabilities $ 154 Operating lease assets $ 193
Summary of other lease information	Year Ended Other Information December 31, ($ in millions) 2021 2020 Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows from operating leases $ 58 $ 60 Right-of-use assets obtained in exchange for lease liabilities: Operating leases $ 77 $ 76 As of As of December 31, 2021 December 31, 2020 Weighted average remaining lease term: Operating leases 6.5 years 5.5 years Weighted average discount rate: Operating leases 4.0 % 4.9 %

Income Taxes (Tables)

Income Taxes (Tables)	12 Months Ended
Income Taxes (Tables)	Dec. 31, 2021
Taxes
Schedule of income before income taxes	(in millions) 2021 2020 2019 Income before income taxes: U.S. $ 39 $ (15) $ 74 Foreign 209 521 508 Total income before income taxes 248 506 582 Provision for income taxes: Current tax (benefit) expense: U.S. federal 2 1 6 State and local 2 2 2 Foreign 180 156 147 Total current tax expense 184 159 155 Deferred tax expense (benefit): U.S. federal (57) (18) (8) State and local (2) (1) — Foreign (2) 12 11 Total deferred tax expense (benefit) (61) (7) 3 Total provision for income taxes $ 123 $ 152 $ 158
Schedule of tax effects of temporary differences between financial reporting basis and tax basis of assets and liabilities	(in millions) 2021 2020 Deferred tax assets attributable to: Employee benefit accruals $ 28 $ 20 Pensions and postretirement plans 14 21 Lease liabilities 49 44 Bad debt 14 2 Inventory reserve 13 9 Net operating loss carryforwards 64 32 Tax credit carryforwards 18 11 Other 36 43 Total deferred tax assets 236 182 Valuation allowances (67) (30) Net deferred tax assets 169 152 Deferred tax liabilities attributable to: Property, plant and equipment 175 173 Identified intangibles 47 46 Right-of-use lease assets 46 42 Foreign withholding and state taxes on unremitted earnings 1 31 Goodwill 27 20 Brazilian indirect tax credits 5 18 Derivative contracts 19 16 Total deferred tax liabilities 320 346 Net deferred tax liabilities $ 151 $ 194
Schedule of reconciliation of US federal statutory tax rate to effective tax rate	2021 2020 2019 Provision for tax at U.S. statutory rate 21.0 % 21.0 % 21.0 % Tax rate difference on foreign income 13.3 9.1 6.2 Foreign currency FX 3.2 1.2 (0.2) Inflation adjustments (4.0) (0.8) (0.3) Tax benefit of intercompany financing (1.6) (0.8) (1.2) U.S. international tax implications 0.8 0.6 2.2 Valuation allowance in Argentina (0.4) (0.6) 0.3 Favorable judgment on the treatment of credits and interest on indirect taxes (4.8) (0.6) — Unremitted earnings (12.1) — — Impairment charge related to Accor joint venture 35.5 — — Other items, net (1.3) 0.9 (0.9) Provision at effective tax rate 49.6 % 30.0 % 27.1 %
Schedule of reconciliation of beginning and ending amount of unrecognized tax benefits, excluding interest and penalties	(in millions) 2021 2020 Balance at January 1 $ 46 $ 22 Additions for tax positions related to prior years 2 33 Reductions for tax positions related to prior years (9) — Additions based on tax positions related to the current year 2 — Reductions related to a lapse in the statute of limitations (12) (9) Balance at December 31 $ 29 $ 46

Pension and Other Postretirem_2

Pension and Other Postretirement Benefits (Tables)	12 Months Ended
Pension and Other Postretirement Benefits (Tables)	Dec. 31, 2021
Pension Plan
Pension and other postretirement benefits
Schedule of funded status	U.S. Plans Non-U.S. Plans (in millions) 2021 2020 2021 2020 Benefit obligation At January 1 $ 409 $ 387 $ 275 $ 254 Service cost 4 5 4 4 Interest cost 8 11 9 10 Benefits paid (24) (23) (13) (12) Actuarial (gain) loss (14) 29 (15) 14 Curtailment/settlement/amendments — — (1) — Foreign currency translation — — (5) 5 Benefit obligation at December 31 $ 383 $ 409 $ 254 $ 275 Fair value of plan assets At January 1 $ 439 $ 408 $ 249 $ 231 Actual return on plan assets 4 53 3 22 Employer contributions 1 1 7 4 Benefits paid (24) (23) (13) (12) Plan settlements — — (1) — Foreign currency translation — — (1) 4 Fair value of plan assets at December 31 $ 420 $ 439 $ 244 $ 249 Funded status $ 37 $ 30 $ (10) $ (26)
Schedule of amounts recognized in the consolidated balance sheets	U.S. Plans Non-U.S. Plans (in millions) 2021 2020 2021 2020 Non-current asset $ 47 $ 41 $ 44 $ 36 Current liabilities (1) (1) (1) (1) Non-current liabilities (9) (10) (53) (61) Net asset (liability) recognized $ 37 $ 30 $ (10) $ (26)
Schedule of amounts recognized in accumulated other comprehensive loss	U.S. Plans Non-U.S. Plans (in millions) 2021 2020 2021 2020 Net actuarial loss $ 11 $ 12 $ 38 $ 61 Transition obligation — — — 1 Prior service (credit) cost (4) (5) — — Net amount recognized $ 7 $ 7 $ 38 $ 62
Schedule of plan obligations and assets for plans with an accumulated benefit obligation in excess of plan assets	U.S. Plans Non-U.S. Plans (in millions) 2021 2020 2021 2020 Projected benefit obligation $ (10) $ (11) $ (57) $ (81) Accumulated benefit obligation (9) (10) (48) (70) Fair value of plan assets — — 3 19
Components of net periodic benefit cost	U.S. Plans Non-U.S. Plans (in millions) 2021 2020 2019 2021 2020 2019 Service cost $ 4 $ 5 $ 5 $ 4 $ 4 $ 3 Interest cost 8 11 14 9 10 10 Expected return on plan assets (17) (21) (18) (8) (8) (8) Amortization of actuarial loss — — 1 2 2 2 Amortization of prior service credit (1) (1) (1) — — — Net periodic benefit cost $ (6) $ (6) $ 1 $ 7 $ 8 $ 7
Schedule of amounts recorded in other comprehensive income and net periodic benefit cost	(in millions, pre-tax) U.S. Plans Non-U.S. Plans 2021 2020 2019 2021 2020 2019 Net actuarial (gain) loss $ (1) $ (3) $ (25) $ (11) $ 1 $ 7 Prior service cost — — — — — 1 Amortization of actuarial loss — — (1) (2) (2) (2) Amortization of prior service credit 1 1 1 — — — Foreign currency translation — — — (11) — — Total recorded in other comprehensive income — (2) (25) (24) (1) 6 Net periodic benefit cost (6) (6) 1 7 8 7 Total recorded in other comprehensive income and net periodic benefit cost $ (6) $ (8) $ (24) $ (17) $ 7 $ 13
Schedule of weighted average assumptions used to determine the company's obligations	U.S. Plans Non-U.S. Plans 2021 2020 2021 2020 Discount rate 2.91 % 2.58 % 3.47 % 2.84 % Rate of compensation increase 4.18 4.26 3.67 3.54 Cash balance interest credit rate 4.11 3.76 — —
Schedule of weighted average assumptions used to determine the company's net periodic benefit cost	U.S. Plans Non-U.S. Plans 2021 2020 2019 2021 2020 2019 Discount rate 2.58 % 3.34 % 4.38 % 2.84 % 3.55 % 4.33 % Expected long-term return on plan assets 4.10 5.30 5.30 3.37 3.81 4.37 Rate of compensation increase 4.26 4.21 4.31 3.54 3.68 3.63 Cash balance interest crediting rate 3.76 4.16 4.49 — — —
Schedule of weighted average asset allocation	U.S. Plans Non-U.S. Plans Asset Category 2021 2020 2021 2020 Equity securities 14 % 20 % 18 % 18 % Debt securities 85 79 57 58 Cash and other 1 1 25 24 Total 100 % 100 % 100 % 100 %
Schedule of fair values of the company's plan assets, by asset category and level	Fair Value Measurements at December 31, 2021 NAV Level 1 Level 2 Total (in millions) 2021 2020 2021 2020 2021 2020 2021 2020 U.S. Plans: Equity index: U.S. a $ — $ — $ — $ — $ 37 $ 45 $ 37 $ 45 International b — — — — 22 44 22 44 Fixed income index: Long bond c — — — — 179 276 179 276 Long government bond d — — — — 109 69 109 69 Other (e) 69 — — — — — 69 — Cash (f) — — — — 4 5 4 5 Total U.S. Plans $ 69 $ — $ — $ — $ 351 $ 439 $ 420 $ 439 Non-U.S. Plans: Equity index: U.S. a $ — $ — $ — $ — $ 26 $ 26 $ 26 $ 26 International b — — — — 17 19 17 19 Fixed income index: Short bond (g) — — — — 34 31 34 31 Intermediate bond (h) — — — — 45 38 45 38 Long bond (i) — — — — 93 106 93 106 Other (j) — — — — 21 26 21 26 Cash (f) — — 8 3 — — 8 3 Total Non-U.S. Plans $ — $ — $ 8 $ 3 $ 236 $ 246 $ 244 $ 249 (a) This category consists of both passively and actively managed equity index funds that track the return of large capitalization U.S. equities. (b) This category consists of both passively and actively managed equity index funds that track an index of returns on international developed market equities. (c) This category consists of an actively managed fixed income index fund that invests in a diversified portfolio of fixed-income corporate securities with maturities generally exceeding 10 years . (d) This category consists of an actively managed fixed income index fund that invests in a diversified portfolio of fixed-income U.S. treasury securities with maturities generally exceeding 10 years . (e) This category consists of an actively managed common collective fund that invests in government bonds, collateralized mortgage obligations, investment grade private credit and real estate debt. This fund is priced monthly at the aggregated market value of the underlying investments and can be redeemed with 95 days notification. (f) This category represents cash or cash equivalents. (g) This category consists of both passively and actively managed fixed income index funds that track the return of short-duration government and investment grade corporate bonds. (h) This category consists of both passively and actively managed fixed income index funds that track the return of intermediate duration government and investment grade corporate bonds. (i) This category consists of both passively and actively managed fixed income index funds that track the return of government bonds and investment grade corporate bonds. (j) This category mainly consists of investment products provided by insurance companies that offer returns that are subject to a minimum guarantee and mutual funds.
Schedule of benefit payments, which reflect anticipated future service, as appropriate and are expected to be made	(in millions) U.S. Plans Non-U.S. Plans 2022 23 12 2023 24 13 2024 24 13 2025 23 13 2026 25 13 Years 2027 - 2031 125 72
Postemployment Retirement Benefits
Pension and other postretirement benefits
Schedule of funded status	(in millions) 2021 2020 Accumulated postretirement benefit obligation At January 1 $ 68 $ 69 Service cost 1 — Interest cost 2 3 Amendments 4 — Actuarial (gain) loss (5) 4 Benefits paid (4) (5) Foreign currency translation (1) (3) At December 31 65 68 Fair value of plan assets — — Funded status $ (65) $ (68)
Schedule of amounts recognized in the consolidated balance sheets	(in millions) 2021 2020 Current liabilities $ (4) $ (4) Non-current liabilities (61) (64) Net liability recognized $ (65) $ (68)
Schedule of amounts recognized in accumulated other comprehensive loss	(in millions) 2021 2020 Net actuarial loss $ 8 $ 17 Prior service cost 5 — Net amount recognized $ 13 $ 17
Components of net periodic benefit cost	(in millions) 2021 2020 2019 Service cost $ 1 $ — $ 1 Interest cost 2 3 3 Amortization of actuarial loss 1 1 — Amortization of prior service credit (2) (2) (2) Net periodic benefit cost $ 2 $ 2 $ 2
Schedule of amounts recorded in other comprehensive income and net periodic benefit cost	(in millions, pre-tax) 2021 2020 2019 Net actuarial loss (gain) $ (5) $ 4 $ 6 Prior service cost 4 — — Amortization of prior service credit 2 2 2 Amortization of actuarial loss (1) (1) — Foreign currency translation (4) — — Total recorded in other comprehensive income (4) 5 8 Net periodic benefit cost 2 2 2 Total recorded in other comprehensive income and net periodic benefit cost $ (2) $ 7 $ 10
Schedule of weighted average assumptions used to determine the company's obligations	2021 2020 Discount rate 4.22 % 3.69 %
Schedule of weighted average assumptions used to determine the company's net periodic benefit cost	2021 2020 2019 Discount rate 3.69 % 4.42 % 5.49 %
Schedule of assumptions made in measuring the company's postretirement benefit obligation	U.S. Canada Brazil 2021 increase in per capita cost 6.00 % 5.74 % 7.79 % Ultimate trend 4.50 % 4.00 % 7.79 % Year ultimate trend reached 2032 2040 2021
Schedule of benefit payments, which reflect anticipated future service, as appropriate and are expected to be made	(in millions) 2022 $ 4 2023 4 2024 4 2025 4 2026 4 Years 2027 - 2031 21

Equity (Tables)

Equity (Tables)	12 Months Ended
Equity (Tables)	Dec. 31, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Schedule of reconciliation of common stock share activity	(Shares of common stock, in thousands) Issued Held in Treasury Outstanding Balance at December 31, 2018 77,811 11,285 66,526 Issuance of restricted stock units as compensation — (105) 105 Performance shares and other share-based awards — (5) 5 Stock options exercised — (182) 182 Purchase/acquisition of treasury stock — — — Balance at December 31, 2019 77,811 10,993 66,818 Issuance of restricted stock units as compensation — (69) 69 Performance shares and other share-based awards — (5) 5 Stock options exercised — (124) 124 Purchase/acquisition of treasury stock — — — Balance at December 31, 2020 77,811 10,795 67,016 Issuance of restricted stock units as compensation — (69) 69 Performance shares and other share-based awards — (6) 6 Stock options exercised — (331) 331 Purchase/acquisition of treasury stock — 765 (765) Balance at December 31, 2021 77,811 11,154 66,657
Schedule of stock based compensation expense	(in millions) 2021 2020 2019 Stock options: Pre-tax compensation expense $ 3 $ 4 $ 3 Income tax benefit — — — Stock option expense, net of income taxes 3 4 3 Restricted stock units ("RSUs"): Pre-tax compensation expense 12 12 10 Income tax benefit (1) (1) (2) RSUs, net of income taxes 11 11 8 Performance shares and other share-based awards: Pre-tax compensation expense 8 7 5 Income tax benefit (1) (1) — Performance shares and other share-based compensation expense, net of income taxes 7 6 5 Total share-based compensation: Pre-tax compensation expense 23 23 18 Income tax benefit (2) (2) (2) Total share-based compensation expense, net of income taxes $ 21 $ 21 $ 16
Schedule of valuation assumptions for stock options	For the Year Ended December 31, 2021 2020 2019 Expected life (in years) 5.5 5.5 5.5 Risk-free interest rate 0.6 % 1.4 % 2.5 % Expected volatility 23.2 % 19.8 % 19.7 % Expected dividend yield 2.9 % 2.9 % 2.7 %
Schedule of stock option transactions	Number of Options (in thousands) Weighted Average Exercise Price per Share Average Remaining Contractual Term (Years) Aggregate Intrinsic Value (in millions) Outstanding as of December 31, 2020 2,238 $ 86.55 5.15 $ 14 Granted 358 87.12 Exercised (331) 62.05 Cancelled (111) 91.39 Outstanding as of December 31, 2021 2,154 $ 90.39 5.26 $ 26 Exercisable as of December 31, 2021 1,591 $ 91.21 4.09 $ 21
Schedule of additional information pertaining to stock option activity	Year Ended December 31, (dollars in millions, except per share) 2021 2020 2019 Weighted average grant date fair value of stock options granted (per share) $ 12.31 $ 11.48 $ 14.02 Total intrinsic value of stock options exercised 10 5 10
Summary of net changes in accumulated other comprehensive loss	(in millions) Cumulative Translation Adjustment Hedging Activities Pension and Postretirement Adjustment AOCL Balance, December 31, 2018 $ (1,080) (5) (69) (1,154) Other comprehensive (loss) income before reclassification adjustments (9) (19) 11 (17) Amount reclassified from accumulated OCL — 14 — 14 Tax benefit (provision) — 1 (2) (1) Net other comprehensive (loss) income (9) (4) 9 (4) Balance, December 31, 2019 (1,089) (9) (60) (1,158) Other comprehensive (loss) income before reclassification adjustments (25) 5 (2) (22) Amount reclassified from accumulated OCL — 65 — 65 Tax (provision) benefit — (19) 1 (18) Net other comprehensive (loss) income (25) 51 (1) 25 Balance, December 31, 2020 $ (1,114) $ 42 $ (61) $ (1,133) Other comprehensive (loss) gain before reclassification adjustments (100) 218 28 146 Loss (gain) reclassified from accumulated OCL 311 (209) — 102 Tax (provision) — (3) (9) (12) Net other comprehensive income 211 6 19 236 Balance, December 31, 2021 $ (903) $ 48 $ (42) $ (897)
Schedule of basic and diluted earnings per common share	2021 2020 2019 Net Income Weighted Per Net Income Weighted Per Net Income Weighted Per Available Average Share Available Average Share Available Average Share (in millions, except per share amounts) to Ingredion Shares Amount to Ingredion Shares Amount to Ingredion Shares Amount Basic EPS $ 117 67.1 $ 1.74 $ 348 67.2 $ 5.18 $ 413 66.9 $ 6.17 Effect of Dilutive Securities: Incremental shares from assumed exercise of dilutive stock options and vesting of dilutive RSUs and other awards 0.7 0.4 0.5 Diluted EPS $ 117 67.8 $ 1.73 $ 348 67.6 $ 5.15 $ 413 67.4 $ 6.13
RSU \| Employee
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Schedule of restricted unit activity	Weighted Number of Average Restricted Fair Value (shares in thousands) Shares per Share Non-vested at December 31, 2020 418 $ 96.45 Granted 239 87.79 Vested (95) 121.80 Cancelled (76) 89.52 Non-vested at December 31, 2021 486 $ 88.34

Segment Information (Tables)

Segment Information (Tables)	12 Months Ended
Segment Information (Tables)	Dec. 31, 2021
Segment Information
Schedule of segment reporting of net sales, operating income and total assets	(in millions) 2021 2020 2019 Net sales to unaffiliated customers: North America $ 4,137 $ 3,662 $ 3,834 South America 1,057 919 960 Asia-Pacific 997 813 823 EMEA 703 593 592 Total net sales $ 6,894 $ 5,987 $ 6,209 Presented below is Ingredion’s operating income by reportable segment for the years indicated: (in millions) 2021 2020 2019 Operating income: North America $ 487 $ 487 $ 522 South America 138 112 96 Asia-Pacific 87 80 87 EMEA 106 102 99 Corporate (133) (122) (99) Subtotal 685 659 705 Acquisition/integration costs (3) (11) (3) Restructuring/impairment charges (47) (93) (57) Impairment on disposition of assets (340) - - Other matters 15 27 19 Total operating income $ 310 $ 582 $ 664 Presented below are Ingredion’s total assets by reportable segment as of December 31, 2021 and 2020: As of December 31, (in millions) 2021 2020 Assets: North America (a) $ 4,203 $ 4,231 South America 799 818 Asia-Pacific 1,403 1,255 EMEA 594 554 Total assets $ 6,999 $ 6,858 (a) For purposes of presentation, North America includes Corporate assets. Presented below are Ingredion’s depreciation and amortization, mechanical stores expense and capital expenditures and mechanical stores purchases by reportable segment: (in millions) 2021 2020 2019 Depreciation and amortization: North America (a) $ 146 $ 147 $ 146 South America 18 19 22 Asia-Pacific 40 32 37 EMEA 16 15 15 Total $ 220 $ 213 $ 220 Mechanical stores expense (b) : North America (a) $ 43 $ 39 $ 40 South America 6 7 10 Asia-Pacific 3 4 4 EMEA 3 4 3 Total $ 55 $ 54 $ 57 Capital expenditures and mechanical stores purchases: North America (a) $ 166 $ 243 $ 226 South America 38 39 45 Asia-Pacific 81 46 40 EMEA 15 12 17 Total $ 300 $ 340 $ 328 (a) North America includes Corporate activities. (b) Represents costs for spare parts used in the production process that are recorded in PP&E as part of machinery and equipment until they are utilized in the manufacturing process and expensed as a period cost.
Schedule of net sales to unaffiliated customers by country of origin	Net Sales (in millions) 2021 2020 2019 U.S. $ 2,509 $ 2,284 $ 2,368 Mexico 1,170 984 1,075 Brazil 586 447 479 Canada 459 393 390 Korea 323 268 270 Others 1,847 1,611 1,627 Total $ 6,894 $ 5,987 $ 6,209
Schedule of long-lived assets (excluding intangible assets) by country	Long-lived Assets (in millions) 2021 2020 U.S. $ 1,317 $ 1,276 Mexico 320 342 Canada 272 245 Brazil 189 202 Thailand 156 165 Germany 135 137 China 128 52 Others 423 423 Total $ 2,940 $ 2,842

Supplementary Information (Tabl

Supplementary Information (Tables)	12 Months Ended
Supplementary Information (Tables)	Dec. 31, 2021
Supplementary Information
Schedule of accounts receivable, net	(in millions) 2021 2020 Accounts receivable — trade $ 950 $ 855 Accounts receivable — other 193 170 Allowance for credit losses (13) (14) Total accounts receivable $ 1,130 $ 1,011
Schedule of inventories	(in millions) 2021 2020 Finished and in process $ 688 $ 584 Raw materials 380 236 Manufacturing supplies 104 97 Total inventories $ 1,172 $ 917
Schedule of PP&E	(in millions) 2021 2020 Land $ 206 $ 207 Buildings 812 802 Machinery and equipment 4,637 4,621 Property, plant and equipment, at cost 5,655 5,630 Accumulated depreciation (3,232) (3,175) Property, plant and equipment, net $ 2,423 $ 2,455
Schedule of accrued liabilities	(in millions) 2021 2020 Compensation-related costs $ 105 $ 96 Current lease liabilities 47 46 Dividends payable 44 43 Taxes payable other than income taxes 44 44 Other accrued liabilities 190 192 Total accrued liabilities $ 430 $ 421
Schedule of other non-current liabilities	(in millions) 2021 2020 Deferred tax liabilities $ 165 $ 217 Non-current operating lease liabilities 154 136 Pension and postretirement liabilities 123 139 Other 82 88 Total other non-current liabilities $ 524 $ 580
Schedule of supplemental cash flow information	(in millions) 2021 2020 2019 Interest paid $ 72 $ 78 $ 80 Income taxes paid 168 120 145
Schedule of quarterly financial data	(in millions, except per share amounts) 1 st QTR (b) 2 nd QTR (c) 3 rd QTR (d) 4 th QTR (e) 2021 Net sales $ 1,614 $ 1,762 $ 1,763 $ 1,755 Gross profit 351 367 323 290 Net income attributable to Ingredion (246) 178 118 67 Basic earnings per common share of Ingredion (3.66) 2.65 1.76 1.00 Diluted earnings per common share of Ingredion (3.66) 2.62 1.75 0.99 Per share dividends declared $ 0.64 $ 0.64 $ 0.65 $ 0.65 (in millions, except per share amounts) 1 st QTR (e) 2 nd QTR (f) 3 rd QTR (g) 4 th QTR (h) 2020 Net sales $ 1,543 $ 1,349 $ 1,502 $ 1,593 Gross profit 323 271 326 352 Net income attributable to Ingredion 75 66 92 115 Basic earnings per common share of Ingredion 1.12 0.98 1.37 1.71 Diluted earnings per common share of Ingredion 1.11 0.98 1.36 1.70 Per share dividends declared $ 0.63 $ 0.63 $ 0.64 $ 0.64 (a) All items in the footnotes below are presented after-tax unless otherwise noted. (b) In the first quarter of 2021, Ingredion recorded $360 million in held for sale impairment charges related to the Arcor joint venture with no income tax benefit, $8 million in net restructuring costs, $3 million in charges for tax matters and $1 million in acquisition/integration costs. (c) In the second quarter of 2021, Ingredion recorded $32 million in income for tax matters, $10 million in other matters income, $4 million in acquisition/integration costs, $3 million in equity method acquisition benefits and $2 million in net restructuring costs. (d) In the third quarter of 2021, Ingredion recorded a $20 million favorable adjustment to the impairment charges related to the Arcor joint venture with no income tax expense, $7 million in net restructuring costs, $4 million in acquisition/integration costs and $4 million in charges for tax matters. (e) In the fourth quarter of 2021, Ingredion recorded $19 million in net restructuring and impairment costs, $12 million in benefits for other matters, $5 million in benefits for fair value adjustments to equity investments, $4 million in charges for tax matters and $1 million in net acquisition/integration costs. (f) In the first quarter of 2020, Ingredion recorded $11 million in net restructuring costs. (g) In the second quarter of 2020, Ingredion recorded $8 million in net restructuring costs and $2 million in acquisition/integration costs. (h) In the third quarter of 2020, Ingredion recorded $15 million in net restructuring costs, $6 million in charges for other tax matters, $4 million in acquisition/integration costs, $4 million in charges for early extinguishment of debt, $3 million in charges for fair value markup of acquired inventory and $2 million in North America storm damage costs. (i) In the fourth quarter of 2020, Ingredion recorded $40 million in net restructuring and impairment costs, $27 million in income for other matters, $4 million in acquisition/integration costs, $3 million in income for other tax matters, $1 million in charges for fair value markup of acquired inventory and $1 million in North America storm damage costs.

Description of the Business a_3

Description of the Business and Summary of Significant Accounting Policies - Property, plant and equipment and definite-lived intangible (Details)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Property, plant and equipment and depreciation
Useful life, Definite-lived intangible assets	17 years	17 years
Minimum
Property, plant and equipment and depreciation
Useful life, Definite-lived intangible assets	2 years
Maximum
Property, plant and equipment and depreciation
Useful life, Definite-lived intangible assets	30 years
Building \| Minimum
Property, plant and equipment and depreciation
Useful life, PP&E	25 years
Building \| Maximum
Property, plant and equipment and depreciation
Useful life, PP&E	50 years
Other Capitalized Property Plant and Equipment \| Minimum
Property, plant and equipment and depreciation
Useful life, PP&E	2 years
Other Capitalized Property Plant and Equipment \| Maximum
Property, plant and equipment and depreciation
Useful life, PP&E	25 years

Description of the Business a_4

Description of the Business and Summary of Significant Accounting Policies - Indefinite-lived intangible assets and Goodwill (Details) $ in Millions	Jul. 01, 2021USD ($)
Impairment
Goodwill impairment	$ 0
Indefinite-lived intangible assets impairment	$ 0

Acquisitions - KaTech (Details)

Acquisitions - KaTech (Details) - USD ($) $ in Millions	Apr. 01, 2021	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Acquisitions
Payment for acquisition, net of cash acquired		$ 40	$ 236	$ 42
Goodwill		$ 914	$ 902
KaTech
Acquisitions
Payment for acquisition, net of cash acquired	$ 40
Goodwill	26
Tangible assets	$ 14
Lag period over which financial results will be reported during the integration process	1 month

Acquisitions - Verdient (Detail

Acquisitions - Verdient (Details) $ in Millions, $ in Millions	Nov. 03, 2020USD ($)	Nov. 03, 2020CAD ($)	Dec. 31, 2021USD ($)	Dec. 31, 2020USD ($)	Dec. 31, 2019USD ($)	Nov. 02, 2021
Acquisitions
Payment for acquisition, net of cash acquired			$ 40	$ 236	$ 42
Goodwill			$ 914	$ 902
Verdient Foods, Inc.
Acquisitions
Ownership percentage						20.00%
Verdient Foods, Inc.
Acquisitions
Additional percentage of outstanding shares acquired	80.00%			80.00%
Payment for acquisition, net of cash acquired	$ 26	$ 33
Goodwill	15
Tangible assets	$ 14

Acquisitions - PureCircle (Deta

Acquisitions - PureCircle (Details) - USD ($) $ in Millions	Jul. 01, 2020	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Acquisitions
Payment for acquisition, net of cash acquired		$ 40	$ 236	$ 42
Goodwill and identifiable intangible assets		$ 1,348	$ 1,346
PureCircle Limited
Acquisitions
Ownership percentage by parent	75.00%
PureCircle Limited \| Former PureCircle Shareholders
Acquisitions
Ownership percentage by noncontrolling owners	25.00%
PureCircle Limited
Acquisitions
Payment for acquisition, net of cash acquired	$ 208
Cash acquired	$ 14

Acquisitions - Purchase price a

Acquisitions - Purchase price and Integration costs (Details) - USD ($) $ in Millions	Jul. 01, 2020	Mar. 01, 2019	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Purchase price allocation
Goodwill			$ 914	$ 902
Payment for acquisition, net of cash acquired			40	236	$ 42
Pre-tax acquisition and integration costs			5	$ 11	$ 3
PureCircle Limited
Purchase price allocation
Working capital (excluding cash)			68
Property, plant and equipment			91
Other, net			(33)
Identifiable intangible assets			68
Goodwill			88
Total fair value, net of cash			282
Less: Non-redeemable non-controlling interests			74
Total purchase price, net of cash			208
Payment for acquisition, net of cash acquired	$ 208
PureCircle Limited \| Proprietary technology
Purchase price allocation
Identifiable intangible assets			$ 32
Estimated useful life			12 years
PureCircle Limited \| Tradenames
Purchase price allocation
Identifiable intangible assets			$ 18
Estimated useful life			15 years
PureCircle Limited \| Customer relationships
Purchase price allocation
Identifiable intangible assets			$ 18
Estimated useful life			12 years
Western Polymer
Purchase price allocation
Payment for acquisition, net of cash acquired		$ 42

Intangible Assets - Goodwill (D

Intangible Assets - Goodwill (Details) - USD ($) $ in Millions	Jul. 01, 2021	Dec. 31, 2021	Dec. 31, 2020
Carrying value of goodwill
Goodwill before impairment charges			$ 1,057
Accumulated impairment charges			(155)
Balance at the beginning of the period		$ 902
Acquisitions		17
Currency translation		(5)
Balance at the end of the period		914
Goodwill impairment	$ 0
North America Segment
Carrying value of goodwill
Goodwill before impairment charges			622
Accumulated impairment charges			(1)
Balance at the beginning of the period		621
Acquisitions		2
Balance at the end of the period		623
South America Segment
Carrying value of goodwill
Goodwill before impairment charges			50
Accumulated impairment charges			(33)
Balance at the beginning of the period		17
Currency translation		(2)
Balance at the end of the period		15
Asia Pacific Segment
Carrying value of goodwill
Goodwill before impairment charges			316
Accumulated impairment charges			(121)
Balance at the beginning of the period		195
Acquisitions		6
Currency translation		1
Balance at the end of the period		202
EMEA Segment
Carrying value of goodwill
Goodwill before impairment charges			$ 69
Balance at the beginning of the period		69
Acquisitions		9
Currency translation		(4)
Balance at the end of the period		$ 74

Intangible Assets - Other intan

Intangible Assets - Other intangible assets (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Gross
Total other intangible assets, Gross	$ 687	$ 673
Accumulated Amortization	(253)	(229)
Net
Total other intangible assets, Net	$ 434	$ 444
Weighted Average Useful Life (years)	17 years	17 years
Patents
Gross
Finite-lived intangible assets, Gross	$ 33	$ 33
Accumulated Amortization	(4)	(2)
Net
Finite-Lived Intangible Assets, Net	$ 29	$ 31
Weighted Average Useful Life (years)	12 years	12 years
Customer relationships
Gross
Finite-lived intangible assets, Gross	$ 365	$ 356
Accumulated Amortization	(134)	(115)
Net
Finite-Lived Intangible Assets, Net	$ 231	$ 241
Weighted Average Useful Life (years)	19 years	20 years
Technology
Gross
Finite-lived intangible assets, Gross	$ 103	$ 103
Accumulated Amortization	(101)	(101)
Net
Finite-Lived Intangible Assets, Net	$ 2	$ 2
Weighted Average Useful Life (years)	9 years	9 years
Other
Gross
Finite-lived intangible assets, Gross	$ 43	$ 38
Accumulated Amortization	(14)	(11)
Net
Finite-Lived Intangible Assets, Net	$ 29	$ 27
Weighted Average Useful Life (years)	15 years	19 years
Trademarks and Trade Names
Gross
Indefinite-lived intangible assets	$ 143	$ 143
Net
Indefinite-lived intangible assets, Net	$ 143	$ 143

Intangible Assets - Amortizatio

Intangible Assets - Amortization expense (Details) - USD ($) $ in Millions	Jul. 01, 2021	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Intangible Assets
Amortization expense		$ 27	$ 30	$ 29
Indefinite-lived intangible assets impairment	$ 0
Intangible asset amortization expense for the next five years
2022		27
2023		26
2024		26
2025		26
2026		$ 25

Investments (Details)

Investments (Details) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
Investments
Equity investments	$ 16	$ 8
Equity method investments	104	10
Marketable securities	12	11
Total investments	$ 132	$ 29

Investments - Amyris & Arcor jo

Investments - Amyris & Arcor joint venture (Details) $ in Millions	Aug. 02, 2021USD ($)	Jun. 01, 2021USD ($)	Dec. 31, 2021USD ($)	Feb. 12, 2021facility
Equity Method Investments
Transaction costs			$ 6
Arcor joint venture
Equity Method Investments
Number of manufacturing facilities to be operated \| facility				5
Amyris joint venture
Equity Method Investments
Ownership percentage		31.00%
Total consideration under equity method investment agreement		$ 28
Cash consideration		10
Non-exclusive license and other consideration		18
Income from equity method investment agreement		$ 8
Arcor joint venture
Equity Method Investments
Fair value of assets and liabilities transferred	$ 71
Ownership percentage	49.00%
Value of shares received as consideration for assets contributed	$ 64
Arcor joint venture \| Grupo Arcor
Equity Method Investments
Cash and other considerations received from joint venture in return of assets and liabilities transferred	$ 7

Restructuring and Impairment _3

Restructuring and Impairment Charges - Charges (Details) - USD ($) $ in Millions	3 Months Ended		12 Months Ended
	Sep. 30, 2021	Mar. 31, 2021	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Restructuring and impairment charges
Restructuring/impairment charges and related adjustments			$ 387	$ 93	$ 57
Impairment on disposition of assets	$ (20)	$ 360	340
Impairment charges				45
Restructuring charges			47	$ 48	57
Arcor joint venture
Restructuring and impairment charges
Impairment on disposition of assets			340
Cost Smart Cost of Sales and SG&A Program
Restructuring and impairment charges
Restructuring charges			$ 44		$ 57

Restructuring and Impairment _4

Restructuring and Impairment Charges - Impairment Charges (Details) - USD ($) $ in Millions	Jul. 01, 2021	Sep. 30, 2021	Mar. 31, 2021	Dec. 31, 2021	Dec. 31, 2020	Nov. 03, 2020
Restructuring and impairment charges
Impairment on disposition of assets		$ (20)	$ 360	$ 340
Indefinite-lived intangible assets impairment	$ 0
Tradenames
Restructuring and impairment charges
Indefinite-lived intangible assets impairment					$ 35
Verdient Foods, Inc.
Restructuring and impairment charges
Additional percentage of outstanding shares acquired					80.00%	80.00%
Arcor joint venture
Restructuring and impairment charges
Impairment on disposition of assets				340
Impairment charge - Cumulative translation adjustment				311
Impairment charge - Write-down of contributed net assets				$ 29
Verdient Foods, Inc.
Restructuring and impairment charges
Equity method investment, Other than temporary impairment					$ 10
Disposal Group, Held for Sale, Not Discontinued Operations \| South American Subsidiaries, PP&E
Restructuring and impairment charges
Impairment on disposition of assets		$ (20)	$ 360

Restructuring and Impairment _5

Restructuring and Impairment Charges - Restructuring Charges (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Restructuring Cost and Reserve [Line Items]
Restructuring charges	$ 47	$ 48	$ 57
Cost Smart Cost of Sales and SG&A Program
Restructuring Cost and Reserve [Line Items]
Restructuring charges	44		57
Cost Smart Cost of Sales and SG&A Program \| Employee-related severance costs
Restructuring Cost and Reserve [Line Items]
Restructuring charges	1
Cost Smart SG&A Program
Restructuring Cost and Reserve [Line Items]
Restructuring charges	17	25	28	$ 11
Cost Smart Cost of Sales Program
Restructuring Cost and Reserve [Line Items]
Restructuring charges	27	$ 23	$ 29	$ 49
Arcor joint venture restructuring \| Employee-related severance costs
Restructuring Cost and Reserve [Line Items]
Restructuring charges	$ 1

Restructuring and Impairment _6

Restructuring and Impairment Charges - Employee-related severance (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Restructuring accrual
Restructuring charges	$ 47	$ 48	$ 57
Employee-related severance costs
Restructuring accrual
Balance in severance accrual at beginning of period	12
Payments made to terminated employees	(11)
Balance in severance accrual at end of period	3	$ 12
Cost Smart Cost of Sales and SG&A Program
Restructuring accrual
Restructuring charges	44		$ 57
Cost Smart Cost of Sales and SG&A Program \| Employee-related severance costs
Restructuring accrual
Restructuring charges	1
Arcor joint venture restructuring \| Employee-related severance costs
Restructuring accrual
Restructuring charges	$ 1

Derivatives Instruments and H_3

Derivatives Instruments and Hedging Activities - Commodity price hedging (Details) bu in Millions, MMBTU in Millions	12 Months Ended
	Dec. 31, 2021MMBTUbu	Dec. 31, 2020MMBTUbu
Commodity Contract [Member] \| Minimum
Financial instruments, derivatives and hedging activities
Maturity period of price risk derivative	12 months
Commodity Contract [Member] \| Maximum
Financial instruments, derivatives and hedging activities
Maturity period of price risk derivative	24 months
Corn Commodity [Member]
Financial instruments, derivatives and hedging activities
Futures contract (in bushels for corn and gallons for ethanol) \| bu	135	95
Natural Gas Commodity [Member]
Financial instruments, derivatives and hedging activities
Natural gas futures contract (in mmbtu) \| MMBTU	35	33

Derivatives Instruments and H_4

Derivatives Instruments and Hedging Activities - Foreign currency hedging (Details) - Foreign Exchange Forward [Member] - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
Short [Member] \| Not Designated as Hedging Instrument
Financial instruments, derivatives and hedging activities
Derivative notional amount	$ 360	$ 410
Long [Member] \| Not Designated as Hedging Instrument
Financial instruments, derivatives and hedging activities
Derivative notional amount	205	224
Cash Flow Hedging \| Short [Member] \| Designated as Hedging Instrument [Member]
Financial instruments, derivatives and hedging activities
Derivative notional amount	505	401
Cash Flow Hedging \| Long [Member] \| Designated as Hedging Instrument [Member]
Financial instruments, derivatives and hedging activities
Derivative notional amount	$ 708	$ 542

Derivatives Instruments and H_5

Derivatives Instruments and Hedging Activities - Interest rate hedging (Details) - 4.625% senior notes due November 1, 2020 - USD ($) $ in Millions	1 Months Ended
	Jul. 31, 2020	Jun. 30, 2020
Financial instruments, derivatives and hedging activities
Amount of debt redeemed	$ 400
Debt, fixed interest rate (as a percent)		4.625%
Fair Value Hedging \| Interest Rate Swap
Financial instruments, derivatives and hedging activities
Principal amount		$ 200

Derivatives Instruments and H_6

Derivatives Instruments and Hedging Activities - CF Hedges in AOCI (Details) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
Accumulated Other Comprehensive Loss.
Accumulated other comprehensive income (loss)	$ (897)	$ (1,133)
Cash Flow Hedging
Accumulated Other Comprehensive Loss.
Accumulated other comprehensive income (loss)	48	42
Cash Flow Hedging \| Commodity Contract [Member]
Accumulated Other Comprehensive Loss.
Accumulated other comprehensive income (loss)	51	47
Tax effect on gains (losses) of derivative instruments	(19)	(16)
Cash Flow Hedging \| Foreign Currency Contracts
Accumulated Other Comprehensive Loss.
Accumulated other comprehensive income (loss)		(1)
Cash Flow Hedging \| Interest Rate Contract [Member]
Accumulated Other Comprehensive Loss.
Accumulated other comprehensive income (loss)	(3)	(4)
Tax effect on gains (losses) of derivative instruments	$ 1	$ 1

Derivatives Instruments and H_7

Derivatives Instruments and Hedging Activities - Balance Sheet Location (Details) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
Designated as Hedging Instrument [Member]
Fair value of derivatives
Fair value of derivative instruments, Assets	$ 67	$ 61
Fair value of derivative instruments, Liabilities	25	18
Fair value of derivative instruments, Net Assets/(Liabilities)	42	43
Designated as Hedging Instrument [Member] \| Accounts Receivable, Net [Member]
Fair value of derivatives
Fair value of derivative instruments, Assets	54	57
Designated as Hedging Instrument [Member] \| Other assets
Fair value of derivatives
Fair value of derivative instruments, Assets	13	4
Designated as Hedging Instrument [Member] \| Accounts Payable and Accrued Liabilities [Member]
Fair value of derivatives
Fair value of derivative instruments, Liabilities	17	16
Designated as Hedging Instrument [Member] \| Non Current Liabilities [Member]
Fair value of derivatives
Fair value of derivative instruments, Liabilities	8	2
Designated as Hedging Instrument [Member] \| Commodity Contract [Member]
Fair value of derivatives
Fair value of derivative instruments, Assets	52	54
Fair value of derivative instruments, Liabilities	7	6
Fair value of derivative instruments, Net Assets/(Liabilities)	45	48
Designated as Hedging Instrument [Member] \| Commodity Contract [Member] \| Accounts Receivable, Net [Member]
Fair value of derivatives
Fair value of derivative instruments, Assets	45	50
Designated as Hedging Instrument [Member] \| Commodity Contract [Member] \| Other assets
Fair value of derivatives
Fair value of derivative instruments, Assets	7	4
Designated as Hedging Instrument [Member] \| Commodity Contract [Member] \| Accounts Payable and Accrued Liabilities [Member]
Fair value of derivatives
Fair value of derivative instruments, Liabilities	5	4
Designated as Hedging Instrument [Member] \| Commodity Contract [Member] \| Non Current Liabilities [Member]
Fair value of derivatives
Fair value of derivative instruments, Liabilities	2	2
Designated as Hedging Instrument [Member] \| Foreign Exchange Forward [Member]
Fair value of derivatives
Fair value of derivative instruments, Assets	15	7
Fair value of derivative instruments, Liabilities	18	12
Fair value of derivative instruments, Net Assets/(Liabilities)	(3)	(5)
Designated as Hedging Instrument [Member] \| Foreign Exchange Forward [Member] \| Accounts Receivable, Net [Member]
Fair value of derivatives
Fair value of derivative instruments, Assets	9	7
Designated as Hedging Instrument [Member] \| Foreign Exchange Forward [Member] \| Other assets
Fair value of derivatives
Fair value of derivative instruments, Assets	6
Designated as Hedging Instrument [Member] \| Foreign Exchange Forward [Member] \| Accounts Payable and Accrued Liabilities [Member]
Fair value of derivatives
Fair value of derivative instruments, Liabilities	12	12
Designated as Hedging Instrument [Member] \| Foreign Exchange Forward [Member] \| Non Current Liabilities [Member]
Fair value of derivatives
Fair value of derivative instruments, Liabilities	6
Not Designated as Hedging Instrument
Fair value of derivatives
Fair value of derivative instruments, Assets	7	8
Fair value of derivative instruments, Liabilities	7	11
Fair value of derivative instruments, Net Assets/(Liabilities)		(3)
Not Designated as Hedging Instrument \| Accounts Receivable, Net [Member]
Fair value of derivatives
Fair value of derivative instruments, Assets	7	7
Not Designated as Hedging Instrument \| Other assets
Fair value of derivatives
Fair value of derivative instruments, Assets		1
Not Designated as Hedging Instrument \| Accounts Payable and Accrued Liabilities [Member]
Fair value of derivatives
Fair value of derivative instruments, Liabilities	6	9
Not Designated as Hedging Instrument \| Non Current Liabilities [Member]
Fair value of derivatives
Fair value of derivative instruments, Liabilities	1	2
Not Designated as Hedging Instrument \| Commodity Contract [Member]
Fair value of derivatives
Fair value of derivative instruments, Assets	4	3
Fair value of derivative instruments, Liabilities	2	1
Fair value of derivative instruments, Net Assets/(Liabilities)	2	2
Not Designated as Hedging Instrument \| Commodity Contract [Member] \| Accounts Receivable, Net [Member]
Fair value of derivatives
Fair value of derivative instruments, Assets	4	3
Not Designated as Hedging Instrument \| Commodity Contract [Member] \| Accounts Payable and Accrued Liabilities [Member]
Fair value of derivatives
Fair value of derivative instruments, Liabilities	2	1
Not Designated as Hedging Instrument \| Foreign Exchange Forward [Member]
Fair value of derivatives
Fair value of derivative instruments, Assets	3	5
Fair value of derivative instruments, Liabilities	5	10
Fair value of derivative instruments, Net Assets/(Liabilities)	(2)	(5)
Not Designated as Hedging Instrument \| Foreign Exchange Forward [Member] \| Accounts Receivable, Net [Member]
Fair value of derivatives
Fair value of derivative instruments, Assets	3	4
Not Designated as Hedging Instrument \| Foreign Exchange Forward [Member] \| Other assets
Fair value of derivatives
Fair value of derivative instruments, Assets		1
Not Designated as Hedging Instrument \| Foreign Exchange Forward [Member] \| Accounts Payable and Accrued Liabilities [Member]
Fair value of derivatives
Fair value of derivative instruments, Liabilities	4	8
Not Designated as Hedging Instrument \| Foreign Exchange Forward [Member] \| Non Current Liabilities [Member]
Fair value of derivatives
Fair value of derivative instruments, Liabilities	$ 1	$ 2

Derivatives Instruments and H_8

Derivatives Instruments and Hedging Activities - Additional information - CF hedges (Details) - Cash Flow Hedging - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Hedging relationships
Gains (Losses) Recognized in OCL	$ 218	$ 5	$ (19)
Gains (Losses) Reclassified from AOCL into Income	209	(65)	(14)
Commodity Contract [Member]
Hedging relationships
Gains (Losses) Recognized in OCL	218	17	(24)
Gains (Losses) Reclassified from AOCL into Income		(62)	(12)
Commodity Contract [Member] \| Cost of Sales [Member]
Hedging relationships
Gains (Losses) Reclassified from AOCL into Income	211
Foreign Currency Contracts
Hedging relationships
Gains (Losses) Recognized in OCL		(7)	5
Foreign Currency Contracts \| Cost of Sales [Member]
Hedging relationships
Gains (Losses) Reclassified from AOCL into Income		(2)
Foreign Currency Contracts \| Net sales/Cost of sales
Hedging relationships
Gains (Losses) Reclassified from AOCL into Income	(1)
Interest Rate Contract [Member]
Hedging relationships
Gains (Losses) Recognized in OCL		(5)
Interest Rate Contract [Member] \| Net sales/Cost of sales
Hedging relationships
Gains (Losses) Reclassified from AOCL into Income		$ (1)	$ (2)
Interest Rate Contract [Member] \| Financing Costs [Member]
Hedging relationships
Gains (Losses) Reclassified from AOCL into Income	$ (1)

Derivatives Instruments and H_9

Derivatives Instruments and Hedging Activities - Gain (Losses) Recognized in Income (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Hedging relationships
Gains expected to be reclassified into earnings during the next twelve months, net of tax	$ 45
Gains expected to be reclassified into earnings during the next twelve months, income tax effect	$ 16
Fair Value Hedging \| Interest Rate Contract [Member] \| Financing Costs [Member]
Hedging relationships
Gains (losses) recognized in income, Hedging instruments		$ (1)	$ 2
Gains (losses) recognized in income, Hedged item		$ 1	$ (2)

Fair Value Measurements (Detail

Fair Value Measurements (Details) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
Fair value of assets and liabilities
Long-term debt	$ 1,957	$ 1,751
Recurring
Fair value of assets and liabilities
Available for sale securities	12	11
Derivative assets	74	69
Derivative liabilities	32	29
Long-term debt	1,957	1,751
Recurring \| Level 1
Fair value of assets and liabilities
Available for sale securities	12	11
Derivative assets	49	53
Derivative liabilities	22	3
Recurring \| Level 2
Fair value of assets and liabilities
Derivative assets	25	16
Derivative liabilities	10	26
Long-term debt	$ 1,957	$ 1,751

Financing Arrangements - Total

Financing Arrangements - Total debt (Details) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
Financing Arrangements
Total debt	$ 2,046	$ 2,186

Financing Arrangements - Revolv

Financing Arrangements - Revolving credit agreement (Details) $ in Millions	Dec. 31, 2021USD ($)	Jun. 30, 2021USD ($)	Mar. 16, 2021	Dec. 31, 2021USD ($)	Dec. 31, 2021USD ($)	Dec. 31, 2021USD ($)	Dec. 31, 2020USD ($)	Dec. 31, 2019USD ($)	Jul. 27, 2021USD ($)
Long-term debt
Payments on debt						$ 1,690	$ 1,224	$ 1,465
Proceeds from borrowings						1,300	$ 1,550	$ 1,209
Foreign Line of Credit
Long-term debt
Unused operating lines of credit	$ 641			$ 641	$ 641	641
Commercial paper
Long-term debt
Maximum aggregate principal amount									$ 1,000
Average amount of commercial paper outstanding				$ 670
Weighted average interest rate (as a percent)				0.27%
Weighted average maturity				48 days
Short-term borrowings	$ 250			$ 250	$ 250	$ 250
Weighted average interest rate of outstanding balance (as a percent)	0.35%			0.35%	0.35%	0.35%
Weighted average maturity of outstanding balance	40 days
Term loan credit agreement due April 12, 2021
Long-term debt
Payments on debt						$ 380
Term loan credit agreement due April 12, 2021 \| London Interbank Offered Rate (LIBOR)
Long-term debt
Basis spread							0.80%
Amended term loan credit agreement due March 15, 2022
Long-term debt
Proceeds from borrowings					$ 0
Amended term loan credit agreement due March 15, 2022 \| London Interbank Offered Rate (LIBOR)
Long-term debt
Basis spread			0.75%
Revolving credit agreement
Long-term debt
Basis spread		0.35%
Debt instrument term		5 years
Maximum aggregate principal amount		$ 1,000
Maximum leverage ratio		3.5
Minimum ratio of consolidated EBIDTA to consolidated net interest expense		3.5

Financing Arrangements - Carryi

Financing Arrangements - Carrying amount and Fair value (Details) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
Financing Arrangements
Long-term debt	$ 1,738	$ 1,748
Total short-term borrowings	308	438
Total debt	2,046	2,186
Long-term debt, noncurrent, Fair Value	1,957	1,751
Total short-term borrowings, Fair Value	308	438
Total debt, Fair Value	$ 2,265	$ 2,189
2.9% senior notes due June 1, 2030
Financing Arrangements
Debt, interest rate (as a percent)	2.90%	2.90%
Long-term debt	$ 595	$ 594
Long-term debt, noncurrent, Fair Value	$ 619	$ 596
3.2% senior notes due October 1, 2026
Financing Arrangements
Debt, interest rate (as a percent)	3.20%	3.20%
Long-term debt	$ 498	$ 497
Long-term debt, noncurrent, Fair Value	$ 531	$ 500
3.9% senior notes due June 1, 2050
Financing Arrangements
Debt, interest rate (as a percent)	3.90%	3.90%
Long-term debt	$ 390	$ 390
Long-term debt, noncurrent, Fair Value	$ 455	$ 395
6.625% senior notes due April 15, 2037
Financing Arrangements
Debt, interest rate (as a percent)	6.625%	6.625%
Long-term debt	$ 253	$ 253
Long-term debt, noncurrent, Fair Value	350	246
Other long-term borrowings
Financing Arrangements
Long-term debt	2	14
Long-term debt, noncurrent, Fair Value	2	14
Term loan credit agreement due April 12, 2021
Financing Arrangements
Long-term debt, current		380
Long-term debt, current, Fair Value		380
Commercial paper
Financing Arrangements
Short-term borrowings	250
Short-term borrowings, Fair Value	250
Other Short-term Borrowings [Member]
Financing Arrangements
Short-term borrowings	58	58
Short-term borrowings, Fair Value	$ 58	$ 58

Financing Arrangements - Maturi

Financing Arrangements - Maturities (Details) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
Financing Arrangements
Guaranteed obligations of consolidated subsidiaries	$ 61	$ 58

Leases - Lease costs (Details)

Leases - Lease costs (Details) - USD ($) $ in Millions	12 Months Ended
Leases - Lease costs (Details) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Lease Cost
Operating lease cost	$ 58	$ 58	$ 55
Variable operating lease cost	26	29	24
Short term lease cost	4	4	3
Lease cost	$ 88	$ 91	$ 82

Leases - Operating lease reconc

Leases - Operating lease reconciliation (Details) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
Reconciliation of future undiscounted cash flows to the operating lease liabilities and the related ROU assets
2022	$ 52
2023	43
2024	33
2025	24
2026	19
Thereafter	52
Total future lease payments	223
Less imputed interest	22
Present value of future lease payments	$ 201
Operating Lease, Liability, Statement of Financial Position	Accrued liabilities, Other
Less current lease liabilities	$ 47	$ 46
Operating Lease, Liability, Current, Statement of Financial Position	Accrued liabilities	Accrued liabilities
Non-current operating lease liabilities	$ 154	$ 136
Operating Lease, Liability, Noncurrent, Statement of Financial Position	Other non-current liabilities	Other non-current liabilities
Operating lease assets	$ 193
Operating Lease, Right-of-Use Asset, Statement of Financial Position	Other assets

Leases - Other Information (Det

Leases - Other Information (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Other information
Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows from operating leases	$ 58	$ 60
Right-of-use assets obtained in exchange for lease liabilities: Operating leases	$ 77	$ 76
Weighted average remaining lease term (years): Operating leases	6 years 6 months	5 years 6 months
Weighted average discount rate: Operating leases	4.00%	4.90%

Income Taxes - Provision for in

Income Taxes - Provision for income taxes (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Income (loss) before income taxes:
U.S.	$ 39	$ (15)	$ 74
Foreign	209	521	508
Income before income taxes	248	506	582
Current tax expense:
U.S. federal	2	1	6
State and local	2	2	2
Foreign	180	156	147
Total current tax expense	184	159	155
Deferred tax expense (benefit):
U.S. federal	(57)	(18)	(8)
State and local	(2)	(1)
Foreign	(2)	12	11
Total deferred tax expense (benefit)	(61)	(7)	3
Total provision for income taxes	$ 123	$ 152	$ 158

Income Taxes - Deferred taxes (

Income Taxes - Deferred taxes (Details) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
Deferred tax assets attributable to:
Employee benefit accruals	$ 28	$ 20
Pension and postretirement plans	14	21
Lease liabilities	49	44
Bad debt	14	2
Inventory reserve	13	9
Net operating loss carryforwards	64	32
Tax credit carryforwards	18	11
Other	36	43
Total deferred tax assets	236	182
Valuation allowance	(67)	(30)
Net deferred tax assets	169	152
Deferred tax liabilities attributable to:
Property, plant and equipment	175	173
Identified intangibles	47	46
Right-of-use lease assets	46	42
Foreign withholding and state taxes on unremitted earnings	1	31
Goodwill	27	20
Brazilian indirect tax credits	5	18
Derivative contracts	19	16
Total deferred tax liabilities	320	346
Net deferred tax liabilities	$ 151	$ 194

Income Taxes - Operating loss c

Income Taxes - Operating loss carryforwards (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Operating losses
Net operating loss carryforwards	$ 64	$ 32
Net operating loss carryforwards, federal	5
Net operating loss carryforwards, state	14
Net operating loss carryforwards, foreign	45
Canada
Operating losses
Net operating loss carryforwards, foreign	$ 17
Foreign carryforward period (in years)	20 years
Argentina
Operating losses
Net operating loss carryforwards, foreign	$ 9
Foreign carryforward period (in years)	5 years
Australia
Operating losses
Net operating loss carryforwards, foreign	$ 8

Income Taxes - Tax credit carry

Income Taxes - Tax credit carryforward valuation allowance (Details) $ in Millions	12 Months Ended
	Dec. 31, 2021USD ($)
Tax credit carryforward valuation allowance
Valuation allowance on foreign subsidiaries net deferred tax assets	$ 9
Increase in foreign net operating loss carryforwards	11
Federal
Tax credit carryforward valuation allowance
Loss carryforwards, valuation allowance	5
State
Tax credit carryforward valuation allowance
Loss carryforwards, valuation allowance	14
Credit carryforwards, valuation allowance	6
Foreign
Tax credit carryforward valuation allowance
Loss carryforwards, valuation allowance	32
Credit carryforwards, valuation allowance	$ 1

Income Taxes - Reconciliation o

Income Taxes - Reconciliation of effective tax rate (Details) - USD ($) $ in Millions	3 Months Ended		12 Months Ended
	Sep. 30, 2021	Mar. 31, 2021	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Reconciliation of effective tax rate
Provision for tax at statutory rate (as a percent)			21.00%	21.00%	21.00%
Tax rate difference on foreign income (as a percent)			13.30%	9.10%	6.20%
Foreign currency FX (as a percent)			3.20%	1.20%	(0.20%)
Inflation adjustments (as a percent)			(4.00%)	(0.80%)	(0.30%)
Tax benefit of intercompany financing (as a percent)			(1.60%)	(0.80%)	(1.20%)
U.S. international tax implications (as a percent)			0.80%	0.60%	2.20%
Valuation allowance in Argentina (as a percent)			(0.40%)	(0.60%)	0.30%
Favorable judgement on the treatment of credits and interest on indirect taxes (as a percent)			(4.80%)	(0.60%)
Unremitted earnings (as a percent)			(12.10%)
Impairment charge related to Accor joint venture (as a percent)			35.50%
Other items - net (as a percent)			(1.30%)	0.90%	(0.90%)
Provision at effective tax rate (as a percent)			49.60%	30.00%	27.10%
Tax impact, Favorable judgement on the treatment of credits and interest on indirect taxes (in dollars)			$ (12)
Impairment on disposition of assets (in dollars)	$ (20)	$ 360	340
Tax expense (benefit) on impairment (in dollars)			0
Tax impact, Unremitted earnings (in dollars)			(30)
Accrual for foreign withholding on unremitted earnings from foreign subsidiaries (in dollars)			1
Tax provision on distributions of unremitted earnings (in dollars)			0
Unremitted earnings of foreign subsidiaries considered permanently reinvested (in dollars)			$ 2,200
Mexico
Reconciliation of effective tax rate
Provision for tax at statutory rate (as a percent)			30.00%
Pakistan
Reconciliation of effective tax rate
Provision for tax at statutory rate (as a percent)			29.00%
Colombia
Reconciliation of effective tax rate
Provision for tax at statutory rate (as a percent)			31.00%
Brazil
Reconciliation of effective tax rate
Provision for tax at statutory rate (as a percent)			34.00%

Income Taxes - Unrecognized tax

Income Taxes - Unrecognized tax benefits (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Taxes
Balance at beginning of period	$ 46	$ 22
Additions for tax positions related to prior years	2	33
Reductions for tax positions related to prior years	(9)
Additions based on tax positions related to the current year	2
Reductions related to a lapse in the statute of limitations	(12)	(9)
Balance at end of period	29	$ 46
Unrecognized tax benefit that, if recognized, could affect the effective tax rate in future periods	18
Remaining unrecognized tax benefits	11
Unrecognized tax benefits, accrued interest expense and penalties	3
Amount of unrecognized tax benefits that may be recognized within 12	0
Unrecognized tax benefits, current	$ 0

Pension and Other Postretirem_3

Pension and Other Postretirement Benefits - Pension Obligation and Funded Status (Details) - Pension Plan - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
UNITED STATES
Benefit obligation
Balance at the beginning of the period	$ 409	$ 387
Service cost	4	5	$ 5
Interest cost	8	11	14
Benefits paid	(24)	(23)
Actuarial (gain) loss	(14)	29
Balance at the end of the period	383	409	387
Fair value of plan assets
Balance at the beginning of the period	439	408
Actual return on plan assets	4	53
Employer contributions	1	1
Benefits paid	(24)	(23)
Balance at the end of the period	420	439	408
Funded status	37	30
Non-US
Benefit obligation
Balance at the beginning of the period	275	254
Service cost	4	4	3
Interest cost	9	10	10
Benefits paid	(13)	(12)
Actuarial (gain) loss	(15)	14
Curtailment / settlement / amendments	(1)
Foreign currency translation	(5)	5
Balance at the end of the period	254	275	254
Fair value of plan assets
Balance at the beginning of the period	249	231
Actual return on plan assets	3	22
Employer contributions	7	4
Benefits paid	(13)	(12)
Plan settlements	(1)
Foreign currency translation	(1)	4
Balance at the end of the period	244	249	$ 231
Funded status	$ (10)	$ (26)

Pension and Other Postretirem_4

Pension and Other Postretirement Benefits - Pension amounts recognized (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Amounts recognized in the Consolidated Balance Sheets
Non-current liabilities	$ (123)	$ (139)
Pension Plan
Amounts recognized in accumulated other comprehensive loss, excluding tax effects, that have not yet been recognized as components of net periodic benefit cost
Accumulated benefit obligation	619	664
Pension Plan \| UNITED STATES
Amounts recognized in the Consolidated Balance Sheets
Non-current asset	47	41
Current liabilities	(1)	(1)
Non-current liabilities	(9)	(10)
Net asset (liability) recognized	37	30
Amounts recognized in accumulated other comprehensive loss, excluding tax effects, that have not yet been recognized as components of net periodic benefit cost
Net actuarial loss	11	12
Prior service cost	(4)	(5)
Net amount recognized	7	7
Information about plan obligations and assets for plans with an accumulated benefit obligation in excess of plan assets
Projected benefit obligation	(10)	(11)
Accumulated benefit obligation	(9)	(10)
Components of net periodic benefit cost
Service cost	4	5	$ 5
Interest cost	8	11	14
Expected return on plan assets	(17)	(21)	(18)
Amortization of actuarial loss			1
Amortization of prior service credit	(1)	(1)	(1)
Net periodic benefit cost	(6)	(6)	1
Amounts recorded in other comprehensive income and net periodic benefit cost
Net actuarial (gain) loss	(1)	(3)	(25)
Amortization of actuarial loss			(1)
Amortization of prior service credit	1	1	1
Total recorded in other comprehensive income		(2)	(25)
Net periodic benefit cost	(6)	(6)	1
Total recorded in other comprehensive income and net periodic benefit cost	(6)	(8)	(24)
Pension Plan \| Non-US
Amounts recognized in the Consolidated Balance Sheets
Non-current asset	44	36
Current liabilities	(1)	(1)
Non-current liabilities	(53)	(61)
Net asset (liability) recognized	(10)	(26)
Amounts recognized in accumulated other comprehensive loss, excluding tax effects, that have not yet been recognized as components of net periodic benefit cost
Net actuarial loss	38	61
Transition obligation		1
Net amount recognized	38	62
Information about plan obligations and assets for plans with an accumulated benefit obligation in excess of plan assets
Projected benefit obligation	(57)	(81)
Accumulated benefit obligation	(48)	(70)
Fair value of plan assets	3	19
Components of net periodic benefit cost
Service cost	4	4	3
Interest cost	9	10	10
Expected return on plan assets	(8)	(8)	(8)
Amortization of actuarial loss	2	2	2
Net periodic benefit cost	7	8	7
Amounts recorded in other comprehensive income and net periodic benefit cost
Net actuarial (gain) loss	(11)	1	7
Prior service cost			1
Amortization of actuarial loss	(2)	(2)	(2)
Foreign currency translation	(11)
Total recorded in other comprehensive income	(24)	(1)	6
Net periodic benefit cost	7	8	7
Total recorded in other comprehensive income and net periodic benefit cost	$ (17)	$ 7	$ 13

Pension and Other Postretirem_5

Pension and Other Postretirement Benefits - Pension assumptions (Details) - Pension Plan	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
UNITED STATES
Weighted average assumptions used to determine the company's obligations
Discount rate (as a percent)	2.91%	2.58%
Rate of compensation increase (as a percent)	4.18%	4.26%
Cash balance interest crediting rate (as a percent)	4.11%	3.76%
Weighted average assumptions used to determine the company's net periodic benefit cost
Discount rate (as a percent)	2.58%	3.34%	4.38%
Expected long-term return on plan assets (as a percent)	4.10%	5.30%	5.30%
Rate of compensation increase (as a percent)	4.26%	4.21%	4.31%
Cash balance interest crediting rate (as a percent)	3.76%	4.16%	4.49%
Non-US
Weighted average assumptions used to determine the company's obligations
Discount rate (as a percent)	3.47%	2.84%
Rate of compensation increase (as a percent)	3.67%	3.54%
Weighted average assumptions used to determine the company's net periodic benefit cost
Discount rate (as a percent)	2.84%	3.55%	4.33%
Expected long-term return on plan assets (as a percent)	3.37%	3.81%	4.37%
Rate of compensation increase (as a percent)	3.54%	3.68%	3.63%
CANADA
Weighted average assumptions used to determine the company's net periodic benefit cost
Expected long-term return on plan assets (as a percent)	3.06%

Pension and Other Postretirem_6

Pension and Other Postretirement Benefits - Pension plan asset weighted average asset allocation (Details) - Pension Plan	Dec. 31, 2021	Dec. 31, 2020
UNITED STATES
Weighted average asset allocation
Weighted average asset allocation (as a percent)	100.00%	100.00%
UNITED STATES \| Equity securities
Weighted average asset allocation
Weighted average asset allocation (as a percent)	14.00%	20.00%
UNITED STATES \| Equity securities \| Minimum
Plan assets
Plan assets allocation percentage	9.00%
UNITED STATES \| Equity securities \| Maximum
Plan assets
Plan assets allocation percentage	19.00%
UNITED STATES \| Debt securities - Fixed income
Weighted average asset allocation
Weighted average asset allocation (as a percent)	85.00%	79.00%
UNITED STATES \| Debt securities - Fixed income \| Minimum
Plan assets
Plan assets allocation percentage	81.00%
UNITED STATES \| Debt securities - Fixed income \| Maximum
Plan assets
Plan assets allocation percentage	91.00%
UNITED STATES \| Cash and other
Weighted average asset allocation
Weighted average asset allocation (as a percent)	1.00%	1.00%
Non-US
Weighted average asset allocation
Weighted average asset allocation (as a percent)	100.00%	100.00%
Non-US \| Equity securities
Weighted average asset allocation
Weighted average asset allocation (as a percent)	18.00%	18.00%
Non-US \| Debt securities - Fixed income
Weighted average asset allocation
Weighted average asset allocation (as a percent)	57.00%	58.00%
Non-US \| Cash and other
Weighted average asset allocation
Weighted average asset allocation (as a percent)	25.00%	24.00%

Pension and Other Postretirem_7

Pension and Other Postretirement Benefits - Pension plan assets by category and FV (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Fixed income index - Long government bond
Plan assets
Redemption notification period	95 days
Pension Plan \| UNITED STATES
Plan assets
Fair value of plan assets	$ 420	$ 439	$ 408
Pension Plan \| UNITED STATES \| Equity index - U.S.
Plan assets
Fair value of plan assets	37	45
Pension Plan \| UNITED STATES \| Equity index - International
Plan assets
Fair value of plan assets	22	44
Pension Plan \| UNITED STATES \| Fixed income index- Long bond
Plan assets
Fair value of plan assets	$ 179	$ 276
Pension Plan \| UNITED STATES \| Fixed income index- Long bond \| Minimum
Plan assets
Fixed income securities maturity (in years)	10 years	10 years
Pension Plan \| UNITED STATES \| Fixed income index - Long government bond
Plan assets
Fair value of plan assets	$ 109	$ 69
Pension Plan \| UNITED STATES \| Fixed income index - Long government bond \| Minimum
Plan assets
Fixed income securities maturity (in years)	10 years	10 years
Pension Plan \| UNITED STATES \| Other.
Plan assets
Fair value of plan assets	$ 69
Pension Plan \| UNITED STATES \| Cash
Plan assets
Fair value of plan assets	4	$ 5
Pension Plan \| UNITED STATES \| NAV
Plan assets
Fair value of plan assets	69
Pension Plan \| UNITED STATES \| NAV \| Other.
Plan assets
Fair value of plan assets	69
Pension Plan \| UNITED STATES \| Level 2
Plan assets
Fair value of plan assets	351	439
Pension Plan \| UNITED STATES \| Level 2 \| Equity index - U.S.
Plan assets
Fair value of plan assets	37	45
Pension Plan \| UNITED STATES \| Level 2 \| Equity index - International
Plan assets
Fair value of plan assets	22	44
Pension Plan \| UNITED STATES \| Level 2 \| Fixed income index- Long bond
Plan assets
Fair value of plan assets	179	276
Pension Plan \| UNITED STATES \| Level 2 \| Fixed income index - Long government bond
Plan assets
Fair value of plan assets	109	69
Pension Plan \| UNITED STATES \| Level 2 \| Cash
Plan assets
Fair value of plan assets	4	5
Pension Plan \| Non-US
Plan assets
Fair value of plan assets	244	249	$ 231
Pension Plan \| Non-US \| Equity index - U.S.
Plan assets
Fair value of plan assets	26	26
Pension Plan \| Non-US \| Equity index - International
Plan assets
Fair value of plan assets	17	19
Pension Plan \| Non-US \| Fixed income index- Short bond
Plan assets
Fair value of plan assets	34	31
Pension Plan \| Non-US \| Fixed income index - Intermediate bond
Plan assets
Fair value of plan assets	45	38
Pension Plan \| Non-US \| Fixed income index- Long bond
Plan assets
Fair value of plan assets	93	106
Pension Plan \| Non-US \| Other.
Plan assets
Fair value of plan assets	21	26
Pension Plan \| Non-US \| Cash
Plan assets
Fair value of plan assets	8	3
Pension Plan \| Non-US \| Level 1
Plan assets
Fair value of plan assets	8	3
Pension Plan \| Non-US \| Level 1 \| Cash
Plan assets
Fair value of plan assets	8	3
Pension Plan \| Non-US \| Level 2
Plan assets
Fair value of plan assets	236	246
Pension Plan \| Non-US \| Level 2 \| Equity index - U.S.
Plan assets
Fair value of plan assets	26	26
Pension Plan \| Non-US \| Level 2 \| Equity index - International
Plan assets
Fair value of plan assets	17	19
Pension Plan \| Non-US \| Level 2 \| Fixed income index- Short bond
Plan assets
Fair value of plan assets	34	31
Pension Plan \| Non-US \| Level 2 \| Fixed income index - Intermediate bond
Plan assets
Fair value of plan assets	45	38
Pension Plan \| Non-US \| Level 2 \| Fixed income index- Long bond
Plan assets
Fair value of plan assets	93	106
Pension Plan \| Non-US \| Level 2 \| Other.
Plan assets
Fair value of plan assets	$ 21	$ 26

Pension and Other Postretirem_8

Pension and Other Postretirement Benefits - Pension benefit payments (Details) - Pension Plan - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
UNITED STATES
Benefit plans
Employer contributions	$ 1	$ 1
Expected contribution in next fiscal year	1
Expected future benefit payments
2022	23
2023	24
2024	24
2025	23
2026	25
Years 2027 - 2030	125
Non-US
Benefit plans
Employer contributions	7	$ 4
Expected contribution in next fiscal year	3
Expected future benefit payments
2022	12
2023	13
2024	13
2025	13
2026	13
Years 2027 - 2030	$ 72

Pension and Other Postretirem_9

Pension and Other Postretirement Benefits - Defined contribution plans (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Pension and Other Postretirement Benefits
Amounts charged to expense for defined contribution plans	$ 22	$ 22	$ 20

Pension and Other Postretire_10

Pension and Other Postretirement Benefits - Postretirement funded status (Details) - Postemployment Retirement Benefits - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Benefit obligation
Balance at the beginning of the period	$ 68	$ 69
Service cost	1		$ 1
Interest cost	2	3	3
Amendments	4
Actuarial (gain) loss	(5)	4
Benefits paid	(4)	(5)
Foreign currency translation	(1)	(3)
Balance at the end of the period	65	68	$ 69
Funded status	$ (65)	$ (68)

Pension and Other Postretire_11

Pension and Other Postretirement Benefits - Postretirement amounts recognized (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Amounts recognized in the Consolidated Balance Sheets
Non-current liabilities	$ (123)	$ (139)
Postemployment Retirement Benefits
Amounts recognized in the Consolidated Balance Sheets
Current liabilities	(4)	(4)
Non-current liabilities	(61)	(64)
Net asset (liability) recognized	(65)	(68)
Amounts recognized in accumulated other comprehensive loss, excluding tax effects, that have not yet been recognized as components of net periodic benefit cost
Net actuarial loss	8	17
Prior service cost	5
Net amount recognized	13	17
Components of net periodic benefit cost
Service cost	1		$ 1
Interest cost	2	3	3
Amortization of actuarial loss	1	1
Amortization of prior service credit	(2)	(2)	(2)
Net periodic benefit cost	2	2	2
Amounts recorded in other comprehensive income and net periodic benefit cost
Net actuarial loss (gain)	(5)	4	6
Prior service cost	4
Amortization of prior service credit	2	2	2
Amortization of actuarial loss	(1)	(1)
Foreign currency translation	(4)
Total recorded in other comprehensive income	(4)	5	8
Net periodic benefit cost	2	2	2
Total recorded in other comprehensive income and net periodic benefit cost	$ (2)	$ 7	$ 10

Pension and Other Postretire_12

Pension and Other Postretirement Benefits - Postretirement assumptions and trends (Details) - Postemployment Retirement Benefits	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Weighted average assumptions used to determine the company's obligations
Discount rate (as a percent)	4.22%	3.69%
Weighted average assumptions used to determine the company's net periodic benefit cost
Discount rate (as a percent)	3.69%	4.42%	5.49%
UNITED STATES
Assumptions used in measuring benefit obligation
2021 increase in per capita cost (as a percent)	6.00%
Ultimate trend (as a percent)	4.50%
Year ultimate trend reached	2032
CANADA
Assumptions used in measuring benefit obligation
2021 increase in per capita cost (as a percent)	5.74%
Ultimate trend (as a percent)	4.00%
Year ultimate trend reached	2040
BRAZIL
Assumptions used in measuring benefit obligation
2021 increase in per capita cost (as a percent)	7.79%
Ultimate trend (as a percent)	7.79%
Year ultimate trend reached	2021

Pension and Other Postretire_13

Pension and Other Postretirement Benefits - Postretirement benefit payments (Details) - Postemployment Retirement Benefits $ in Millions	Dec. 31, 2021USD ($)
Expected future benefit payments
2022	$ 4
2023	4
2024	4
2025	4
2026	4
Years 2027 - 2031	$ 21

Pension and Other Postretire_14

Pension and Other Postretirement Benefits - Multiemployer Plans (Details) $ in Millions	12 Months Ended
	Dec. 31, 2021USD ($)item	Dec. 31, 2020USD ($)	Dec. 31, 2019USD ($)
Multiemployer Plans
Multiemployer benefit plan that company contributes to \| item	1
Multiemployer Plan, Pension, Significant, Employer Contribution Exceeds Five Percent [true false]	false
Multiemployer plan contributions \| $	$ 14	$ 14	$ 13

Equity - Preferred stock (Detai

Equity - Preferred stock (Details) - $ / shares	Dec. 31, 2021	Dec. 31, 2020
Preferred stock:
Preferred stock, authorized (in shares)	25,000,000	25,000,000
Preferred stock, par value (in dollars per share)	$ 0.01	$ 0.01
Preferred stock, issued (in shares)	0	0
Preferred stock, outstanding (in shares)	0	0

Equity - Treasury stock (Detail

Equity - Treasury stock (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Millions	Feb. 06, 2019	Feb. 05, 2019	Nov. 05, 2018	Dec. 31, 2021	Dec. 31, 2019	Oct. 22, 2018
Additional Paid-in Capital
Treasury stock:
Repurchases of common stock (in dollars)					$ (32)
Treasury Stock
Treasury stock:
Purchase/acquisition of treasury stock (in shares)				765
Repurchases of common stock (in dollars)				$ 68	$ (31)
ASR agreement
Treasury stock:
Payment made for repurchase of shares			$ 455
Purchase/acquisition of treasury stock (in shares)	4,000		4,000
Repurchases of common stock (in dollars)	$ 392		$ 423
VWAP (in dollars per share)		$ 98.04
Amount of cash returned from upfront payment in repurchase of stock		$ 63
2018 Stock Repurchase Program
Treasury stock:
Shares authorized to be repurchased (in shares)						8,000

Equity - Share activity (Detail

Equity - Share activity (Details) - shares shares in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Increase (decrease) in common stock, number of shares
Balance at beginning of period (in shares)	67,016	66,818	66,526
Stock options exercised	331	124	182
Purchase/acquisition of treasury stock (in shares)	(765)
Balance at end of period (in shares)	66,657	67,016	66,818
RSU \| Employee
Increase (decrease) in common stock, number of shares
Issuance of share-based awards (in shares)	69	69	105
Performance shares and other share-based awards
Increase (decrease) in common stock, number of shares
Issuance of share-based awards (in shares)	6	5	5
Common Stock
Increase (decrease) in common stock, number of shares
Balance at beginning of period (in shares)	77,811	77,811	77,811
Balance at end of period (in shares)	77,811	77,811	77,811
Treasury Stock
Increase (decrease) in common stock, number of shares
Balance at beginning of period (in shares)	10,795	10,993	11,285
Stock options exercised	(331)	(124)	(182)
Purchase/acquisition of treasury stock (in shares)	765
Balance at end of period (in shares)	11,154	10,795	10,993
Treasury Stock \| RSU \| Employee
Increase (decrease) in common stock, number of shares
Issuance of share-based awards (in shares)	(69)	(69)	(105)
Treasury Stock \| Performance shares and other share-based awards
Increase (decrease) in common stock, number of shares
Issuance of share-based awards (in shares)	(6)	(5)	(5)

Equity - Share-based payments (

Equity - Share-based payments (Details) - USD ($) shares in Millions, $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Share-based compensation expense
Pre-tax compensation expense	$ 23	$ 23	$ 18
Income tax benefit	(2)	(2)	(2)
Total share-based compensation expense, net of income taxes	$ 21	21	16
Stock Incentive Plan
Shares authorized under Stock Incentive Plan	8
Additional shares authorized under Stock Incentive Plan	2.5
Shares available for future grants under Stock Incentive Plan	3.8
Employee Stock Option [Member]
Share-based compensation expense
Pre-tax compensation expense	$ 3	4	3
Total share-based compensation expense, net of income taxes	3	4	3
RSU \| Employee
Share-based compensation expense
Pre-tax compensation expense	12	12	10
Income tax benefit	(1)	(1)	(2)
Total share-based compensation expense, net of income taxes	11	11	8
Performance shares and other share-based awards
Share-based compensation expense
Pre-tax compensation expense	8	7	5
Income tax benefit	(1)	(1)
Total share-based compensation expense, net of income taxes	$ 7	$ 6	$ 5

Equity - Stock options (Details

Equity - Stock options (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Assumptions used to measure the fair value of awards
Expected life	5 years 6 months	5 years 6 months	5 years 6 months
Risk-free interest rate (as a percent)	0.60%	1.40%	2.50%
Expected volatility (as a percent)	23.20%	19.80%	19.70%
Expected dividend yield (as a percent)	2.90%	2.90%	2.70%
Stock options, Number of Options
Outstanding at the beginning of the period (in shares)	2,238
Granted (in shares)	358	336	247
Exercised (in shares)	(331)	(124)	(182)
Cancelled (in shares)	(111)
Outstanding at the end of the period (in shares)	2,154	2,238
Exercisable at the end of the period (in shares)	1,591
Stock options, Weighted Average Exercise Price per Share
Outstanding at the beginning of the period (in dollars per share)	$ 86.55
Granted (in dollars per share)	87.12
Exercised (in dollars per share)	62.05
Cancelled (in dollars per share)	91.39
Outstanding at the end of the period (in dollars per share)	90.39	$ 86.55
Exercisable at the end of the period (in dollars per share)	$ 91.21
Additional information pertaining to stock options
Average Remaining Contractual Term, Outstanding	5 years 3 months 3 days	5 years 1 month 24 days
Average Remaining Contractual Term, Exercisable	4 years 1 month 2 days
Aggregate Intrinsic Value, Outstanding (in dollars)	$ 26	$ 14
Aggregate Intrinsic Value, Exercisable (in dollars)	21
Cash received from exercise of stock options	$ 21	$ 6	$ 6
Weighted average grant date fair value of stock options granted (per share)	$ 12.31	$ 11.48	$ 14.02
Total intrinsic value of stock options exercised	$ 10	$ 5	$ 10
Employee Stock Option [Member]
Share-based compensation
Term of award	10 years
Period of vesting	3 years
Additional information pertaining to stock options
Unrecognized compensation cost	$ 2
Weighted-average period for amortization of unrecognized compensation cost	1 year 8 months 12 days

Equity - Restricted stock units

Equity - Restricted stock units (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Other disclosures
Share-based payments subject to redemption	$ 36	$ 30	$ 31	$ 37
RSU \| Employee
Share-based compensation
Vesting terms	3 years
Restricted stock unit activity
Non-vested at the beginning of the period (in shares)	418
Granted (in shares)	239
Vested (in shares)	(95)
Cancelled (in shares)	(76)
Non-vested at the end of the period (in shares)	486	418
Weighted-average fair value per share
Non-vested at the beginning of the period (in dollars per share)	$ 96.45
Granted (in dollars per share)	87.79
Vested (in dollars per share)	121.80
Cancelled (in dollars per share)	89.52
Non-vested at the end of the period (in dollars per share)	$ 88.34	$ 96.45
Other disclosures
Fair value of awards vested during the year	$ 12	$ 17	$ 16
Unrecognized compensation cost	$ 17
Weighted-average period for amortization of unrecognized compensation cost	1 year 9 months 18 days
Share-based payments subject to redemption	$ 25	$ 23

Equity - Performance shares (De

Equity - Performance shares (Details) $ / shares in Units, shares in Thousands, $ in Millions	12 Months Ended
	Dec. 31, 2021USD ($)item$ / sharesshares	Dec. 31, 2020USD ($)item$ / sharesshares	Dec. 31, 2019USD ($)$ / sharesshares	Dec. 31, 2018USD ($)
Share-based compensation
Share-based payments subject to redemption	$ 36	$ 30	$ 31	$ 37
Performance Shares
Share-based compensation
Vesting terms			3 years
Number of tranches \| item	2	2
Granted (in shares) \| shares	108	81	70
Weighted-average fair value per share, Granted (in dollars per share) \| $ / shares	$ 100.29	$ 94.48	$ 92.57
Cancelled (in shares) \| shares	27
Unrecognized compensation cost	$ 7
Remaining requisite service period (in years)	1 year 10 months 24 days
Share-based payments subject to redemption	$ 11	$ 7
Performance shares, vesting based on TSR
Share-based compensation
Vesting terms	3 years
Percentage of share-based compensation award	50.00%	50.00%
Performance shares calculation period (in years)	3 years
Performance shares, vesting based on TSR \| Minimum
Share-based compensation
Performance shares available for vesting (as a percent)	100.00%
Performance shares, vesting based on TSR \| Maximum
Share-based compensation
Performance shares available for vesting (as a percent)	200.00%
Performance shares, vesting based on Adjusted ROIC
Share-based compensation
Vesting terms	3 years
Percentage of share-based compensation award	50.00%	50.00%
Performance shares calculation period (in years)	3 years	3 years
Performance shares, vesting based on Adjusted ROIC \| Minimum
Share-based compensation
Performance shares available for vesting (as a percent)	0.00%
Performance shares, vesting based on Adjusted ROIC \| Maximum
Share-based compensation
Performance shares available for vesting (as a percent)	200.00%
2018 Awards \| Performance Shares
Share-based compensation
Award pay out achieved (as a percent)	0.00%
2019 Awards \| Performance Shares
Share-based compensation
Estimated pay out (as a percent)	0.00%
2021 Awards \| Performance Shares
Share-based compensation
Number of award segments \| item	2
2021 Award, Segment Two \| Performance shares, vesting based on Adjusted ROIC
Share-based compensation
Percentage of share-based compensation award	100.00%

Equity - Other share-based awar

Equity - Other share-based awards under the SIP (Details) - USD ($) shares in Thousands, $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Other share-based awards under the SIP
Amount of Directors' retainer paid in stock	$ 130
Percentage of additional Directors' retainer paid in stock	50.00%
Total share-based compensation expense included in net income	$ 23,000	$ 23,000	$ 18,000
RSU \| Director
Other share-based awards under the SIP
Minimum period over which deferred shares may be transferred after director's termination of service	6 months
Total share-based compensation expense included in net income	$ 2,000	$ 2,000	$ 1,000
Awards outstanding (in shares)	253
Carrying value of share units outstanding	$ 17,000

Equity - AOCL (Details)

Equity - AOCL (Details) - USD ($) $ in Millions	12 Months Ended
Equity - AOCL (Details) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Accumulated Other Comprehensive Loss
Balance at the beginning of the period	$ 2,951
Balance at the end of the period	3,100	$ 2,951
Accumulated Translation Adjustment [Member]
Accumulated Other Comprehensive Loss
Balance at the beginning of the period	(1,114)	(1,089)	$ (1,080)
Other comprehensive gain (loss) before reclassification adjustments	(100)	(25)	(9)
(Gain) reclassified from accumulated OCL	311
Net other comprehensive income (loss)	211	(25)	(9)
Balance at the end of the period	(903)	(1,114)	(1,089)
Hedging Activities
Accumulated Other Comprehensive Loss
Balance at the beginning of the period	42	(9)	(5)
Other comprehensive gain (loss) before reclassification adjustments	218	5	(19)
(Gain) reclassified from accumulated OCL	(209)	65	14
Tax (provision) benefit	(3)	(19)	1
Net other comprehensive income (loss)	6	51	(4)
Balance at the end of the period	48	42	(9)
Accumulated Defined Benefit Plans Adjustment [Member]
Accumulated Other Comprehensive Loss
Balance at the beginning of the period	(61)	(60)	(69)
Other comprehensive gain (loss) before reclassification adjustments	28	(2)	11
Tax (provision) benefit	(9)	1	(2)
Net other comprehensive income (loss)	19	(1)	9
Balance at the end of the period	(42)	(61)	(60)
Accumulated Other Comprehensive Income (Loss)
Accumulated Other Comprehensive Loss
Balance at the beginning of the period	(1,133)	(1,158)	(1,154)
Other comprehensive gain (loss) before reclassification adjustments	146	(22)	(17)
(Gain) reclassified from accumulated OCL	102	65	14
Tax (provision) benefit	(12)	(18)	(1)
Net other comprehensive income (loss)	236	25	(4)
Balance at the end of the period	$ (897)	$ (1,133)	$ (1,158)

Equity - EPS (Details)

Equity - EPS (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions	3 Months Ended								12 Months Ended
	Dec. 31, 2021	Sep. 30, 2021	Jun. 30, 2021	Mar. 31, 2021	Dec. 31, 2020	Sep. 30, 2020	Jun. 30, 2020	Mar. 31, 2020	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Basic EPS:
Net Income Available to Ingredion - basic									$ 117	$ 348	$ 413
Weighted average number of shares outstanding, basic									67.1	67.2	66.9
Basic earnings per common share of Ingredion (in dollars per share)	$ 1	$ 1.76	$ 2.65	$ (3.66)	$ 1.71	$ 1.37	$ 0.98	$ 1.12	$ 1.74	$ 5.18	$ 6.17
Effect of Dilutive Securities:
Incremental shares from assumed exercise of dilutive stock options and vesting of dilutive RSUs and other awards									0.7	0.4	0.5
Diluted EPS:
Net Income Available to Ingredion - diluted									$ 117	$ 348	$ 413
Weighted average number of shares outstanding - diluted, Total									67.8	67.6	67.4
Diluted earnings per common share of Ingredion (in dollars per share)	$ 0.99	$ 1.75	$ 2.62	$ (3.66)	$ 1.70	$ 1.36	$ 0.98	$ 1.11	$ 1.73	$ 5.15	$ 6.13
Antidilutive securities excluded in calculation of diluted EPS:
Antidilutive securities excluded from computation of earnings per share amount									0.9	1.7	1.1

Segment Information - Net sales

Segment Information - Net sales and operating income (Details) - USD ($) $ in Millions	3 Months Ended								12 Months Ended
	Dec. 31, 2021	Sep. 30, 2021	Jun. 30, 2021	Mar. 31, 2021	Dec. 31, 2020	Sep. 30, 2020	Jun. 30, 2020	Mar. 31, 2020	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Segment information
Net sales	$ 1,755	$ 1,763	$ 1,762	$ 1,614	$ 1,593	$ 1,502	$ 1,349	$ 1,543	$ 6,894	$ 5,987	$ 6,209
Operating income Subtotal									685	659	705
Acquisition / integration costs									(3)	(11)	(3)
Restructuring/impairment charges									(47)	(93)	(57)
Impairment on disposition of assets		$ 20		$ (360)					(340)
Other matters									15	27	19
Operating income									310	582	664
North America Segment
Segment information
Net sales									4,137	3,662	3,834
South America Segment
Segment information
Net sales									1,057	919	960
Asia Pacific Segment
Segment information
Net sales									997	813	823
EMEA Segment
Segment information
Net sales									703	593	592
Operating Segments [Member] \| North America Segment
Segment information
Operating income Subtotal									487	487	522
Operating Segments [Member] \| South America Segment
Segment information
Operating income Subtotal									138	112	96
Operating Segments [Member] \| Asia Pacific Segment
Segment information
Operating income Subtotal									87	80	87
Operating Segments [Member] \| EMEA Segment
Segment information
Operating income Subtotal									106	102	99
Corporate, Non-Segment [Member]
Segment information
Operating income Subtotal									$ (133)	$ (122)	$ (99)

Segment Information - Assets (D

Segment Information - Assets (Details) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
Segment information
Total assets	$ 6,999	$ 6,858
North America Segment [Member]
Segment information
Total assets	4,203	4,231
South America Segment [Member]
Segment information
Total assets	799	818
Asia Pacific Segment [Member]
Segment information
Total assets	1,403	1,255
EMEA Segment [Member]
Segment information
Total assets	$ 594	$ 554

Segment Information - Depreciat

Segment Information - Depreciation, store expense and capital expenditures (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Segment information
Depreciation and amortization	$ 220	$ 213	$ 220
Mechanical stores expense	55	54	57
Capital expenditures and mechanical stores purchases	300	340	328
North America Segment
Segment information
Depreciation and amortization	146	147	146
Mechanical stores expense	43	39	40
Capital expenditures and mechanical stores purchases	166	243	226
South America Segment
Segment information
Depreciation and amortization	18	19	22
Mechanical stores expense	6	7	10
Capital expenditures and mechanical stores purchases	38	39	45
Asia Pacific Segment
Segment information
Depreciation and amortization	40	32	37
Mechanical stores expense	3	4	4
Capital expenditures and mechanical stores purchases	81	46	40
EMEA Segment
Segment information
Depreciation and amortization	16	15	15
Mechanical stores expense	3	4	3
Capital expenditures and mechanical stores purchases	$ 15	$ 12	$ 17

Segment Information - Sales and

Segment Information - Sales and long-lived assets (Details) - USD ($) $ in Millions	3 Months Ended								12 Months Ended
	Dec. 31, 2021	Sep. 30, 2021	Jun. 30, 2021	Mar. 31, 2021	Dec. 31, 2020	Sep. 30, 2020	Jun. 30, 2020	Mar. 31, 2020	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Segment information
Net sales	$ 1,755	$ 1,763	$ 1,762	$ 1,614	$ 1,593	$ 1,502	$ 1,349	$ 1,543	$ 6,894	$ 5,987	$ 6,209
Long-lived assets	2,940				2,842				2,940	2,842
U.S.
Segment information
Net sales									2,509	2,284	2,368
Long-lived assets	1,317				1,276				1,317	1,276
Mexico
Segment information
Net sales									1,170	984	1,075
Long-lived assets	320				342				320	342
Canada
Segment information
Net sales									459	393	390
Long-lived assets	272				245				272	245
Brazil
Segment information
Net sales									586	447	479
Long-lived assets	189				202				189	202
Thailand
Segment information
Long-lived assets	156				165				156	165
Germany
Segment information
Long-lived assets	135				137				135	137
China
Segment information
Long-lived assets	128				52				128	52
Korea
Segment information
Net sales									323	268	270
Other Countries [Member]
Segment information
Net sales									1,847	1,611	$ 1,627
Long-lived assets	$ 423				$ 423				$ 423	$ 423

Commitments and Contingencies (

Commitments and Contingencies (Details) - USD ($) $ in Millions	1 Months Ended	12 Months Ended
	May 31, 2021	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Commitments and Contingencies
Brazilian indirect tax credits		$ 5	$ 18
Indirect tax credits \| Foreign \| Brazil
Commitments and Contingencies
Brazilian indirect tax credits		5
Indirect tax credits \| Foreign \| Brazil \| Other Assets and Prepaid Expenses
Commitments and Contingencies
Future tax credits		41
Indirect tax credits \| Foreign \| Tax years 2005 - 2018 \| Maximum \| Brazil
Commitments and Contingencies
Amount of indirect tax credits expected to receive				$ 66
Indirect tax credits \| Foreign \| Tax years 2015 - 2018 \| Brazil
Commitments and Contingencies
Amount of indirect tax credits expected to receive	$ 15
Indirect tax credits \| Foreign \| Tax years 2015 - 2018 \| Other operating income, net \| Brazil
Commitments and Contingencies
Foreign pre-tax benefits		$ 15
Indirect tax credits \| Foreign \| Tax years 2005 - 2014 \| Brazil
Commitments and Contingencies
Amount of indirect tax credits expected to receive				22
Indirect tax credits \| Foreign \| Tax years 2005 - 2014 \| Other operating income, net \| Brazil
Commitments and Contingencies
Foreign pre-tax benefits			$ 35	$ 22

Supplementary Information - Acc

Supplementary Information - Accounts Receivable, Net (Details) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
Supplementary Information
Accounts receivable - trade	$ 950	$ 855
Accounts receivable - other	193	170
Allowance for doubtful accounts	(13)	(14)
Total accounts receivable	$ 1,130	$ 1,011

Supplementary Information - Inv

Supplementary Information - Inventories (Details) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
Supplementary Information
Finished and in process	$ 688	$ 584
Raw materials	380	236
Manufacturing supplies and other	104	97
Total inventories	$ 1,172	$ 917

Supplementary Information - PP&

Supplementary Information - PP&E (Details) - USD ($) $ in Millions	3 Months Ended		12 Months Ended
	Sep. 30, 2021	Mar. 31, 2021	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Property, plant and equipment and depreciation
Property, plant and equipment, at cost			$ 5,655	$ 5,630
Accumulated depreciation			(3,232)	(3,175)
Property, plant and equipment, net			2,423	2,455
Amount of interest capitalized to PP&E			4	7	$ 5
Impairment charges				45
Impairment on disposition of assets	$ (20)	$ 360	340
Depreciation expense			194	183	$ 191
Land
Property, plant and equipment and depreciation
Property, plant and equipment, at cost			206	207
Building
Property, plant and equipment and depreciation
Property, plant and equipment, at cost			812	802
Machinery and Equipment
Property, plant and equipment and depreciation
Property, plant and equipment, at cost			$ 4,637	$ 4,621

Supplementary Information - A_2

Supplementary Information - Accrued Liabilities (Details) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
Supplementary Information
Compensation-related costs	$ 105	$ 96
Current lease liabilities	47	46
Dividends payable	44	43
Taxes payable other than income taxes	44	44
Other accrued liabilities	190	192
Total accrued liabilities	$ 430	$ 421
Operating Lease, Liability, Current, Statement of Financial Position	Total accrued liabilities	Total accrued liabilities

Supplementary Information - Oth

Supplementary Information - Other Non-Current Liabilities (Details) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
Non-current liabilities:
Deferred tax liabilities	$ 165	$ 217
Non-current operating lease liabilities	154	136
Pension and postretirement liabilities	123	139
Other	82	88
Total other non-current liabilities	$ 524	$ 580
Operating Lease, Liability, Noncurrent, Statement of Financial Position	Total other non-current liabilities	Total other non-current liabilities

Supplementary Information - Sup

Supplementary Information - Supplemental Income Statements and Cash Flow Information (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Supplemental Income Statements Information
Research and development expense	$ 43	$ 43	$ 44
Supplemental Cash Flow Information
Interest paid	72	78	80
Income taxes paid	$ 168	$ 120	$ 145

Supplementary Information - Qua

Supplementary Information - Quarterly Financial Data (Details) - USD ($) $ / shares in Units, $ in Millions	3 Months Ended								12 Months Ended
	Dec. 31, 2021	Sep. 30, 2021	Jun. 30, 2021	Mar. 31, 2021	Dec. 31, 2020	Sep. 30, 2020	Jun. 30, 2020	Mar. 31, 2020	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Quarterly Financial Data (Unaudited)
Net sales	$ 1,755	$ 1,763	$ 1,762	$ 1,614	$ 1,593	$ 1,502	$ 1,349	$ 1,543	$ 6,894	$ 5,987	$ 6,209
Gross profit	290	323	367	351	352	326	271	323	1,331	1,272	1,312
Net income attributable to Ingredion	$ 67	$ 118	$ 178	$ (246)	$ 115	$ 92	$ 66	$ 75	$ 117	$ 348	$ 413
Basic earnings per common share of Ingredion (in dollars per share)	$ 1	$ 1.76	$ 2.65	$ (3.66)	$ 1.71	$ 1.37	$ 0.98	$ 1.12	$ 1.74	$ 5.18	$ 6.17
Diluted earnings per common share of Ingredion (in dollars per share)	0.99	1.75	2.62	(3.66)	1.70	1.36	0.98	1.11	$ 1.73	$ 5.15	$ 6.13
Dividends declared (in dollars per share)	$ 0.65	$ 0.65	$ 0.64	$ 0.64	$ 0.64	$ 0.64	$ 0.63	$ 0.63

Supplementary Information - Add

Supplementary Information - Additional Quarterly Financial Data (Details) - USD ($) $ in Millions	3 Months Ended								12 Months Ended
	Dec. 31, 2021	Sep. 30, 2021	Jun. 30, 2021	Mar. 31, 2021	Dec. 31, 2020	Sep. 30, 2020	Jun. 30, 2020	Mar. 31, 2020	Dec. 31, 2021
Supplementary Information
Impairment on disposition of assets		$ (20)		$ 360					$ 340
Restructuring charges, after tax		7	$ 2	8		$ 15	$ 8	$ 11
Charges (income) for tax matters, after tax	$ 4	4	(32)	3	$ (3)	6
Acquisition/integration costs, after tax	1	$ 4	4	$ 1	4	4	$ 2
Income for other matters, after tax	12		10		27
Amount of benefit in equity method acquisition charges			$ 3
Restructuring and impairment costs, after tax	19				40
Amount of benefit in after-tax, fair value adjustment to equity investments	$ 5
Extinguishment of debt, after tax						4
Fair value markup of acquired inventory, after tax					1	3
Storm damage cost, after tax					$ 1	$ 2